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  Abstract VIII
ABSTRACT 
PART I: Marine organisms have been a rich source of fascinating halogenated 
natural products. Several brominated sesquiterpenoids have been isolated from the sea hare 
Aplysia dactylomela, which is frequently found in the shallow seawater of tropical and 
subtropical coasts. Interestingly, these compounds appear to originate from the seaweed diet 
of the opistobranch mollusks. A remarkable representative is aplydactone, an unprecedented 
[2]-ladderane natural product, whose isolation reflects the diversity and beauty of 
naturally-occurring frameworks. Moreover, the high density of stereogenic and non-
stereogenic quaternary centers as well as the low decoration with functional groups in 
combination with the intrinsic ring strain of the system renders its total synthesis highly 
challenging and therefore attractive for the synthetic community. 
In a first approach, the non-biomimetic total synthesis of aplydactone was 
investigated relying onto a key photochemical [2+2] cycloaddition for the formation of tricycle 
II in high diastereoselectivity (Scheme A). The required photoprecursor I was synthesized in 
a multi-step sequence from simple starting materials on gram scale which was essential for 
further developments. A photo-induced Wolff ring contraction of an α-diazo ketone, accessed 
via a modified Regitz diazo transfer, allowed for the synthesis of the pivotal 
bicyclo[2.2.0]hexane containing intermediate III. Functional group interconversions led to the 
desired primary iodide IV which cyclized in a Barbier-type ring closure following a substantial 
conformational change of the intermediate lithium organyl species. For the completion of the 
first total synthesis of aplydactone, new radical conditions for the conversion of a 
thiocarbonyl imidazole to the corresponding neopentylic bromide had to be developed. 
 
 
Scheme A. Non-biomimetic total synthesis of aplydactone. 
In a combined synthetic and computational approach, studies on the biosynthetic 
connection of aplydactone led to the synthesis of three additional chamigrane natural 
products from Aplysia dactylomela (Scheme B). Furthermore, 8-epi-isoaplydactone was 
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identified as an anticipated natural product resulting from a photocycloaddition under 
biomimetic conditions. 
Our synthesis commenced with the preparation of the spiro[5.5]undecane core 
structure of the chamigrane carbon skeleton by a Diels–Alder reaction of enone VI and 
isoprene under high pressure conditions. The introduction of a trimethylsilyl group as 
traceless directing element is unprecedented and solved diastereoselectivity issues recently 
reported in the literature. Global deprotection involving a rare Brook rearrangement in 
combination with the developed radical bromination conditions gave access to 
10-bromo-β-chamigrene which was transformed to dactylone and 10-epi-dactylone in 
bioinspired diastereodivergent oxidation sequences. Investigations guided by excited-state 
theory allowed for the biomimetic synthesis of aplydactone via a photochemical [2+2] 
cycloaddition of dactylone that violates the photochemical “rule of five”, first mentioned by 
Srinivasan and Hammond. In contrast, photochemical conversion of 10-epi-dactylone forms 
the less strained bicyclo[2.1.1]hexane structure due to the conformational anchoring by the 
secondary bromide.  
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Scheme B. Biomimetic total synthesis of aplydactone. 
 
PART II: The second part of this thesis describes the investigations on the biomimetic 
total synthesis of merochlorin A and B, two members of a small family of chlorinated 
meroterpenoids isolated from the marine bacterium Streptomyces spectabilis strain 
CNH-189. These efforts, which also aimed for uncovering a possible biosynthetic pathway, 
culminated in the first total synthesis of merochlorin B. 
The synthetic investigations were initiated by a biosynthetic proposal for the isomeric 
members merochlorin A and B based on an oxidative (5+2) or (3+2) cycloaddition, 
respectively, of an intermediate phenoxonium cation. A convergent and scalable synthesis of 
the biomimetic cyclization precursor X involving the tetrahydroxynaphthalene fragment VIII 
X  Abstract 
and the isosesquilavandulyl side chain IX allowed for an in-depth investigation of the 
proposed cyclization step. To this end, the use of an in situ generated derivative of Koser’s 
reagent led to the selective formation of merochlorin B. This approach complements a 
recently reported selective biomimetic synthesis of merochlorin A by the George group which 
described the use of a related precursor. These results demonstrate the significant influence 
of subtle structural changes on the outcome of biomimetic key steps in natural product total 
synthesis.  
 
 
Scheme C. Biomimetic total synthesis of merochlorin B. 
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1 PHOTOCHEMICAL SYNTHESIS 
1.1 A brief historical perspective 
The conversion of an organic compound under irradiation of light represents an 
economical and “green” procedure1 for the formation of organic materials, especially in a 
world of limited resources. The long history of photochemical conversions dates back to 
1834, when Hermann Trommsdorff observed a color change of santonin (1.1) crystals upon 
exposure to sunlight (Scheme 1.1a).2,3 Although a structural identification of the product, 
lumisantonin (1.2), was not feasible in those days, Trommsdorff could demonstrate a 
wavelength dependence for this transformation by selective irradiation with the spectral 
colors of visible light, which he generated with a prism.3 The structural elucidation of 
lumisantonin 1.2 was eventually accomplished by Barton in 1958.4 The mechanism follows a 
di-π-methane-type rearrangement starting from a triplet biradical intermediate of the 
corresponding dienone structure.5 
 
 
Scheme 1.1 Early photochemical transformations of a) santonin (1.1); b) thymoquinone (1.3) and 
cinnamic acid (1.5) and c) carvone (1.7). 
In 1877, Carl Liebermann dimerized thymoquinone (1.3) in the solid state under 
sunlight irradiation in a photochemical [2+2] cycloaddition (Scheme 1.1b).6 Although 
Liebermann suggested an incorrect dimeric structure, this experiment represents a starting 
point for the development of modern organic photochemistry. An analogous dimerization of 
cinnamic acid (1.5) into α-truxillic acid (1.6) was reported by Riiber in 1902.7 Photoinduced 
halogenations and photoreductions of carbonyl compounds were investigated at the same 
time by Schramm8 and Klinger.9 The first intramolecular [2+2] photocycloaddition was 
observed by Ciamician in 1908, when he exposed carvone (1.7) in ethanolic solution to 
Italian sunlight for several months (Scheme 1.1c).10 The obtained photoadduct was identified 
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by Ciamician as carvone camphor (1.8) containing a bicyclo[2.1.1]hexane. Interestingly, the 
corresponding isomeric bicyclo[2.2.0]hexane 1.9 was not obtained in this experiment. The 
favored formation of the regioisomer which contains a five-membered ring in intramolecular 
photochemical [2+2] cycloadditions arising from a triplet biradical pathway was formulated by 
Srinivasan and Hammond in 1967 and is known today as the “rule of five”.11 
In the middle of the 20th century, the chemical community realized the advantages of 
photochemical excitation of organic compounds during the formation of complex structures 
which would be otherwise difficult or impossible to synthesize. The first use of a 
photochemical enone [2+2] cycloaddition in natural product total synthesis in 1963 is 
depicted in Scheme 1.2a.12 
 
 
Scheme 1.2 a) The first photochemical enone [2+2] cycloaddition in natural product total synthesis; b) 
Structures of paeoniflorin (1.17), retigeranic acid (1.18), longifolene (1.19) and merrilactone A (1.20). 
Corey and coworkers reported the stereodivergent synthesis of racemic 
isocaryophyllene (1.15) and caryophyllene (1.16) starting from cyclohexenone (1.10), which 
was transformed into cyclobutane 1.11 upon irradiation with isobutylene at −40 °C. Initially, a 
4:1 mixture of trans- and cis-product was formed. However, basic treatment quantitatively 
converted the mixture into the thermodynamically favored cis-product. It was possible to 
reach intermediate 1.12 within seven steps, which could be selectively transformed to 
isocaryophyllene (1.15) and caryophyllene (1.16) by a Grob fragmentation of tosylates 1.13 
and 1.14 followed by epimerization to the trans-products. The use of photochemical key 
steps in the field of natural product synthesis has culminated in elegant total syntheses, 
exemplified by paeoniflorin (1.17) using a photochemical [2+2] cycloaddition,13 retigeranic 
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acid A (1.18) by applying a meta-photocyclization,14 and longifolene (1.19) using a sequence 
of photocycloaddition/retro-aldol reaction (De Mayo reaction, Scheme 1.2b).15 Furthermore, 
Inoue and coworkers synthesized merrilactone A (1.20) relying on a photochemical [2+2] 
cycloaddition to form a key cyclobutane intermediate which was opened later in the synthesis 
to provide the core structure of 1.20.16 
In the last two decades, the control of stereoselectivity in photochemical reactions by 
catalysis has attracted significant attention from the synthetic community.17 The challenge in 
the realization of such a process is the suppression of racemic background reactions. Bach 
and coworkers reported the enantioselective conversion of prochiral lactam 1.21 into 
cyclobutane 1.23 by irradiation with 300 nm light in the presence of the chiral host 1.24 
(Scheme 1.3).18 Through hydrogen bonding, 1.24 controls the orientation of the allylic side 
chain during the cyclization event, thus providing 1.23 in 93% ee. However, 
superstoichiometric quantities of the chiral host 1.24 were necessary to suppress racemic 
background reactions.  
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Scheme 1.3 Asymmetric [2+2] photocycloaddition of lactams 1.21 and 1.22. 
To overcome this problem, a triplet sensitizer was incorporated into the host structure, 
resulting in xanthone 1.27, which can be excited in the presence of lactam 1.22 and results in 
selective sensitization of host-bound alkene 1.22.19 In this case, a regioisomeric mixture of 
photoadducts 1.25 and 1.26 in 91% ee was obtained in the presence of just 10 mol% of 
xanthone 1.27. In addition, chiral organocatalysts have been used to control the 
stereoselectivity in photochemical [2+2] cycloadditions.20 However, these methods suffer 
from structural restrictions of the starting material and are not broadly applicable.  
The use of visible light in combination with photoredox catalysts has recently gained 
the attention from the synthetic community,21 despite the first use of [Ru(bpy)3]Cl2 (1.220, 
Scheme 1.24b) as a photoredox catalyst in organic synthesis already being reported by 
Kellogg in 1978. Sulfonium ions were reduced to the corresponding alkanes and thioethers 
using N-substituted 1,4-dihydropyridines as the terminal reductant under photomediated 
conditions.22 Interestingly, the full impact of this new type of reactivity was only recognized 
over two decades after the first report by Kellogg, leading to the vibrant field of visible light 
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photoredox catalysis observed in recent years. The general idea behind visible light 
photoredox catalysis is the use of metal complexes or organic dyes which are poor oxidants 
and reductants in their ground state, but possess excited states which show a strong ability 
to start single-electron transfer (SET) events. This opens up the possibility of chemoselective 
transformation without the use of high-energy UV irradiation.  
An exciting example, which combines photoredox and enamine organocatalysis, was 
reported by the MacMillan group for the synthesis of α-trifluoromethylated aldehydes 1.31 
(Scheme 1.4a).23 In the presence of imidazolidinone organocatalyst 1.32, iridium 
photocatalyst 1.33 and trifluoroiodomethane, several aldehydes 1.28 could be converted into 
the corresponding enantioenriched trifluoromethylated aldehydes by attack of a nucleophilic 
enamine intermediate 1.29 onto an electrophilic trifluoromethyl radical 1.30.  
 
 
Scheme 1.4 Recent examples of photoredox catalytic transformations. 
Furthermore, the merger of photoredox and transition metal catalysis allows difficult 
Csp3–Csp2 couplings as exemplified by the work of Molander (Scheme 1.4b).24 The 
secondary alkyl radicals formed from the trifluoroborates 1.34 under photoredox catalytic 
conditions are proposed to form an alkyl-Ni(I) complex 1.36 followed by oxidative addition to 
the aryl halide 1.35. Reductive elimination provides the desired cross-coupled products 1.37.  
In addition to these two selected recent examples, the fascinating field of 
photochemistry and photoredox catalysis seems to undergo a renaissance and the 
continuously growing scope of the reported methods generates high expectations for future 
developments. 
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1.2 Photochemical key steps in the total synthesis of natural 
products 
1.2.1 Biomimetic transformations 
Photochemical key reactions which occur late in the biosynthesis of natural products 
are relatively rare. However, existing examples display the power of these transformations in 
the efficient synthesis of complex structures of high biological activity. The biosynthetic 
formation of the secosteroids vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol 1.41, 
Scheme 1.5) might be the most prominent examples in this class. In the human body, 
vitamin D3 (1.41) upregulates the intestinal absorption of calcium and other ions. This is 
essential for the prevention of rickets, which causes deformation of the bones due to calcium 
deficiency during childhood, among other diseases.25 
 
 
Scheme 1.5 Industrial synthesis of vitamin D3 (1.41) and conversion to calcitriol (1.42) in vertebrates. 
Interestingly, 37.5 tons of vitamin D3 (1.41) are produced annually worldwide, 
particularly for the production of fodder and food additives.26 An industrial synthesis of 1.41 
was reported by Hoffmann–La Roche which applies a semisynthetic route mimicking the 
biosynthesis performed in the skin by irradiation under UV-B light (Scheme 1.5). The 
synthesis starts from cholesterol acetate (1.38), which is brominated in the allylic position 
followed by elimination to give 7-dehydrocholesterol (1.39). Irradiation of this compound with 
UV light yields previtamin D3 (1.40) via a photochemical conrotatory 6π electrocyclic ring 
opening. This intermediate undergoes a thermal antarafacial [1,7]-sigmatropic hydride shift to 
vitamin D3 (1.41). However, the active compound in vertebrates is actually calcitriol (1.42), 
which is formed by hydroxylases in the liver and kidneys by oxidation at C1 and C25.26,27 
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1.2.1.1 Photochemical [2+2] cycloadditions 
Cyclobutanes are fascinating structural motifs that are frequently found in nearly all 
natural product classes. They are either formed by cationic cyclization or by photochemical 
[2+2] cycloaddition.28 Figure 1.1 shows a selection of natural products which are supposedly 
made by inter- or intramolecular [2+2] photocycloaddition, typically by excitation of an enone-
type structure within the biosynthetic precursor due to the ease by which this motif is excited 
by sunlight.29 
 
 
Figure 1.1 Natural products biosynthetically formed by photochemical [2+2] cycloaddition. 
Mechanistically, upon irradiation of an enone structure 1.48, a short-lived singlet state 
(S1), formed by nπ* excitation, decays by intersystem crossing (ISC) to a lower-lying, 
biradical triplet state (1.48 T1, Scheme 1.6).30 In acyclic systems, cis-trans isomerization by 
rotation of the biradical structure can be a competing event leading to reduced intersystem 
crossing and cycloaddition. Therefore, cyclic enone structures are favorable substrates since 
bond rotation cannot occur. The triplet biradical state forms a triplet exciplex 1.50 with a 
ground state alkene 1.49, which is part of the same molecule in the case of intramolecular 
reactions. From this exciplex, a triplet 1,4-biradical 1.51 is generated by the first bond 
formation. Before the formation of the second σ-bond and the closure to cyclobutane 1.52, 
an additional ISC to a singlet 1,4-biradical 1.51 has to occur. 
 
 
Scheme 1.6 General mechanism of enone-alkene [2+2] photocycloadditions. 
Several total syntheses of naturally occurring cyclobutanes were inspired by their 
proposed biosynthetic formation.30c,31 A fascinating example of an intramolecular [2+2] 
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photocycloaddition as a key step in the biosynthesis of a natural product was demonstrated 
by the MacMillan group in their work on the total synthesis of the constituents of Verbena 
littoralis, a perennial herb used in traditional folk medicine (Scheme 1.7a).32 The heptacyclic 
iridoid constituent littoralisone (1.57) was proposed to be biosynthetically derived from 
brasoside (1.58), isolated from the same plant, and coumaric acid (1.59).  
 
 
Scheme 1.7 Biomimetic intramolecular [2+2] photocycloaddition in the total synthesis of a) littoralisone 
(1.57) and b) rhododaurichromanic acid A (1.61) and B (1.62).  
In their synthesis, MacMillan and coworkers were able to synthesize the iridoid core 
structure 1.55 in only seven steps by use of an organocatalyzed intramolecular Michael 
addition. The use of L-proline as catalyst was necessary to overcome the undesired 
substrate-directed trans-selectivity in the cyclization step to give bicycle 1.55. The proposed 
glucose-tethered photoprecursor 1.56 was reached in a five step sequence. Irradiation of 
1.56 with UV-A light provided littoralisone (1.57) selectively in excellent yield after global 
deprotection, thus validating the proposed biosynthesis. An analogous intramolecular 
photocyclization was reported in the total synthesis of rhododaurichromanic acid A (1.61) and 
B (1.62), which could be formed as a separable mixture by the irradiation of 
E-daurichromenic acid methyl ester (1.60), as depicted in Scheme 1.7b. The formation of 
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both epimers in a single step was rationalized by the E/Z-isomerization of the starting 
material 1.60 under irradiation with UV-A light.33  
 However, [2+2]-cycloadditions in the biosynthesis of cyclobutane-containing natural 
products are not limited to intramolecular reactions. Biyouyanagin A (1.72), isolated from the 
leaves of Hypericum chinense L. var. salicifolium, represents an exciting example of how 
substrate control can provide regio- and stereoselectivity in intramolecular photochemical 
[2+2] cycloadditions.34 
 
 
Scheme 1.8 a) Total synthesis of biyouyanagin A (1.72) by Nicolaou et al.; b) Transition state 
structures in the biomimetic [2+2] cycloaddition. 
As outlined in Scheme 1.8a, Nicolaou and coworkers were able to synthesize the two 
biosynthetic photoprecursors ent-zingiberene (1.66) and hyperolactone C (1.71) in a concise 
and elegant fashion.35 Asymmetric access to cyclohexadiene 1.66 was made possible by an 
organocatalytic, diastereoselective Robinson annulation starting from citronellal (1.63), 
whereas the spirocyclic core structure of hyperolactone C (1.71) was formed in a 
carbonylative insertion cascade. Treatment of alkyne 1.67, derived from L-malic acid, in the 
presence of phenyl iodide with Pd(PPh3)4 under a CO/CO2 atmosphere resulted in a 
sequence of carbonylative cross coupling, carbonate formation and 1,4-addition to 
intermediate 1.68. Formation of palladium allyl species 1.69 by extrusion of CO2 followed by 
reductive elimination provided spirocyclic intermediate 1.70 as a single stereoisomer, which 
could be converted to 1.71. Irradiation of hyperolactone C (1.71) and ent-zingiberene (1.66) 
with UV-A light in the presence of a triplet sensitizer provided regio- and stereoselectively 
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biyouyanagin A (1.72) via a favored exo-transition state (Scheme 1.8b). Nicolaou’s 
biomimetic approach allowed for an efficient synthesis of 1.72 in a longest linear sequence of 
7 steps from a literature known compound in 19% overall yield. Furthermore, it was possible 
to revise the originally proposed all-cis cyclobutane structure which would be formed by a 
sterically unfavored endo-transition state.  
 The cyclobutane ring formed in a [2+2] cycloaddition does not have to be preserved 
during further biosynthetic transformations to the natural product, especially as the ring strain 
in a four-membered system makes them prone to opening. The biosynthesis of the racemic 
natural products linderaspirone A (1.78) and bi-linderone (1.80) represents one example 
where an initially formed four-membered ring has enough intrinsic reactivity to fragment 
(Scheme 1.9).36 The Wang group synthesized methyl linderone (1.76), the biomimetic 
precursor, via a semipinacol rearrangement of dithiane 1.73 upon heating. Irradiation of 1.76 
as a thin film in the solid state with UV-A light or simply sunlight provided mixtures of 
cyclobutane 1.77, linderaspirone A (1.78) and bi-linderone (1.80) accompanied by its 3-
epimer.36a The high regioselectivity can be explained by π-stacking effects in the crystal 
packing of 1.76, which has been recently reported.37 Irradiation in solution provided only 
trace amounts of the desired natural products.36a,38 
 
 
Scheme 1.9 Solid state photochemical formation of linderaspirone A (1.78) and bi-linderone (1.80). 
Presumably, 1.78 is formed by a strain-releasing Cope rearrangement from 
cyclobutane 1.77, whereas 1.80 could be formed by a radical opening of the cyclobutane ring 
to the allylic radical 1.79 followed by radical recombination to the six-membered ring system 
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of bi-linderone (1.80). This proposal is supported by the fact that cyclobutane 1.77 
quantitatively forms the two natural products 1.78 and 1.80 upon heating in the dark.  
 In conclusion, four-membered rings are present in the structure of natural products 
and their formation is often mediated under solar irradiation. This has been utilized to 
synthesize these compounds in a step-economic way. Furthermore, the strain-releasing 
opening of the cyclobutane structures allows nature to broaden the structural complexity of 
its products. 
 
1.2.1.2 Other photochemical cycloadditions, rearrangements and electrocyclizations 
The repertoire of photochemical reactions found in the biosynthesis of natural 
products exceeds the simple [2+2] photocycloadditions mentioned in the previous chapter by 
far. Not only have other modes of cycloaddition been reported for the biosynthesis of natural 
metabolites, but also different types of rearrangements, isomerizations and 
electrocyclizations. 
 
 
Scheme 1.10 Photochemical formation of intricarene (1.87) from O-methyl bipinnatin J (1.82). 
Intricarene (1.87) represents a polycyclic furanocembranoid isolated from the 
octocoral Pseudopterogorgia kallos (Scheme 1.10).39 Trauner40 and Pattenden41 reported 
bioinspired syntheses of 1.87, relying on a thermal, ionic oxidopyrilium-alkene (5+2) 
cycloaddition under refluxing conditions in DMSO or MeCN, starting from the natural 
precursor bipinnatin J (1.81), in three steps. Nevertheless, these conditions clearly do not 
represent the biosynthetic pathway chosen by nature. One possibility is the participation of 
an enzyme to lower the activation barrier for the cyclization. However, the biological 
specimens, from which the natural product was isolated, were collected near the Columbian 
Caribbean Isla de Providencia (water depth 1−45 m), an intensely irradiated region. This 
prompted Trauner and coworkers to investigate a photochemical pathway to intricarene 
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(1.87).42 In a combined synthetic and computational approach, it was possible to show that 
irradiation of diene dione 1.83, obtained by photochemical singlet oxygen cycloaddition of 
O-methyl bipinnatin J (1.82), with a UV-A rich reptile lamp yielded the natural product 
intricarene (1.87) at ambient temperature. The formal (5+2) mechanism can be described by 
an initial excitation of 1.83 to its first excited singlet state (S1) followed by ISC to the triplet 
radical intermediate 1.84 (T1) which is further transformed to triplet oxidopyrilium 1.85 (T1). A 
two-step cyclization pathway involving a final ISC to a singlet state yields 1.87. These 
findings raise doubts if intricarene (1.87) is a real natural product synthesized in corals, 
especially as 1.82 has been reported to be an isolation artefact from the methanolysis of 
bipinnatin J (1.81).43 
 Another mechanism for the photochemical formation of an oxidopyrilium species was 
reported by Porco and coworkers in their synthesis of methyl rocaglate (1.93), a member of 
the polycyclic rocaglamide natural product family isolated from the tropical plant genus Aglaia 
(Scheme 1.11).44 Upon irradiation, an excited-state intramolecular proton transfer (ESIPT) 
forms an oxidiopyrilium species 1.90 from 3-hydroxyflavone 1.88 which reacts with 
cinnamate 1.89 in an endo-transition state to form the tricyclic intermediate 1.91. The 
proposed biomimetic ketal rearrangement could be induced under basic conditions to yield 
methyl rocaglate (1.93) after subsequent reduction. The use of a TADDOL ligand in the 
cycloaddition step enabled the asymmetric synthesis of several rocaglamide natural products 
and derivatives based on this biomimetic consideration.44b,45 
 
 
Scheme 1.11 Biomimetic synthesis of the Aglaia natural product methyl rocaglate (1.93) via ESIPT 
induced (5+2) cycloaddition. 
 The occurrence of a di-π-methane rearrangement46 in the biosynthesis of 
erythrolide A (1.97), a chlorinated diterpenoid from a Caribbean octocoral, could be 
demonstrated by irradiation of a methanolic seawater solution of erthyrolide B (1.94) with 
sunlight (Scheme 1.12a).47 By excitation of the enone structure, biradical 1.95 should be 
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formed after initial cyclopropyl ring closure, followed by a subsequent cyclopropyl opening. 
Erythrolide A (1.97) is obtained by final ring closure of singlet biradical 1.96. 
 
 
Scheme 1.12 Rearrangement reactions in the biomimetic formation of a) erythrolide A (1.97) and b) 
komarovispirone (1.104). 
Majetich and Yu described a photochemically-induced radical cascade for the 
formation of a spirocyclic center in their biomimetic synthesis of komarovispirone (1.104) 
(Scheme 1.12b).48 The precursor, komaroviquinone (1.101), was synthesized via a multistep 
sequence containing a key Friedel–Crafts cyclization of enone 1.99 to the tricyclic core 
structure 1.100.49 Irradiation of 1.101, which was accessible in nine steps from 1.100, led to a 
nπ* excitation of the quinone moiety forming 1.102 followed by a [1,5]-hydrogen atom 
transfer and opening of the seven-membered ring to give biradical 1.103. Generation of the 
spirocyclic center yielded komarovispirone (1.104) diastereoselectively. The same non-
enzymatic rearrangement was selectively observed under normal daylight within two days, 
demonstrating the efficiency of photochemical conversions in the preparation of quaternary 
stereocenters.  
Interestingly, Gademann and coworkers50 recently elucidated the biogenetic 
connection between komarivispirone (1.104) and cyclocoulterone (1.108) isolated from the 
same plant Dracocephalum komarovi (Scheme 1.13).51 Under their conditions using sunlight 
irradiation of komaroviquinone (1.101) an equimolar ratio of 1.108 and 1.104 was obtained in 
63% overall yield. A possible mechanism for the formation of cyclocoulterone (1.108) is 
depicted in Scheme 1.13, which contains a similar reaction cascade involving 1.102 as 
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described for the formation of 1.104. A fascinating consecutive [1,5]- and [1,6]-hydrogen 
atom transfer forms the benzo[1,3]dioxole structure of 1.108 via the intermediates 1.105–
1.107. A similar cascade was reported in the biosynthesis of taiwaniaquinol A from 
taiwaniaquinol F under sunlight irradiation.52 
 
 
Scheme 1.13 Photochemical formation of cyclocoulterone (1.108) and kamorovispirone (1.104) under 
sunlight irradiation. 
Photochemical irradiation is also capable of generating intermediates which can 
undergo subsequent reactions under thermal conditions in complex cascade processes. As 
outlined in Scheme 1.14, Hu and Tang described the biomimetic synthesis of several 
xanthanolide dimers by photochemically triggered reaction cascades.53 Irradiation of 
xanthatin (1.109) with a high-pressure mercury lamp led to the isomerization of the C1–C5 
double bond within the seven-membered ring, leading to trans-cycloheptene (Z,E)-1.109. 
One possible reaction pathway is the dimerization of this reactive intermediate in a [4+2] 
cycloaddition to cyclohexene intermediate 1.110 which could be identified as a minor 
reaction product under certain reaction conditions. However, 1.110 is prone to undergo an 
additional intramolecular photochemical [2+2] cycloaddition to mogolide A (1.112) and its 
epimer 3-epi-mogolide A (1.111). Interestingly, 1.112 was only identified as a natural product 
in the Xanthium mogolium Kitag plant after its biomimetic total synthesis. 
Additionally, in the presence of DBU, the dimerization is prevented and an epimeric 
mixture of 1.114 was observed as the sole reaction product, presumably arising from 
isomerization of the C2–C3 double bond followed by 6π electrocyclic ring closure. For the 
success of the isomerization step, UV irradiation and the addition of DBU was absolutely 
critical, which led to the prediction of enolate 1.113, formed by 1,6-addition of DBU to the 
vinylogous Michael system, as a possible key intermediate in the isomerization. A 
subsequent [4+2] cycloaddition with photochemically generated singlet oxygen provided 
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access to endoperoxide 1.116, which was isolated from the aerial parts of Xanthium 
strumarium, and its epimer 1.115.54 
 
 
Scheme 1.14 Photoisomerization triggered reaction cascades towards xanthatin dimers. 
The use of a photochemical 6π electrocyclization in a biomimetic fashion enabled the 
formation of granulatimide (1.117), a G2 cell cycle checkpoint inhibitor from the Brazilian 
ascidian Didemnum granulatum, after oxidative rearomatization (Scheme 1.15).55 
Furthermore, the γ-pyrone-containing sacoglossan mollusk natural products tridachia-
hydropyrone (1.118) and photodeoxytridachione (1.120) were prepared by relying on photo-
mediated electrocyclizations.56 In the case of 1.120, it was demonstrated by in vitro57 as well 
as in vivo58 experiments that this compound is made from 9,10-deoxytridachione (1.119) in a 
photochemical transformation which can be either described as a [σ2a+π2a] elctrocyclization 
or via a triplet biradical mechanism.59 
 
 
Scheme 1.15 Natural products 1.117–1.120 synthesized by biomimetic photochemical 
electrocyclizations. 
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1.2.2 Non-biomimetic transformations 
Photochemical reactions have been extensively used as non-biomimetic key steps in 
the synthesis of natural products.30c,31 In the following chapter, a short selection of total 
syntheses involving such key steps are described. Firstly, [2+2] cycloadditions and different 
photochemical cyclizations and rearrangements are presented. The last part of this chapter 
concerns the use of modern visible light photoredox catalysis in natural product total 
synthesis. 
 
1.2.2.1 Photochemical [2+2] cycloadditions 
One of the most unusual and extraordinary class of cyclobutane-containing natural 
products is represented by the so called ladderane lipids, which contain up to five condensed 
cyclobutane rings ([5]-ladderanes) within their backbone (1.121, 1.122, Scheme 1.16a).60 
These compounds were isolated from ammonium-oxidizing bacteria found in the Black Sea, 
at a water depth of 90 m. The oxidation process of ammonia occurs in a specialized cell 
compartment (anammoxosome), where toxic intermediates in the form of NH2NH2 and 
NH2OH are formed. The ladderane lipids constitute a significant fraction of the 
anammoxosome membrane and are thought to prevent the diffusion of these toxic 
intermediates into the cytosol by forming densely packed membranes. 
 
 
Scheme 1.16 Structure and total synthesis of ladderane lipids by the Corey group. 
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The Corey group described an efficient asymmetric synthesis of 
pentacycloanammoxic acid methyl ester (1.134, Scheme 1.16b), which was also found in 
anammox bacteria, starting with a photochemical [2+2] cycloaddition of cyclopentenone 
(1.124) and cyclobutene (1.123).61 The resulting cyclopentanone 1.125 was ring-contracted 
via a sequence of formylation and deformylative Regitz diazo transfer followed by a 
photochemical Wolff ring contraction of the corresponding α-diazo ketone 1.126 to obtain an 
epimeric mixture of the [3]-ladderane carboxylic acid 1.127 after saponification. Formation of 
the acid chloride upon heating with oxalyl chloride and subsequent addition of sodium salt 
1.128 led to the formation of Barton ester 1.129. This labile intermediate was transformed 
into a secondary bromide under irradiation with a sunlamp via a radical decarboxylation to a 
secondary alkyl radical which was trapped with BrCCl3. Elimination afforded the reactive 
cyclobutene 1.130, which was diastereoselectively converted to silane 1.132 by an additional 
photochemical [2+2] cycloaddition. This adduct 1.132 could be converted into 
pentacycloanammoxic acid methyl ester (1.134) in eight steps including a second Wolff ring 
contraction to 1.133. The use of no less than five photochemical key reactions in the whole 
synthesis demonstrates thereby the synthetic power of photo-induced transformations. 
Interestingly, the biosynthesis of the ladderane lipids is unknown to date. It seems unlikely 
that photochemical transformations are involved due to the dark habitat of the bacteria.62 
 
 
Scheme 1.17 Total synthesis of a ladderane lipid by the Burns group. 
In 2016, the Burns group reported on the synthesis of a full phosphatidylcholine 
ladderane lipid 1.143 containing [3]- and [5]-ladderane moieties (Scheme 1.17).63 Key to their 
successful synthesis was the multigram preparation of bicyclo[2.2.0]hexene (1.137) using a 
Ramberg–Bäcklund olefination strategy starting from the maleic anhydride-derived 
cyclobutandiol 1.135. Dimerization of 1.137 was performed by irradiation with UV-C light in 
presence of a copper catalyst, as reported by Kochi and Salomon,64 to obtain intermediate 
1.138. This intermediate was converted into [5]-ladderanoic acid (1.139) relying on an 
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asymmetric hydroboration and Zweifel olefination. The photochemical dimerization had to be 
carried out in a benzene matrix at temperatures below 0 °C to suppress the electrocyclic ring 
opening of 1.137 mediated by the copper catalyst which also occurred in absence of light. 
Moreover, photochemical [2+2] cycloaddition of bicyclohexene (1.137) with dibromide 1.140 
provided the [3]-ladderane structure 1.141 after stereoselective deprotonation from the 
convex face. Within additional five steps, [3]-ladderanol 1.142 could be synthesized which 
was transformed in a short sequence to ladderane phosphocholine lipid 1.143. Initial 
investigations of the biophysical behavior showed facile self-assembly of this lipid to 
unilamellar vesicles. 
 
 
Scheme 1.18 a) Structure and b) total syntheses of aquatolide (1.146); c) Formal total synthesis of 
solanoeclepin A (1.158). 
Another ladderane-containing structure was originally proposed for aquatolide (1.145) 
in 1989 by San Feliciano and coworkers (Scheme 1.18a).65 This structure was later revised 
to bicyclo[2.1.1]hexane 1.146 based on computational calculations and, eventually, 
confirmed by single-crystal X-ray analysis.66 The [2]-ladderane structure 1.145 and the 
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revised structure 1.146 represent regioisomers of the proposed [2+2] cycloaddition of the 
presumptive biogenetic precursor asteriscunolide C (1.144).67  
The group of Hiemstra reported the first total synthesis of 1.146 by an allene-enone 
[2+2] cycloaddition of 1.149 to yield intermediate 1.150, which they converted to the natural 
product in nine steps using a key Mukaiyama aldol reaction for the closure of the seven-
membered ring (Scheme 1.18b).68 Just recently, Zhang and Gu reported a completely 
different approach to 1.146 by a late-stage photo-Wolff ring contraction of α-diazo ketone 
1.153, which was derived from diketone 1.152 via tosyl hydrazone formation followed by α-
elimination.69 The resulting ring-contracted carboxylic acid 1.154 was transformed to 1.146 
by a key epimerization of the stereocenter next to the carbonyl atom and subsequent ring 
closure by a Nozaki–Hiyama–Kishi reaction. 
Hiemstra again reported a formal total synthesis of the intriguing structure of 
solanoeclepin (1.158), a terpenoid hatching agent of the potato cyst nemato, by making use 
of Tanino’s intermediate 1.157 (Scheme 1.18c).70 In their approach, Hiemstra and coworkers 
cyclized cyclohexanone 1.155 regio- and diastereoselectively to key intermediate 1.156 
under photochemical flow conditions. 
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Scheme 1.19 Radical cyclobutane fragmentation in the total synthesis of a) lubiminol (1.167) and b) 
guanacastepene E (1.171). 
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A cyclobutane-containing ring system that is formed via intra- or intermolecular 
cycloaddition can be used to access other complex polycyclic structures by opening of the 
four-membered ring. As depicted in Scheme 1.19a, Crimmins and coworkers reported a total 
synthesis of the spirovetivane natural product lubiminol (1.167) by a radical cyclobutane 
opening/rearrangement reaction cascade.71  
The key enone precursor was synthesized from β-hydroxy ester 1.159 
diastereoselectively via a zinc homoenolate addition. Irradiation of 1.160 yielded a single 
diastereomer 1.161 which was converted to thiocarbonyl imidazole 1.162 as a precursor for 
the radical ring opening. Slow addition of Bu3SnH to the reaction mixture led to the formation 
of a secondary cyclobutylcarbinyl radical 1.163 which opened up to primary radical 1.164. At 
this stage of the mechanism, a radical ring expansion, originally described by Dowd and 
Beckwith,72 took place with an initial attack of the primary radical onto the carbonyl group. 
The resulting bicyclo[3.1.0]hexane-1-oxyl radical 1.165 is immediately fragmented to obtain 
the desired spirocyclic compound 1.166 after hydrogen atom transfer from Bu3SnH. No 
diastereoselectivity in the hydrogen transfer was observed, delivering 1.166 in a 3:2 
diastereomeric mixture. With key intermediate 1.166 in hand, it was possible to finish the 
synthesis of lubiminol (1.167) in eleven steps. 
Another reductive radical fragmentation was used as a key reaction for the synthesis 
of guanacastepene E (1.171) by Sorensen and coworkers (Scheme 1.19b).73 The 
corresponding radical fragmentation precursor 1.169 was obtained by intramolecular [2+2] 
cycloaddition of enone 1.168. Treatment of the obtained cyclobutane 1.169 with SmI2 
generated a ketyl radical anion and a subsequent opening of the cyclobutylcarbinyl radical to 
the required seven-membered ring. The intermediate samarium enolate that is formed by a 
second reduction was quenched with PhSeBr. The selective fragmentation of the exocyclic 
cyclobutane bond can be explained by its almost parallel orientation towards the π-system of 
the carbonyl group. The introduction of the selenyl ether into 1.170 provided a regioselective 
handle for the further functionalization to guanacastepene E (1.171) in five steps. 
 
1.2.2.2 Other photochemical cycloadditions, rearrangements and electrocyclizations 
The excitation of a carbonyl group 1.172 can lead to several reaction pathways 
involving cleavage of C–C and C–H bonds which are referred as the Norrish fragmentations 
(Scheme 1.20). Norrish type I reactions involve the cleavage of the bond between the 
carbonyl C-atom and one of the α-C-atoms, whereas the reaction outcome after the first 
bond cleavage depends on the exact nature of the starting material.30c,74  
 Decarbonylative recombination to 1.175, C–H abstraction/alkene 1.177 formation and 
ketene 1.178 or carbene 1.176 formation are possible. A Norrish type II reaction is 
characterized by an intramolecular γ-hydrogen abstraction forming a 1,4-biradical 1.180 
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which can fragment either to a carbonyl 1.183 and an alkene compound 1.182, or in the case 
of a Norrish–Yang cyclization, close up to a cyclobutanol 1.181.30c,75 
  
 
Scheme 1.20 Norrish fragmentations of carbonyl compounds. 
 A Norrish type I reaction was used by Iwabuchi and coworkers in their synthesis of 
the sesquiterpenoid juvabione (1.186, Scheme 1.21a).76 When ketone 1.184, synthesized by 
an asymmetric intramolecular aldol reaction, was irradiated, the desired C–C bond cleavage 
occurred followed by C–H abstraction and formation of the unsaturated aldehyde 1.185.  
 
 
Scheme 1.21 Use of photochemical fragmentations in the total synthesis of natural products. 
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 In addition, Norrish–Yang cyclizations have been used in the synthesis of natural 
products, exemplified by Baran’s work on the semisynthesis of the aglyconic cardiotonic 
steroid ouabagenin (1.190, Scheme 1.21b).77 Starting from ketal 1.187, the C19 oxidation 
could be achieved by Norrish–Yang cyclization to cyclobutanol 1.188. Interestingly, in order 
to suppress competitive Norrish type I side reactions, the irradiation of 1.187 had to be 
carried out in the solid state as an aqueous suspension. Cyclobutanol 1.188 could be opened 
via an unstable hypoiodite species under photochemical conditions. Selective homolysis of 
the C11–C19 bond and radical recombination afforded the desired iodide 1.189 which was 
converted to ouabagenin (1.190).  
 Yates and Stevens applied an oxa-di-π-methane rearrangement (Scheme 1.21c), 
which generally occurs upon triplet sensitization of a β,γ-unsaturated ketone,46 in the formal 
synthesis of the cedranoid sesquiterpene cedrol (1.194).78 Using acetophenone as a solvent 
and triplet sensitizer, irradiation of 1.191 led to cyclopropane 1.193 via sensitization of the 
carbonyl group followed by generation of biradical intermediate 1.192. Six additional steps 
converted this key compound to an intermediate of the cedrol synthesis of Stork and Clark.79 
 
 
Scheme 1.22 Use of meta-photocycloadditions in the total synthesis of natural products. 
 Another cedranoid sesquiterpene, α-cedrene (1.205), was synthesized by Wender 
using arene photocycloaddition (Scheme 1.22b).80 In general, upon excitation of an arene in 
the presence of an alkene or an alkyne, three different cyclization modes, ortho, meta and 
para, are possible.81 However, only the meta-photocycloaddition is of synthetic use, forming 
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three new rings and up to six stereocenters in a single step. It has been extensively applied 
in the field of natural product synthesis.82 From a mechanistic point of view, irradiation with 
UV light leads to an excitation of the aromatic system 1.195 to the excited singlet state 1.195 
(S1) which forms a polarized exciplex adduct 1.197 with an inter- or intramolecular alkene 
1.196 controlling the regioselectivity by the optimal stabilization of the partial charges 
(Scheme 1.22a). From 1.197, a biradical 1.198 is formed which can in general recombine to 
the cyclopropyl-containing allylic regioisomers 1.199 and 1.200.  
In his synthesis of 1.205, Wender irradiated arene 1.201 to obtain the two isomeric 
photocycloadducts 1.202 and 1.203. Both compounds could be converted to bromide 1.204 
by cyclopropane cleavage induced by a nucleophilic attack of the alkene onto bromine. 
Reduction of the C–Br bond and removal of the carbonyl group under Wolff-Kishner 
conditions afforded α-cedrene (1.205). 
The oxa-fenestrane insecticide penifulvin A (1.210), isolated from the fungus 
Penicillium griseofulvum,83 was synthesized by Mulzer and Gaich through application of a 
meta-photocycloaddition of arene 1.206 (Scheme 1.22c).84 Asymmetric formation of 1.206 
was possible by Myers alkylation. The resulting regioisomers 1.207 and 1.208 could be 
separated and 1.208 was ring opened under Birch conditions to deliver key intermediate 
1.209 which was transformed to the natural product 1.210 within three steps. This strategy 
allowed for the generation of the triquinane structure of 1.210 in just eight steps in an 
asymmetric fashion. 
 
a) Total synthesis of daphenylline (1.216)
b) Side product formation of the photochemical electrocyclization in the presence of air
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Scheme 1.23 Photochemical transformations in the total synthesis of daphenylline (1.216). 
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The daphniphyllum alkaloid daphenylline (1.216), isolated from the fruit bodies of D. 
longeracemosum,85 contains an intriguing tetrasubstituted arene core unique among this 
class of natural products (Scheme 1.23a). Li and coworkers synthesized this structural 
element using a photochemical isomerization/6π-electrocyclization/aromatization 
sequence.86 Starting from sulfonamide 1.211, the central bicyclic core of 1.216 was 
generated via a gold catalyzed 6-exo-dig Conia-ene reaction. The resulting ketone 1.212 was 
put forward to triene (E)-1.213 which underwent E/Z-isomerization to (Z)-1.213 followed by a 
conrotatory electrocyclization under photochemical conditions. Thermal conditions for the 
electrocyclization failed, presumably due to steric hindrance in the disrotatory cyclization by 
forming a cis-substituted cyclohexadiene. Aromatization was observed by treatment with 
DBU under an oxygen atmosphere. The first total synthesis of 1.216 could be finished in just 
nine additional steps. Interestingly, attempts for direct oxidative aromatization in the 
electrocyclization step under air failed, delivering a single side product 1.219 (Scheme 
1.23b). The formation of this compound was rationalized by an initial singlet oxygen [4+2] 
cycloaddition of 1.214 followed by a Norrish type I fragmentation of 1.217. The resulting 
biradical 1.218 is able to form lactone 1.219 through the homolytic cleavage of the O–O 
bond.  
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1.2.2.3 Visible light photoredox catalysis 
As mentioned in chapter 1.1, redox catalysis under the irradiation of visible light using 
organic dyes and transition metal complexes is a modern and growing field in 
photochemistry.  
 
 
Scheme 1.24 a) General photocatalytic cycles; b) Common photoredox catalysts 1.220–1.223. 
Consequently, several total syntheses were reported within the last years relying on 
the radical pathways initiated under mild conditions.21b,30c Generally, the reaction pathway 
can be described either by an oxidative quenching cycle generated by single electron 
transfer from an excited, long-lived triplet state of the catalyst to an acceptor molecule 
forming a radical anion or by a reductive quenching cycle forming a radical cation of a donor 
compound by single electron transfer (Scheme 1.24a). In each case, the catalytic cycle has 
to be closed by reduction or oxidation of the catalyst. Common organic and transition metal 
complex photocatalysts 1.220–1.223 are depicted in Scheme 1.24b. 
 A powerful tertiary radical formation enabled Overman to make the difficult C8–C14 
bond in the synthesis of the spongian diterpenoid aplyviolene (1.231, Scheme 1.25a).87 In an 
earlier approach, an enolate Michael addition was used for this crucial bond formation 
whereas the carbonyl group, essential for the enolate formation, had to be removed 
afterwards.88 This could be circumvented by the synthesis of N-acyloxyphthalimide 1.225 
from fenchnone (1.224). Conversion of this compound in the presence of a photocatalyst 
1.220 and Hantzsch ester 1.226 led to radical anion 1.227, which generated the tertiary 
radical 1.228 under the extrusion of CO2. A 1,4-addition with enone 1.229 afforded the 
coupling product 1.230, which was converted by analogy with the earlier synthesis into 
aplyviolene (1.231). A similar generation of tertiary radicals from the corresponding alcohol 
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via the N‐phthalimidoyl oxalates or the cesium oxalates was recently described by the same 
group.89 
Another intermolecular coupling reaction mediated by visible light photoredox 
catalysis, reported by the Stephenson group, is highlighted in Scheme 1.25b. In their 
synthesis of the hexahydropyrroloindole alkaloid gliocladin C (1.236), the authors used a 
photoredox catalytic reductive dehalogenation of bromopyrrolindoline 1.232 to generate the 
benzylic radical 1.233.90 In the presence of indole 1.234, the desired coupling product 1.235 
was observed. The introduction of the aldehyde group, which was removed by Tsuji–
Wilkinson decarbonylation, was necessary to block the C2 position.91 In just five additional 
steps, the total synthesis of gliocladin C (1.236) could be completed. 
 
 
Scheme 1.25 Photoredox catalysis in natural product total synthesis. 
To conclude, photochemical transformations have been extensively used by synthetic 
chemists to generate complex structures, particularly in the field of natural product total 
synthesis. Furthermore, biomimetic syntheses have exploited photochemical conversions 
observed in nature to access secondary metabolites in an efficient way. More recently, the 
field of photoredox catalysis has led to a new era of synthetic photochemistry independent of 
high energy UV irradiation and expensive lamps or reaction setups. 
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2 NON-BIOMIMETIC AND BIOMIMETIC TOTAL SYNTHESIS 
OF APLYDACTONE 
2.1 Introduction 
2.1.1 Isolation and structure 
The opistobranch mollusks of the genus Aplysia have been a rich source of bioactive 
natural products including a considerable proportion of organohalogens (Figure 2.1a).92 The 
content of halogenated natural products found in all sea slugs mainly depends on their diet 
which largely consists of the red algae Laurencia and cyanobacteria on the seaweed.92a,93 
Furthermore, this quite abundant genus of algae is a known source of halogenated natural 
products including a class of spiro[5.5]undecane sesquiterpenoids, called chamigranes 
(Figure 2.1b).94 It is proposed that the mollusks which live in the shallow seawater of tropical 
regions use this natural source of bioactive and cytotoxic compounds, which they chemically 
modify and store in their digestive gland, as a defensive strategy against various predators. 
 
 
Figure 2.1 a) Natural products 2.1–2.4 from the sea hare Aplysia; b) Chamigranes 2.5–2.10 from the 
red algae Laurencia. 
In 2001, Stonik and coworkers reported the isolation of aplydactone (2.11, Figure 
2.2a), a complex brominated sesquiterpeniod with a low molecular weight, from the sea hare 
Aplysia dactylomela.95 The biological specimens had been already collected in 1986 at the 
northern coast of Madagascar in a water depth of 3−5 m. Nevertheless, it took more than a 
decade to elucidate the structure of 2.11 which was finally confirmed by single-crystal X-ray 
analysis (Figure 2.2a). In addition, the Stonik group isolated several brominated chamigrane 
natural products from the same source including the anticancer compound dactylone (2.12) 
and its epimer 10-epi-dactylone (2.13, Figure 2.2b).96 Furthermore, debromochamigrene 2.14 
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is proposed to be biosynthetically derived from dactylone (2.12) as the result of a bromide 
elimination, [1,2]-methyl shift and subsequent exo-methylene formation.96d 
The structure of aplydactone (2.11) contains a unique tetracyclo-
[4.4.2.01,6.03,11]dodecane skeleton which possesses an unprecedented [2]-ladderane moiety. 
As previously mentioned, condensed cyclobutane structures are scarce in nature’s repertoire 
of structural elements, and the [3]- and [5]-ladderane containing lipids described in chapter 
1.2.2.1 represent, to the best of our knowledge, the only other natural product class with this 
feature. Furthermore, 2.11 is a halogenated natural product with a sterically encumbered 
secondary neopentylic bromide and contains five stereocenters, three of which are 
quaternary. A gem-dimethyl moiety, contiguous to two of the quaternary stereocenters, 
increases the steric hindrance within the structure. 
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Figure 2.2 a) Structure of aplydactone (2.11); b) Chamigranes 2.12–2.17 isolated from Aplysia 
dactylomela. 
Careful inspection of the bond angles and bond lengths within the compressed core 
structure of 2.11 reveals a large aberrance from the usual values of puckered cyclobutanes. 
The longest bond is the C1–C6 connection with a value of 1.61 Å, which is significantly 
longer than 1.55 Å found in an isolated cyclobutane (Figure 2.2a). Furthermore, a bond angle 
of just 85.3° is found for the C11–C1–C6 bond angle, reflecting the highly compressed and 
sterically hindered core structure.  
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Scheme 2.1. Strain-releasing rearrangement of aplydactone (2.11) to isomer 2.20. 
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Consequently, aplydactone (2.11) readily rearranges to the less strained polycycle 
2.20 upon treatment with pTsOH (Scheme 2.1).95 The mechanism was described as a 
rearrangement cascade and involves an initial protonation of the carbonyl oxygen followed 
by a Wagner–Meerwein shift to obtain carbocation 2.19 as an intermediate. A pinacol-type 
[1,2]-shift delivers isomer 2.20 as a single compound. 
 
2.1.2 Biosynthesis 
The spirocyclic core structure of chamigrane natural products isolated from the 
mollusk genus Aplysia is presumably synthesized by the red algae Laurencia that constitutes 
the main diet for these sea hares. For the biosynthesis of spirocyclic [5.5]undecane 
sesquiterpenoids, a bromonium cation-induced cyclization of a farnesyl precursor has been 
proposed. Biomimetic approaches towards α- and β-chamigranes supporting this hypothesis 
have been reported (Scheme 2.2). Faulkner and coworkers could diastereoselectively cyclize 
geranylacetone (2.21) to the bicyclic ether 2.23 via the intermediate bromonium cation 2.22 
(Scheme 2.2a).97 Tertiary alcohol 2.24, derived from the cyclization product 2.23, formed 
10-bromo-α-chamigrene (2.6) under acidic conditions. However, an alternative cyclization 
mode was reported by Martin and coworkers in their bioinspired synthesis of 
10-bromo-β-chamigrene (2.5) based on a bromonium-induced spirocyclization of 
intermediate 2.26 (Scheme 2.2b).98 
 
 
Scheme 2.2. Biomimetic approaches towards chamigranes 2.6 and 2.5. 
 As a result of these observations, two possible biosynthetic pathways for the 
formation of C10-brominated chamigranes can be formulated depending on the order of ring 
formation, as depicted in Scheme 2.3.97b,99 Nucleophilic attack of the trisubstituted double 
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bond of farnesyl pyrophosphate (2.30, FPP) onto a formal Br+-species and subsequent 
cyclization delivers bromomonocyclofarnesyl pyrophosphate (2.32) via the formation of 
bromonium cation 2.31. Upon expulsion of pyrophosphate, allylic cation 2.25 is formed which 
is prone to formation of spirocycle 2.5. However, it is also feasible that FPP (2.30) first 
cyclizes to γ-bisabolene (2.34) followed by a subsequent bromonium-induced spirocyclization 
to 10-(S)-bromo-β-chamigrene (2.5). In general, the bromonium cation or a synthetic 
equivalent (HOBr, Br3−, Enz-Br+) is most likely provided by a haloperoxidase, or more 
specifically by a vanadium-dependent haloperoxidase (chapter 3).100 To date, just the 
10-(S)-enantiomer of 2.5 has been isolated from several Laurencia species. However, 
different chamigranes with R-configuration at this stereocenter have been reported.94a 
 
 
Scheme 2.3. Proposed biosynthesis of 10-(S)-bromo-β-chamigrene (2.5). 
 The concomitant isolation of dactylone (2.12) and 10-epi-dactylone (2.13) from 
Aplysia dactylomela suggests a biosynthetic hypothesis where both metabolites are formed 
by modification of a chamigrane precursor ingested as part of the diet. Allylic oxidation of 
naturally occurring 2.5, followed by subsequent oxidation to the enone system would 
generate 10-epi-dactylone (2.13, Scheme 2.4a). Starting from the enantiomeric 
10-(R)-bromo-β-chamigrene (ent-2.5), which has yet to be isolated, allows for the 
biosynthesis of dactylone (2.12). At first, diol 2.16, isolated from the same mollusk, could be 
formed by a diastereoselective dihydroxylation. From this intermediate, a two-step procedure 
including oxidation of the secondary alcohol and elimination of the tertiary alcohol to the 
α,β-unsaturated ketone would afford the natural product 2.12. In general, the existence of the 
enantiomeric 10-bromo-β-chamigrenes 2.5 and ent-2.5 can be either explained via a 
nonselective bromonium-induced cyclization via a formal Br+-species outside the active site 
of the haloperoxidase or by the existence of two haloperoxidases which deliver 
enantioselectively one of the cyclized brominated chamigrane intermediates 2.5 and ent-2.5. 
Face-selective and racemic bromination–cyclization modes of vanadium dependent 
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haloperoxidases in the biosynthesis of terpenoids were recently reported by Butler and 
coworkers.101 
Due to the shallow seawater habitat of Aplysia dactylomela in tropical and subtropical 
regions with high intensity of solar irradiation, it is reasonable to consider a photochemical 
[2+2] cycloaddition for the formation of the ladderane structure within aplydactone (2.11). 
Therefore, irradiation exciting the enone moiety of dactylone (2.12) could deliver the 
ladderane structure of 2.11 (Scheme 2.4b). However, the less strained “rule of five” product 
(Chapter 1.1), called isoaplydactone (2.36) would be feasible by regioisomeric 
photocycloaddition. Nonetheless, this compound has not been isolated yet from any natural 
source. By analogy, 10-epi-dactylone (2.13) could cyclize under solar irradiation to provide 
the ladderane containing 8-epi-aplydactone (2.38) or the “rule of five” product 
8-epi-isoaplydactone (2.37).  
 
 
Scheme 2.4 a) Proposed biosynthesis of dactylone (2.12) and 10-epi-dactylone (2.13); b) Possible 
photocycloaddition products of dactylone (2.12) and 10-epi-dactylone (2.13). 
Stonik and coworkers attempted to cyclize dactylone (2.12) under UV irradiation, 
which did not yield any desired product.95 However, no detailed reaction conditions including 
wavelengths, solvent, temperature or reaction time were reported. 
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2.1.3 Project outline 
Aplydactone (2.11) and the epimeric chamigranes dactylone (2.12) and 10-epi-
dactylone (2.13) represent a unique and challenging target for total synthesis and, at the 
beginning of this project, no completed synthesis for any of these products had been 
reported.102 Above all, the unprecedented [2]-ladderane scaffold condensed onto a decalin 
system within the carbon framework of 2.11 was expected to cause several difficulties in its 
preparation. Furthermore, the low degree of functionalization present in 2.11 severely limited 
the possible retrosynthetic disconnections.  
Therefore, we planned to access aplydactone (2.11) by two approaches. At first, we 
aimed to synthesize the complex core structure of 2.11 in a non-biomimetic approach by 
disconnection of either bond a and b (chapter 2.2.1.1–2.2.1.2) or c and d (chapter 2.2.1.3–
2.2.1.6) relying on established methodology for the synthesis of cyclobutanes and 
ladderanes (Figure 2.3 left).  
 
 
Figure 2.3 Planned non-biomimetic (left) and biomimetic (right) retrosynthetic bond disconnections. 
In addition, we wanted to synthesize the biomimetic precursor dactylone (2.12), and 
its epimer 2.13, to prove if irradiation of 2.12, as reported by Stonik, is not able to deliver 2.11 
(Scheme 2.3 right). However, we were concerned about the reported investigations, since 
the presence of a secondary alkyl bromide within the photoprecursor 2.12 could enable 
possible degradation pathways under irradiation with UV-light, especially if non-biomimetic 
wavelengths were chosen. Furthermore, we were interested if the other possible cyclization 
products 2.36−2.38 might be observable under carefully designed reaction conditions. This 
purpose rendered a synthesis of both compounds, 2.12 and 2.13, essential and was 
intended to be achieved in a diastereodivergent manner. 
To support our experimental work with theoretical investigations, computational 
calculations on the excited states of dactylone (2.12) and 10-epi-dactylone (2.13) were 
absolutely crucial and performed by our collaborators Dr. Patrick Kölle and Prof. Dr. Regina 
de Vivie-Riedle at the Ludwig-Maximilians Universität, Munich. 
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2.2 Results and discussion 
2.2.1 Non-biomimetic total synthesis of aplydactone  
2.2.1.1 First generation approach – Retrosynthetic analysis 
The initial approach for the synthesis of aplydactone (2.11) is depicted in Scheme 2.5. 
It was envisioned to access 2.11 via a final intramolecular alkylation of intermediate 
cyclobutyl cation 2.39, which should undergo a ring closure with the methyl vinyl ether 
moiety. Two ideas for the generation of the cyclobutyl cation 2.39 were elaborated. On the 
one hand, 2.39 could be generated by a cyclopropylcarbinyl-cyclobutyl rearrangement 
starting from the corresponding cyclopropylcarbinol intermediate 2.40.103 For the 
diastereoselective formation of 2.40 the best solution would be an intramolecular 
cyclopropanation of diazo compound 2.41 accessed from 2.42.104 On the other hand, cationic 
intermediate 2.39 can be traced back to cyclobutanone 2.43, which should be accessible via 
intramolecular ketene [2+2] cycloaddition of 2.44.105  
 
 
Scheme 2.5. Retrosynthetic analysis of a) aplydactone (2.11) and b) common intermediate 2.42. 
The advantage of this retrosynthetic analysis is that intermediate 2.42, used for both 
synthetic pathways, could be synthesized via Birch reduction of tetralone 2.45 derived from 
naphthalene 2.46. 
 
2.2.1.2 Cyclopropanation and ketene cycloaddition towards aplydactone 
The synthesis commenced with the preparation of methyl vinyl ether 2.42 (Scheme 
2.6) starting from 2,7-dimethoxynaphthalene (2.46). Hydrolysis of the intermediate methyl 
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vinyl ether obtained from the Birch reduction of 2.46 afforded 2-tetralone 2.45, which could 
be dimethylated in the α-position of the ketone upon treatment with methyl iodide and 
potassium hydroxide in a biphasic system.106 Initial attempts to introduce the methyl group on 
the aromatic ring by formylation and subsequent reduction failed. Therefore, 2.47 was 
selectively brominated with NBS followed by Negishi cross coupling with dimethylzinc to 
obtain trimethylated tetralone 2.48 in gram quantities.107 
 
 
Scheme 2.6. Synthesis of key diazo compound 2.41. 
The asymmetric reduction of tetralone systems like intermediate 2.47 were 
reported,108 however we decided to use racemic material in preliminary investigations of this 
synthetic route. Therefore, ketone 2.48 was reduced with NaBH4 and a subsequent second 
Birch reduction provided the desired cyclohexadiene 2.42 in good yield.109  
 
 
Scheme 2.7. Mechanism of the formation of diazo compound 2.41 under Raines conditions. 
With compound 2.42 in hand, several literature known procedures for the formation of 
α-diazo esters and acetates were tested.110 To this end, a methodology, introduced by 
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Raines and coworkers for the conversion of azides to diazo compounds, provided the 
desired compound 2.41 in excellent yield.111 Alcohol 2.42 was esterified in the presence of α-
azido acid 2.49 and EDC·HCl followed by treatment of the azide 2.50 with Raines reagent 
2.51. In order to obtain high yields, the initial temperature of the reaction had to be kept 
below 15 °C. From a mechanistic point of view, this reaction is proposed to start with the 
formation of phosphazide 2.52 which is trapped due to the reactive ester functionality as acyl 
triazenophosphonium salt 2.53 (Scheme 2.7).111a Hydrolysis of 2.53 generates acyl triazene 
2.54 which upon basic treatment fragments to diazo compound 2.41 and amide 2.55. 
With key diazo compound 2.41 in hand, several transition metal-catalyzed 
cyclopropanation conditions were screened, which are presented in Table 2.1. 
Table 2.1. Screening of the intramolecular cyclopropanation of 2.41. 
 
 
No. solvent temperature catalyst (mol%) observation 
1 CH2Cl2 r.t. Rh2(OAc)4 (2.0) complex mixture 
2 CH2Cl2 −30 °C to 0 °C Rh2(OAc)4 (2.0) complex mixture 
3 CH2Cl2 −30 °C to 40 °C Rh2(TFA)4 (2.0) decomposition 
4 CH2Cl2 −10 °C to r.t. Rh2(esp)2 (2.0) complex mixture 
5 CH2Cl2 −10 °C to r.t. Rh2(pfb)4 (2.0) complex mixture 
6 CH2Cl2 0 °C to r.t. Rh2(cap)4∙2 MeCN (2.0) no reaction 
7 DCE 50 °C Rh2(cap)4∙2 MeCN (2.0) decomposition 
8 toluene 45 °C Cu(TBS)2 (2.0) complex mixture 
9 MeNO2 r.t. Cu(OTf)2 (2.0) decomposition 
10 CH2Cl2 0 °C to 40 °C Cu(OTf)2 (2.0) decomposition 
11 CH2Cl2 0 °C to r.t. Cu(acac)2 (2.0) dimerization 
12 CH2Cl2 40 °C to r.t. CuI∙P(OEt)3 (2.0) dimerization 
13 DCE 40 °C Cu(hfacac)2 (2.0) dimerization 
 
All screening conditions were performed under high dilution conditions with a starting 
material concentration of 0.01−0.02 M. Furthermore, a solution of diazo compound 2.41 was 
slowly added to the catalyst solution by syringe pump to prevent intermolecular dimerization 
reactions. Unfortunately, all conditions using dimeric rhodium(II) catalysts104,112 only provided 
complex mixtures (entry 1,2,4,5) or resulted in decomposition (entry 3). In the case of 
Rh2(cap)4, which was reported to be highly selective for cyclopropanation whilst avoiding 
competitive C–H insertion,113 no conversion of the diazo compound 2.41 was observed at r.t. 
(entry 6), whereas elevated temperatures led to decomposition (entry 7). Due to the 
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unsuccessful conversion to the desired cyclopropane 2.56, several copper (II) and copper (I) 
catalysts were screened.114 However, most reactions again afforded complex mixtures of 
several unidentified products (entry 8–10). In the case of Cu(acac)2, CuI and Cu(hfacac)2, the 
undesired dimerized alkene product was identified as major product despite the high dilution 
and the slow addition of the starting material 2.41 (entry 11–13). Possibly, the ester 
functionality adopts a s-cis conformation where the diazo group or the resulting metal 
carbenoid is pointing away from the alkene as described for α-diazo amides.115 This 
conformation could be even more pronounced by the steric bulk of the gem-dimethyl moiety.  
 
 
Scheme 2.8 Arene cyclopropanation of diazo compound 2.58. 
Inspired by the recent work of the Reisman group on arene cyclopropanation,116 we 
examined the cyclopropanation of the corresponding aromatic diazo compound 2.58 
(Scheme 2.8), which was prepared by a similar sequence (see supporting information). It 
was proposed that the desired norcaradiene 2.59 would be favored over cycloheptatriene 
2.60, formed by 6π electrocyclic ring opening, due to geometric constraints.117 However, 
complex mixtures or dimerization were observed even under high dilution and slow addition 
using rhodium or copper catalysis. Neither the norcaradiene 2.59 nor cycloheptatriene 2.60 
could be identified in the reaction mixtures which supports the proposal of strong steric 
hindrance due to the neighboring quaternary carbon. 
Consequently, attention was turned towards an intramolecular [2+2] cycloaddition. 
Moreover, it was realized that the use of keteniminium salts in the [2+2] cycloaddition would 
have several advantages.105,118 First, these reactive species are known to be much more 
electrophilic and reactive than their oxygen equivalents. Second, keteniminium salts are 
much less prone to dimerization. Therefore, cyclohexadiene 2.42 was converted to amide 
2.62 under basic treatment with α-chloro amide 2.61 (Scheme 2.9a). Treatment of amide 
2.62 with triflic anhydride under different conditions, originally reported by Ghosez and 
coworkers, did not provide the desired cyclobutanone 2.43.119 The majority of conditions 
yielded a complex mixture of several products or, in the case of elevated temperatures, one 
major reaction product. After full NMR analysis of this unstable compound, enamine 2.63 
represents a plausible structure which can be formed by the mechanism in Scheme 2.9b.  
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Scheme 2.9 a) Keteniminium [2+2] cycloaddition of amide 2.62; b) Possible mechanism for the 
formation of enamine 2.63. 
After an initial isomerization of the 1,4- to the 1,3-cyclohexadiene 2.64, which was 
observed in other transformations at elevated temperature, the desired keteniminium ion 
2.65 is formed. Attack by the nucleophilic tetrasubstituted double bond forms a quaternary 
stereocenter. Instead of nucleophilic attack by the enamine onto the tertiary cation, 
elimination takes place to deliver alkene 2.63.  
 
OMeO
1) NaBH4 (99%)2) Li, NH3, EtOH,
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OHMeO
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O
O

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Scheme 2.10 Synthesis of ketal 2.68. 
In addition, intermolecular ketene and keteniminium [2+2] cycloadditions were 
investigated.120 Therefore precursor 2.68, which lacks the methyl vinyl ether to avoid 
chemoselectivity problems, was synthesized by a straightforward sequence (Scheme 2.10). 
Formation of dichloroketene or keteniminium triflate in the presence of 2.68 did not result in 
the formation cyclobutanone 2.69 and mainly unreacted starting material was recovered, 
demonstrating the steric hindrance of the tetrasubstituted alkene (Table 2.2). At elevated 
temperature, the ketal moiety was opened followed by oxidative aromatization (entry 4). 
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Table 2.2 Screening of the intermolecular ketene or keteniminium [2+2] cycloaddition of 2.68. 
 
 
No. solvent reagents (eq) temperature/time observation 
1 C6H12 NEt3 (2.5), Cl2HCOCl (2.5) r.t./overnight no reaction 
2 C6H12 NEt3 (2.5), Cl2HCOCl (2.5) 55 °C/overnight no reaction 
3 DCE Tf2O (3.5), DMA (3.0), collidine (3.5) −30 °C to r.t./15 h no reaction 
4 DCE Tf2O (3.5), DMA (3.0), collidine (3.5) −30 °C to 80 °C/15 h ketal opening 
5 C6H6 Tf2O (3.5), DMA (3.0), collidine (3.5) 80 °C/9 h no reaction 
6 DCE Tf2O (3.5), DMA (3.0), collidine (7.0) −15 °C to 80 °C/9 h no reaction 
 
As a result of the unsuccessful formation of the quaternary stereocenters from an 
unsaturated decalin system, it was decided to change the strategy focusing on the formation 
of the ladderane substructure, as described in the next chapter. 
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2.2.1.3 Second generation approach – Retrosynthetic analysis 
For the second generation strategy, it was envisioned to trace aplydactone (2.11) 
back to an intermediate which contains a [2]-ladderane substructure to build upon reported 
strategies towards ladderane systems (Scheme 2.11).60b,121  
 
 
Scheme 2.11 Retrosynthetic analysis of aplydactone (2.11) via cyclobutadiene (2+2) cycloaddition. 
Therefore, we aimed to generate the decalin substructure in 2.11 by a late stage 
Barbier-type ring closure. Furthermore, the secondary bromide as well as the α-methyl group 
could be introduced at a later stage of the synthesis. Taking all of these ideas into 
consideration, one arrives at diol intermediate 2.70, which is accessible from the 
ladderane-containing lactone 2.71. For the generation of the bicyclo[2.2.0]hexane system, 
the intramolecular oxidative (2+2) cycloaddition of cyclobutadiene iron tricarbonyl complexes, 
reported by the Snapper group, represented a promising approach. The desired precursor 
2.72 also fulfills the requirement of reduced degrees of conformational freedom due the 
lactone moiety.122 This is important because intermolecular dimerization of free 
cyclobutadiene is the main side reaction observed during cyclobutadiene cycloadditions, 
which necessitates substrate preorganization. Key intermediate 2.72 was planned to be 
derived by cross metathesis of γ-butyrolactone 2.73 and iron complex 2.74 or 2.75,123  which 
in turn was intended to be generated from the commercially available pyrone 2.76. 
 
2.2.1.4 A cross metathesis approach towards the cycloaddition precursor 
For the preparation of the key iron tricarbonyl complexes 2.74 and 2.75, pyrone 2.76 
was irradiated with a Rayonet lamp (350 nm, 250 W) in degassed benzene to accomplish a 
4π disrotatory electrocyclization to β-lactone 2.77, which was not isolated (Scheme 2.12). 
Treatment of 2.77 with Fe2(CO)9 at 50 °C led to iron tricarbonyl complex 2.78 via extrusion of 
CO2. This procedure was originally described by Roberts124 and further optimized by Snapper 
and coworkers.122b In general, cyclobutadiene iron tricarbonyl complexes are considered to 
be ”metalloaromatic”125 exemplified by their aromatic reactivity.126 The ester moiety could be 
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completely reduced to the methyl group in presence of LiAlH4 and boron trifluoride diethyl 
etherate to obtain 2.79.122b Subsequent formylation under Vilsmeier–Haack conditions 
delivered a separable 4:1 mixture of ortho- and para-substitution products 2.80 and 
2.81.126d,127 The necessary alkene moiety for the desired cross metathesis was installed after 
some optimization by Kauffmann olefination128 of aldehyde 2.81 for the formation of the 
terminal alkene 2.74 or by Takai olefination129 via a gem-dichromium species to generate 
disubstituted alkene 2.75. 
 
 
BF3·OEt2,
LiAlH4,
(95%)
PhMeNCHO,
POCl3
(74%,
para:or tho 4:1)
O
O
MeO2C
Rayonet
(350 nm) OMeO2C
O Fe2(CO)950 °C
(55%, 
2 steps) 2.78
Fe(CO)3
CO2Me
2.772.76 2.79
Fe(CO)3
Fe(CO)3
O
H
2.80 (15%)
Fe(CO)3
O
H
2.81 (59%)
Fe(CO)3R
2.74 R = H
2.75 R = CH3 (E/Z 2.5:1)
Mo(O)Cl3(THF)2,MeLi (78%)
or CrCl2, CH3CHI2(77%)
+ 
 
Scheme 2.12 Synthesis of iron tricarbonyl complexes 2.74 and 2.75. 
The synthesis of the other cross metathesis coupling partner 2.73 commenced with a 
literature known Johnson–Claisen rearrangement of prenol 2.82 and triethyl orthoactete 
(Scheme 2.13).130 Subsequent Sharpless asymmetric dihydroxylation afforded the desired 
γ-lactone 2.84 after spontaneous cyclization of the intermediate diol 2.86 in varying yields 
and moderate enantioselectivity. The use of (DHQ)2PYR as catalyst, which is known to 
provide generally better enantioselectivity for terminal alkenes, did not lead to improved 
selectivity.131  
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Scheme 2.13 Synthesis of γ-butyrolactone 2.73. 
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Alternatively, alkene 2.83 was treated with mCPBA to obtain epoxide 2.85. A kinetic 
resolution of 2.85 provided a mixture of diol 2.86 and epoxide 2.87 which, inspired by the 
work of Liu,132 was upon addition of trifluoroacetic acid converted to a single enantiomer 2.84 
in 67% yield by lactonization under inversion or retention. The enantiomeric excess of 90% 
was determined from the diastereomeric ratio of the corresponding Mosher ester (see 
supporting information).  
The transformation of the primary alcohol 2.84 to the corresponding terminal alkene 
2.73 turned out to be challenging due to the instability of the intermediate aldehyde 2.88 and 
the volatility of the target alkene 2.73. After extensive optimization, 2.73 could be obtained in 
varying yields by use of an oxoammonium oxidation under Piancatelli’s conditions133 followed 
by immediate Kauffmann olefination of the crude material.  
With both coupling partners in hand, the cross metathesis reaction was investigated 
(Table 2.3).123 The use of Grubbs-II catalyst in combination with the terminal alkene 2.74 in 
benzene led to isolation of the desired cross metathesis product (E)-2.89 with dimerization of 
the iron tricarbonyl complex 2.74 as major side product (entry 1). In addition, a further 
consumption of the isolated dimer in the reaction was not observed whereas dimerization of 
alkene 2.73 could not be detected. Changing the solvent to DCE or switching to the Grubbs I 
catalyst resulted in isolation of starting material (entry 2 and 3). The more reactive Grubbs-
Hoveyda II catalyst in CH2Cl2 provided only dimer formation (entry 4), whereas in benzene 
the cross metathesis product could be isolated in 26% yield (entry 6). Slow addition of 2.74 
over 2 h by syringe pump did not improve the yield (entry 5). Several other metathesis 
catalysts were tested and nitro-Grela catalyst 2.93134 provided a slightly improved yield and a 
clean reaction (entry 7–11). However, the main problem in all cases was dimerization of 2.74 
as major competing side reaction.  
These observations imply that based on the classification of alkenes and their 
reactivity reported by Grubbs and coworkers,135 alkene 2.73 represents a Type III olefin 
whereas iron tricarbonyl complex 2.74 can be categorized as Type II olefin due to the fast 
generation of dimerized product which is not further consumed. In general, those systems 
can be successfully coupled if the reaction rate of the cross metathesis event is not too slow 
compared to the dimerization process. To overcome the dimerization problem, a large 
excess of lactone 2.73 was added leading to an improvement of the yield to 47% with 40% of 
competing dimer formation. It was reported that 1,2-disubstituted alkenes tend to give better 
yields in the case of dimerization side products.135 However, when alkene 2.75 was reacted 
in presence of excess lactone 2.73 and different catalysts, dimerization could not be 
suppressed (entry 12–16). 
The modest yield obtained in the cross metathesis also in presence of a large excess 
of lactone 2.73 limited the scalability and the practicability of this synthetic route. Therefore, it 
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was decided to change the initially envisioned synthesis which is presented in the next 
chapter. 
Table 2.3 Cross metathesis of cyclobutadiene iron tricarbonyl complex 2.74 or 2.75 and lactone 2.73. 
 
No. solvent catalyst temperature 2.74/2.75 (eq 2.73) observation 
1 C6H6 G-II (20 mol%) 40 °C 2.74 (2.0) 26% 
2 DCE G-II (10 mol%) 35 °C 2.74 (2.7) no reaction 
3 C6H6 G-I (10 mol%) 40 °C 2.74 (2.0) no reaction 
4 CH2Cl2 GH-II (10 mol%) 40 °C 2.74 (2.0) dimerization 
5a C6H6 G-II (15 mol%) 40 °C 2.74 (2.0) 26% 
6 C6H6 GH-II (10 mol%) 40 °C 2.74 (2.0) 26% 
7 C6H6 2.90 (10 mol%) 40 °C 2.74 (2.0) ~25% 
8 C6H6 2.91 (10 mol%) 40 °C 2.74 (2.0) traces 
9 C6H6 2.92 (10 mol%) 40 °C 2.74 (2.0) no reaction 
10 C6H6 2.93 (10 mol%) 40 °C 2.74 (2.0) 30% 
11 C6H6 2.93 (10 mol%) 40 °C 2.74 (8.0) 47%, 40% dimer  
12 C6H6 2.93 (15 mol%) 40 °C 2.75 (4.0) 30%, 35% dimer  
13 C6H6 2.93 (20 mol%) 40 °C 2.75 (4.0) 27% 
14 C6F6 2.93 (20 mol%) 40 °C 2.75 (4.0) 50% conversion 
15 C6H6 Schrock (20 mol%) 40 °C 2.75 (4.0) no reaction 
16 C6H6 2.92 (15 mol%) 40 °C 2.75 (4.0) no reaction 
a slow addition of 2.74 via syringe pump. 
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2.2.1.5 Revised second generation strategy – An alkyne addition approach 
An alkyne addition strategy was assumed to be a more scalable and practical 
approach towards the synthesis of the desired cyclization precursor 2.72. Asymmetric 
additions of aryl substituted alkynes were reported which were assumed to be adaptable for 
the “metalloaromatic” system.136 Nevertheless, we decided to test the synthetic route with 
racemic material initially. The synthesis of the desired iron tricarbonyl complex 2.72 is 
depicted in Scheme 2.14. Under Bestmann–Ohira conditions, aldehyde 2.81 could be 
converted to the corresponding terminal alkyne 2.95 in good yield.137 Furthermore, the 
Johnson–Claisen product 2.83 was ozonolyzed to aldehyde 2.96, which was found to be very 
unstable upon concentration and had to be stored at low temperature in solution.  
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Scheme 2.14 Synthesis of enone 2.72. 
With both fragments 2.95 and 2.96 in hand, the crucial alkyne addition was 
investigated. Deprotonation of the terminal alkyne 2.95 at low temperature followed by 
addition of aldehyde 2.96 resulted in a mixture of the corresponding secondary alcohol and 
lactone 2.97. However, the crude reaction mixture could be completely converted to the 
closed lactone 2.97 in good yield under acidic conditions. In the next step, the triple bond had 
to be completely reduced to the alkyl side chain. Initial results using heterogeneous catalysis 
were promising. Unfortunately, upon scale up, the reactions did not go to completion even 
when high pressure conditions (up to 11 bar H2) were applied. After some optimization, 
diimide reduction conditions using tosyl hydrazide and sodium acetate in large excess at 
elevated temperatures proved to be ideal, delivering the fully reduced compound 2.98 in very 
good yield.138 The installation of the alkene, necessary for the intramolecular cycloaddition, 
was performed by Eschenmoser methenylation139 and exo-methylene lactone 2.72 could be 
unambiguously identified by single crystal X-ray analysis. 
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Table 2.4 Intramolecular cyclobutadiene (2+2) cycloaddition of 2.72. 
 
No. oxidant (eq) temperature solvent time observation 
1 CAN (5.0) r.t. acetone 10 min degradation 
2a CAN (5.0) r.t. to 40 °C C6H6 20 h degradation 
3 CAN (5.0) 75 °C DMF 10 min degradation 
4 DDQ (4.0) r.t. C6H6 3.5 h no conversion 
5 DDQ (4.0) 65 °C C6H6 3.5 h no conversion 
6 Pb(OAc)4 (2×5.0) r.t. pyridine 15 min no conversion 
7 Pb(OAc)4 (15.0) 75 °C C6H6 5 min degradation 
8 O2 (1 atm) 45 °C C6H5CF3 12 h no conversion 
9 pyridine-N-oxide (15) 55 °C C6H5CF3 20 h no conversion 
10 CuCl2·H2O (15) 40 °C C6H5CF3 1 h degradation 
11 FeCl3·6H2O (10) r.t. THF/EtOH 13 h no conversion 
12 TMAO (2×10) 50 °C acetone 12.5 h complex mixture 
13 TMAO (2×4.0) 60 °C acetone 7.5 h complex mixture 
14 TMAO (2×4.0) 85 °C C6H6 21 h 39% diene 2.100 
15 TMAO (15) 75 °C C6H6 12 h 2.72:2.99:2.100   0.7:1.0:1.5 
16 TMAO (15) 65 °C C6H5CH3 12 h 2.72:2.99:2.100   1.0:1.0:0.8 
17 TMAO (15) 65 °C xylene 12 h no conversion 
18 TMAO (15) 55 °C C6H5CH3 12 h no conversion 
19 TMAO (15) 55 °C C6H5CF3 12 h traces of 2.99 
20 TMAO (15) 55 °C THF 13 h complex mixture 
21 TMAO (15) 55 °C 1,4-dioxane 13 h complex mixture 
22 TMAO (15) 55 °C MeCN 13 h no conversion 
23 TMAO (15) 55 °C EtOH 16 h no conversion 
24 TMAO (15) 55 °C TFE 16 h no conversion 
25 TMAO (15) 55 °C EtOAc 13 h complex mixture 
26 TMAO (15) 55 °C DMA 13 h degradation 
27 TMAO (15) 40 °C DMA 13 h 3% 2.99 (NMR), degradation 
a slow addition of the starting material 2.72. 
 
For the intramolecular [2+2] cycloaddition, iron tricarbonyl complex 2.72 was treated 
with several oxidants known to promote oxidative decomplexation, releasing the reactive 
cyclobutadiene (Table 2.4).122a However, initial experiments using several single- and 
two-electron oxidants (CAN,140 DDQ,141 Pb(OAc)4,142 O2, pyridine-N-oxide, CuCl2,143 FeCl3141) 
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were not successful (entry 1–11). When trimethylamine N-oxide144 was added as oxidant at 
85 °C, the undesired cyclohexadiene 2.100 was observed as major reaction product (entry 
14). Presumably, this compound is formed by ring opening of the desired cyclobutene 2.99 
via a diradical mechanism (Scheme 2.15a). This reactivity was used by Snapper for the 
synthesis of cyclohexadienes. However, the reported standard procedure was conducted at 
temperatures above 200 °C,145 reflecting the labile C–C bond in ladderane intermediate 2.99. 
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Scheme 2.15 Thermal opening of the cycloaddition product 2.99. 
At lower reaction temperature, the desired cycloaddition product 2.99 could be 
isolated as an inseparable mixture with residual starting material 2.72 and identified by full 
NMR analysis and high resolution mass spectroscopy (entry 15 and 16). Subjecting this 
material to a temperature gradient experiment (Scheme 2.15b), a slow opening of the 
unsaturated ladderane system to cyclohexadiene 2.100 was observed at 50 °C.  
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Scheme 2.16 Attempts to prevent ring opening during the (2+2) cycloaddition. 
Attempts to lower the reaction temperature in different solvents led to either no 
reaction or complete decomposition (entry 12, 13, 17–27). Furthermore, the feasibility of an 
in situ trapping of the reactive cyclobutene double bond by dihydroxylation or epoxidation via 
the addition of OsO4 or mCPBA was investigated (Scheme 2.16). These experiments were 
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just as unsuccessful as the attempt to isomerize the double bond in situ to the exocyclic 
position in the presence of Pd(OAc)2.146 The use of substoichiometric quantities of Lewis acid 
to decrease the reaction temperature by LUMO-lowering activation of the enone system led 
to either degradation or no conversion. 
In addition, a possible reason for the inefficient cyclization of the system could be the 
difficulty of the formation of six-membered rings by cyclobutadiene cycloadditions, as 
described by Snapper.122a Consequently, (Z)-alkene 2.106 was synthesized in two steps from 
the known intermediate 2.97 to obtain an even more organized transition state in the 
oxidative cyclization step (Scheme 2.17). Interestingly, hydrogenation of the triple bond in 
EtOH stopped chemoselectively at (Z)-2.89. Unfortunately, upon oxidative decomplexation 
with CAN or trimethylamine N-oxide, no desired cyclization product 2.107 could be identified 
in the reaction mixture. 
 
 
Scheme 2.17 Synthesis of (Z)-alkene 2.107. 
 Moreover, the unexpected instability of the desired cyclobutene 2.99 was justified by 
the additional strain introduced by the polycyclic lactone structure within the desired product 
2.99. Hence, derivatization of 2.72 or 2.98 to several linear cyclization precursors was 
investigated (Scheme 2.18). The opening of the exocyclic unsaturated lactone moiety was 
difficult and resulted in 1,4-addition products or complex mixtures (MeMgBr; KOH/BnBr; 
HC(OMe)3/H2SO4).  
Treatment of lactone 2.98 with pyrrolidine under Lewis acidic conditions afforded the desired 
amide 2.115 after protection of the neopentylic alcohol. However, formation of the 
unsaturated linear precursor 2.116 under Eschenmoser methenylation conditions failed, 
presumably due to the steric hindrance of the neighboring gem-dimethyl moiety.  
Diol formation by reduction of 2.72 with DIBAL-H occurred cleanly and protection of 
the allylic alcohol 2.109 afforded TBS-protected alcohol 2.110. Compounds 2.109 and 2.110, 
however, provided complex mixtures upon oxidative decomplexation using CAN or trimethyl-
amine N-oxide. This might be explained by the higher degrees of freedom in the case of 
linear precursors leading to a slower cyclization rate. As the intermolecular dimerization of 
Synthesis of aplydactone  49 
 
cyclobutadienes is known to proceed in a diffusion controlled manner, it is likely that the 
cyclization of the linear precursors 2.109 and 2.110 is too slow to compete with the 
dimerization.122a 
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Scheme 2.18 Derivatization of iron tricarbonyl complexes 2.72 and 2.98. 
In conclusion, the oxidative (2+2) cycloaddition of iron tricarbonyl complex 2.72 
provided the desired ladderane moiety present in aplydactone (2.11). Nonetheless, the 
instability of the desired intermediate 2.99 rendered its synthetic use impossible. Thus, it was 
envisioned to use another type of (2+2) cycloaddition for the formation of the desired 
ladderane structure which would result in a more stable intermediate (Scheme 2.19). This 
seemed especially attractive due to the formation of three adjacent quaternary carbons in a 
single operation which was shown to be feasible by the observation of intermediate 2.99.  
 
 
Scheme 2.19 General idea for a revised cycloaddition approach towards the ladderane scaffold. 
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2.2.1.6 Third generation approach – A non-biomimetic photochemical total 
synthesis of aplydactone 
 
 
 
 
 
 
 
Reprinted with permission from R. Meier, D. Trauner, Angew. Chem. Int. Ed. 2016, 55, 
11251–11255. Copyright © 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. 
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2.2.2 Investigations on the biosynthesis of chamigrane natural products from 
Aplysia dactylomela – Total synthesis of dactylone, 10-epi-dactylone, 
aplydactone and 8-epi-isoaplydactone 
 
 
 
 
 
 
 
Reprinted with permission from B. S. Matsuura,† P. Kölle,† D. Trauner, R. de Vivie-Riedle, R. 
Meier, ACS Cent. Sci. 2017, 3, 39–46. Copyright © American Chemical Society. 
 
† These authors contributed equally to this work. 
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2.3 Conclusion 
In conclusion, the first total synthesis of the complex ladderane natural product 
aplydactone was achieved and biosynthetic relationships between the isolated chamigrane 
natural products from Aplysia dactylomela were uncovered.  
Initial attempts to access the complex core structure of aplydactone via a 
cyclopropanation or ketene cycloaddition strategy failed due to the high steric congestion of 
the unsaturated decalin system. An approach using intramolecular cyclobutadiene (2+2) 
cycloaddition for the formation of the essential [2]-ladderane system provided promising 
results. During these investigations the two crucial neighboring quaternary stereocenters 
next to a gem-dimethyl moiety could be formed in a single step. Although this cycloaddition 
could not be optimized to exclusively yield the desired cyclization product due to a competing 
radical ring opening of a highly strained cyclobutene subunit, this approach was crucial for 
the subsequent successful planning of a non-biomimetic photochemical strategy.  
A high yielding and scalable route towards the [2+2] photoprecursor was achieved 
from cheap starting materials and the key [2+2] cycloaddition provided the necessary tricyclic 
6-4-5 system in good yield and high diastereoselectivity. A photochemical Wolff ring 
contraction provided not only the desired [2]-ladderane structure of aplydactone, but also an 
ester functionality which served as a handle to diastereoselectively install the last quaternary 
stereocenter. For the completion of the first total synthesis of aplydactone, the decalin 
system had to be closed. This was achieved by an intramolecular Barbier reaction which 
involved a fascinating conformational ring flip of a highly strained intermediate. For the final 
introduction of the secondary bromide, new radical conditions had to be developed in order 
to finish the synthesis. 
In a second approach, aplydactone was synthesized from its proposed biomimetic 
precursor dactylone via an intramolecular [2+2] photocycloaddition. Although this 
transformation was reported to be nonviable, computational investigations by Dr. Patrick 
Kölle and Prof. Dr. Regina de Vivie-Riedle demonstrated that the choice of wavelength in this 
photochemical transformation is essential to prevent degradation pathways originating from 
C–Br bond cleavage. A Diels–Alder approach using a highly optimized enone intermediate 
containing a traceless directing group allowed us, in combination with our radical bromination 
conditions, to synthesize the natural product 10-bromo-β-chamigrene. This key intermediate 
could be converted in a diastereodivergent manner to either dactylone or its naturally 
occurring epimer 10-epi-dactylone using bioinspired oxidation strategies. Irradiation of 
dactylone with UV-A light provided aplydactone as a single reaction product, thereby 
violating the “rule of five”. Moreover, irradiation under the same biomimetic conditions, 
converted 10-epi-dactylone to a so far unknown “rule of five” product, which was named 8-
epi-isoaplydactone. Based on these results, it was proposed that this compound is a natural 
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product produced non-enzymatically in Aplysia dactylomela. Further computational 
investigations unveiled that the secondary bromide, in the structure of dactylone and its 
epimer, is the decisive controlling element for the outcome of the photochemical [2+2] 
cycloaddition. 
To conclude, these two strategically different approaches towards aplydactone 
highlight the outstanding synthetic possibilities offered by photochemistry to access 
connectivities which are otherwise impossible to generate. 
 Synthetic studies towards merochlorin A and B were previously covered in the Master’s thesis of Robin Meier, 
LMU Munich, 2013. Results on the synthesis of the two fragments were already described there. 
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3 HALOGENATED NATURAL PRODUCTS  
The incorporation of halogens into natural products has been observed frequently and 
more than 5000 organohalogens have been isolated and structurally identified to date with 
new compounds being reported at a rate of about 200 members annually.147 The vast 
majority has been isolated from marine sources like sponges, corals, seaweed and sea 
slugs, presumably due to the high content of the corresponding salts in seawater. 
Furthermore, chloride and bromide substituents are most abundant compared to the 
relatively small number of iodide and especially fluoride containing natural products.148 
Halogenation is not limited to a special natural product class as halogens have been found in 
the structures of alkaloids, terpenoids, polyketides, fatty acids, steroids and simple alkanes 
(3.1–3.13 Figure 3.1).147a,149 In humans, relatively few organohalogens are synthesized. The 
most prominent members of human halogenated natural products are the iodinated thyroid 
hormones represented by the structure of thyroxine (3.2).147c,d Interestingly, 
bromoacetoacetate 3.13 was isolated from human cerebrospinal fluid and was identified to 
be an inducer of rapid-eye-movement (REM) sleep.150 
 
 
Figure 3.1 Structures of representative naturally occurring organohalogens 3.1–3.13. 
Halogen-containing natural products in general show high bioactivity and different 
members have been described to show antimicrobial, antifungal, antibiotic, antiviral and 
anticancer activity.147a The role of the halogen-containing natural products for the producing 
organism is not always known, however antifeedant and chemical defense function have 
been reported as well as their function as regulatory hormones and signaling molecules. 
  
Solvated halide anions serve as the major halogen source and are introduced by 
nature using three general reaction pathways which are summarized in Scheme 3.1a.151 
Oxidation of a halide anion forms an electrophilic halonium species (“X+”) which is transferred 
to a nucleophilic aromatic system or an alkene. Three mechanistically and structurally 
different enzymes were reported to follow this electrophilic halogenation pathway. While 
haem- and vanadium-dependent haloperoxidases generate hypohalous acid from hydrogen 
peroxide and a halide by making use of their metal center, a FAD (flavin-adenine 
dinucleotide) cofactor is used by flavin-dependent haloperoxidases. 
 
 
Scheme 3.1 a) Overview of the halogenation mechanisms in biosynthesis; b) Catalytic cycle of a 
vanadium-dependent haloperoxidase. 
A radical rebound mechanism, similar to the one used by FeNH-αKG-oxygenases, 
allows for the halogenation of unactivated Csp3-H bonds by the activity of a non-haem iron 
halogenase. The mechanism involves the oxidative decarboxylation of α-ketoglutarate to 
succinate for the generation of an active Fe(IV)-oxo intermediate.  
In the biosynthesis of organofluorides, it is not possible to generate a formal “F+” or “F·” 
under physiological conditions as consequence of the positive reduction potential of fluorine, 
which would be necessary to synthesize fluorinated natural products by an electrophilic or 
radical enzyme mechanism. Therefore, nature uses the nucleophilicity of fluoride to 
incorporate fluorine into secondary metabolites. Mechanistically, the fluorinases have to 
dissolvate the fluoride anion in their active site by specific interactions with the protein 
scaffold to generate a strong nucleophile for the substitution reaction.147f Similar 
transformations were reported for S-adenosyl methionine chlorinases and halide methyl 
transferases. 
In the biosynthesis of halogenated marine natural products, which represent the 
majority of natural organohalogens, vanadium-dependent haloperoxidases are proposed to 
play a prevalent role, e.g. in the formation of halogenated cyclic terpenes or the formation of 
halogenated cyclic ethers.100 From a mechanistic point of view, these enzymes coordinate 
hydrogen peroxide in the active site forming a side-on bound η2-peroxo complex 3.15, which 
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can oxidize a halide to the corresponding hypohalous acid bound to the vanadate center 3.16 
(Scheme 3.1b). At this point, it is not known if this reactive bromination reagent is attacked by 
the nucleophilic substrate within the active site or if hypohalite is released from the metal 
center. Compared to the haem-dependent haloperoxidases, the metal center does not 
change its oxidation state during the catalytic cycle in the case of vanadium-dependent 
haloperoxidases.
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4 BIOMIMETIC TOTAL SYNTHESIS OF THE MARINE 
NATURAL PRODUCT MEROCHLORIN B 
4.1 Introduction 
4.1.1 Isolation and structure 
In 2012, the isolation of merochlorin A (4.1, Figure 4.1), a chlorine containing mixed 
polyketide-terpenoid natural product from the marine sediment bacterium Streptomyces 
spectabilis strain CNH-189 collected at the Californian coast, was reported.152 In the same 
year, Moore and Fenical isolated three other members of this marine meroterpenoid family, 
named merochlorin B–D (4.2–4.4).153 The antibiotic activity of merochlorin A (4.1) and B (4.2) 
against Clostridium difficile and various multi-drug resistant Staphylococcus aureus strains 
was of major interest along with the unprecedented carbon frameworks of 4.1 and 4.2. 
 
 
Figure 4.1 Members of the merochlorin family. 
In addition to their isomeric chemical formula, merochlorin A (4.1) and B (4.2) 
represent several common structural motifs including a resorcinol unit, a 
propan-2-ylidenecyclopentane substructure and a terpene side chain. Moreover, 4.1 contains 
a unique chlorinated bicyclo[3.2.1]octadiene, whereas 4.2 possesses a chlorinated 6-5-5-
fused tricycle with three stereogenic centers. The carbon skeleton of merochlorin A (4.1) 
could be unambiguously determined by single crystal X-ray analysis of a methylated and 
acetylated derivative.153 
The macrocyclic merochlorin C (4.3), most likely derived from merochlorin D (4.4) via 
chloroetherification, contains two chloride substituents and a 1,4-cyclohexanedione structure. 
The absolute configuration of the secondary C18-chloride substituent has not yet been 
assigned. An additional methyl and hydroxyl substituent on the framework of merochlorin C 
(4.3) and D (4.4) indicate contribution of an oxygenase and a methyltransferase to modify the 
common biosynthetic precursor of the merochlorin family. 
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4.1.2 Biosynthesis 
The isolation chemists could identify a 57.6 kb merochlorin gene cluster containing 41 
open reading frames (mcl 1–41).153 By making use of sequence homology, enzymatic 
synthesis and gene knock out experiments, a polyketide type III synthase (mcl 17) was 
reported to catalyse the formation of 1,3,6,8-tetrahydroxynaphthalene (4.6) from five malonyl-
CoA subunits (4.5, Scheme 4.1).154  
 
 
Scheme 4.1 Biosynthesis of the key cyclization precursor 4.12. 
The synthesis of the unusual sesquiterpene isosesquilavandulyl diphosphate (4.10) 
was rationalized by a “head-to-torso” coupling of geranyl pyrophosphate (GPP, 4.8) and 
dimethyl allyl diphosphate (DMAPP, 4.7). A Mg2+-dependent polyprenyl synthase (mcl 22) 
was detected within the gene cluster catalyzing this transformation. A possible mechanism 
for the formation of 4.10 involves an initial attack of the nucleophilic double bond of DMAPP 
(4.7) onto the allylic position of GPP (4.8) followed by an elimination of the tertiary cation to 
the tetrasubstituted double bond.  
For the formation of merochlorin A (4.1) and B (4.2), the electron-rich polyketide fragment 4.6 
is coupled by a prenyltransferase (mcl 23) to the sesquiterpenoid side chain 4.10 to deliver 
the intermediate 4.11, which can be chlorinated at the aromatic core to 4.12 by the activity of 
a vanadium-dependent chloroperoxidase (mcl 24). 
For the formation of 4.1 and 4.2 from intermediate 4.12, Moore and coworkers initially 
proposed a cascade involving epoxidation or chlorination of the central trisubstituted double 
bond.153 However, an oxidative dearomatization of the electron-rich naphthalene core to 
phenoxonium ion 4.13 and subsequent stepwise (5+2) cyclization to merochlorin A (4.1) is 
another possibility (Scheme 4.2a). For the formation of the complex structure of 
merochlorin B (4.2), a (3+2) cyclization of the intermediate phenoxonium cation 4.13 was 
proposed by us and others.155 This oxidative process was recently shown to be catalyzed by 
the same chloroperoxidase (mcl 24) which is responsible for the chlorination of the 
naphthalene core.156  
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While our investigations were ongoing, George and coworkers synthesized 
merochlorin A (4.1) from cyclization precursor 4.15 by oxidation with Pb(OAc)4 (Scheme 
4.2b). Interestingly, they could not identify merochlorin B (4.2) under the applied conditions. 
 
 
Scheme 4.2 a) Oxidative (5+2) and (3+2) cyclization to merochlorin A (4.1) and B (4.2); b) Biomimetic 
cyclization of 4.15 by George and coworkers. 
Further oxidation of 4.6 leads to flaviolin hydroquinone (4.17) which is proposed to be 
coupled to 4.10 to obtain merochlorin D (4.4) after chlorination (mcl 24) and methylation 
(mcl 21, Scheme 4.3). A second vanadium-dependent chloroperoxidase (mcl 40) within the 
gene cluster can mediate the chloroetherification of 4.4 to merochlorin C (4.3) via an 
intermediate tertiary cation 4.19. 
 
 
Scheme 4.3 Biosynthesis of merochlorin C (4.3) and D (4.4). 
In conclusion, all members of the merochlorin family are derived from a polyketide 
and sesquiterpenoid fragment which are modified by oxidation, chlorination, cyclization 
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towards the different family members. Interestingly, the natural products 4.1 and 4.2 were 
obtained as single enantiomers implying formation within the chiral environment of the 
vanadium-dependent chloroperoxidase (mcl 24) to induce asymmetric cyclization of the 
prochiral phenoxonium cation 4.13. 
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4.2 Results and discussion  
 
 
 
 
 
 
 
Reprinted with permission from R. Meier, S. Strych, D. Trauner, Org. Lett. 2014, 16, 2634–
2637. Copyright © 2014 American Chemical Society. 
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4.3 Conclusion 
In this chapter, the first total synthesis of merochlorin B, a chlorinated meroterpenoid 
isolated from the marine sediment bacterium Streptomyces spectabilis strain CNH-189 in a 
biomimetic fashion was described. Crucial for the completion of the synthesis of this complex 
natural product was the development of a reliable route towards the chlorinated naphthalene 
core. This could be achieved by a directed-ortho metalation (DoM) relying on the cooperative 
effect of two methoxy groups in meta-position. The desired isosesquilavandulyl side chain 
was accessible via a Peterson olefination-based strategy. Both fragments could be accessed 
on multigram scale allowing for the screening of the crucial coupling reaction and the 
proposed biomimetic oxidative dearomization cascade.  
Ortho-allylation of a 2-naphthol intermediate with the isosesquilavandulyl bromide 
afforded the desired biomimetic cyclization precursor. Initial investigations using lead(IV) 
oxidants, as described in the synthesis of merochlorin A by George and coworkers, just 
provided the corresponding Wessely oxidation products, which could not be converted to any 
desired cyclization product. However, after intense screening of oxidative conditions, a rarely 
applied in situ generated version of Koser’s reagent provided merochlorin B in a formal (3+2) 
cycloaddition of an intermediate phenoxonium cation after final deprotection. This result 
confirmed the initial biomimetic proposal for the formation of merochlorin A and B.  
This is even more fascinating due to the fact that merochlorin A which was the only 
product in George’s biomimetic synthesis formed by a (5+2) cycloaddition, could not be 
identified in the reaction mixture. A comparison of the two similar biomimetic cyclization 
precursors gave rise to the assumption that a methyl protecting group in the merochlorin B 
precursor alters the nucleophilicity within the system to such an extent that the (3+2) 
cyclization mode is favored. This reflects that a subtle change in the reactant structure can 
drastically alter the outcome of a biomimetic transformation. 
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5 GENERAL EXPERIMENTAL DETAILS 
All reactions were carried out with magnetic stirring, and if moisture or air sensitive, under 
nitrogen or argon atmosphere using standard Schlenk techniques in oven-dried glassware 
(140 °C oven temperature), further dried under vacuum with a heat-gun at 650 °C. External 
bath temperatures were used to record all reaction temperatures. If catalytic amounts of 
transitions metals were used and in the case of photochemical reactions, the solvents were 
degassed by freeze-pump-thaw method (3 × 10 min) or by sparging with argon (20–30 min). 
Low temperature reactions were carried out in a Dewar vessel filled with             
Et2O/liq. N2 (–115 °C), acetone/dry ice (–78 °C) or distilled water/ice (0 °C). High temperature 
reactions were conducted using a heated silicon oil bath in reaction vessels equipped with a 
reflux condenser or in a pressure tube. Tetrahydrofuran (THF) and diethyl ether (Et2O) were 
distilled over sodium and benzophenone prior to use. Dichloromethane (CH2Cl2), 
triethylamine (Et3N), diisopropylethylamine (DIPEA) and diisopropylamine (DIPA) were 
distilled over calcium hydride under a nitrogen atmosphere. All other solvents were 
purchased from Acros Organics as ‘extra dry’ reagents. All other reagents with a purity 
> 95% were obtained from commercial sources (Sigma Aldrich, Acros, Alfa Aesar and 
others) and used without further purification. 
 
Photochemical reactions were performed in a Rayonet RPR-200 photochemical reactor 
using 300 nm or 350 nm lamps (16 × RPR-3000Å, 250W) at room temperature or in a 
vacuum isolated Pyrex® immersion well equipped with a medium pressure mercury lamp 
(150 W) using a Heraeus power supply at –78 °C. 
 
Flash column chromatography was carried out with Merck silica gel 60 (0.040–0.063 mm). 
In a few cases, flash column chromatography was carried out with Grace Davison silica 
(Davisil® LC60A 40–63 Micron).  
 
Analytical thin layer chromatography (TLC) was carried out using Merck silica gel 60 
F254 glass-backed plates and visualized under UV light at 254 nm. Staining was performed 
with ceric ammonium molybdate (CAM) or by oxidative staining with an aqueous basic 
potassium permanganate (KMnO4) solution and subsequent heating. 
 
NMR spectra (1H NMR and 13C NMR) were recorded in deuterated chloroform (CDCl3), 
benzene (C6D6), dichloromethane (CD2Cl2), acetonitrile (CD3CN) or dimethylsulfoxide (d6-
DMSO) on a Bruker Avance III HD 400 MHz spectrometer equipped with a CryoProbe™, a 
Varian VXR400 S spectrometer, a Bruker AMX600 spectrometer or a Bruker Avance III HD 
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800 MHz spectrometer equipped with a CryoProbe™ and are reported as follows: chemical 
shift δ in ppm (multiplicity, coupling constant J in Hz, number of protons) for 1H NMR spectra 
and chemical shift δ in ppm for 13C NMR spectra. Multiplicities are abbreviated as follows: s = 
singlet, d = doublet, t = triplet, q = quartet, quint = quintet, br = broad, m = multiplet, or 
combinations thereof. Residual solvent peaks of CDCl3 (δH = 7.26 ppm, δC = 77.16 ppm), 
C6D6 (δH = 7.16 ppm, δC = 128.06 ppm), CD2Cl2 (δH = 5.32 ppm, δC = 54.00 ppm), CD3CN (δH 
= 1.94 ppm, δC = 118.26 ppm) or d6-DMSO (δH = 2.50 ppm, δC = 39.52 ppm) were used as 
an internal reference. NMR spectra were assigned using information ascertained from 
COSY, HMBC, HSQC and NOESY experiments.  
 
High resolution mass spectra (HRMS) were recorded on a Varian MAT CH7A or a Varian 
MAT 711 MS instrument by electron impact (EI) or electrospray ionization (ESI) techniques 
at the Department of Chemistry, Ludwig-Maximilians-University Munich. 
 
Infrared spectra (IR) were recorded from 4000 cm−1 to 600 cm−1 on a PERKIN ELMER 
Spectrum BX II, FT-IR instrument. For detection a SMITHS DETECTION DuraSamplIR II 
Diamond ATR sensor was used. Samples were prepared as a neat film or a thin powder 
layer. IR data in frequeny of absorption (cm−1) is reported as follows: w = weak, m = medium, 
s = strong, br = broad or combinations thereof. 
 
Melting Points were measured with a BÜCHI Melting Point B-450 instrument in open 
glascapillaries and are uncorrected. 
 
Optical rotation values were recorded on a polarimeter P8000-T from A. Krüss Optronic 
GmbH or on a PERKIN ELMER 241 polarimeter. The specific rotation is calculated as 
follows:  
     [α]λϑ ൌ	 α ∙ 100c ∙ d  
The wavelength λ is reported in nm and the measuring temperature ϑ in °C. The recorded 
optical rotation is α, the concentration of the analyte is used in 10 mg/mL and the length of 
the cuvette is in dm. Thus, the specific rotation is given in 10-1 deg cm2 g-1. Usage of the 
sodium D line (λ = 589 nm) is indicated by D. The concentration as well as the solvent is 
reported at the relevant section of the experimental part. 
 
UV-visible spectra were recorded on a Varian Cary 50 Bio UV-Visible Spectrophotometer 
using Starna 29/B/12 quartz cuvettes with 10 mm section thickness.  
 
All yields are isolated, unless otherwise specified. 
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6 EXPERIMENTAL PROCEDURES, SPECTROSCOPIC AND  
X-RAY CRYSTALLOGRAPHIC DATA  
6.1 Supporting information for Chapter 2.2.1.1–2.2.1.5 
6.1.1 Experimental procedures 
 
 
7-Methoxy-3,4-dihydronaphthalen-2-one (2.45) To a stirred solution of naphthalene 2.46 
(15.0 g, 79.7 mmol, 1.0 eq) in EtOH (315 mL) was carefully added sodium metal (20.7 g, 
901 mmol, 11.3 eq) at reflux and the resulting reaction mixture was stirred for 30 min. The 
reaction mixture was cooled to 0 °C followed by addition of H2O (100 mL) and conc. HCl 
(300 mL). The resulting mixture was refluxed for 10 min. The layers were separated and the 
aqueous layer was extracted with CH2Cl2 (3 × 150 mL). The combined organic layers were 
washed with brine (150 mL) and dried over Na2SO4. After filtration and concentration in 
vacuo, the crude product was purified by flash column chromatography (hexanes:EtOAc 9:1) 
on silica to afford ketone 2.45 (9.40 g, 53.3 mmol, 67%) as a white solid. Compound 2.45 
has been reported in the literature.106b 
 
Data for 2.45: Rf: 0.24 (hexanes:EtOAc 9:1); 1H NMR (400 MHz, CDCl3): δ = 7.14 (d, 
J = 8.3 Hz, 1H), 6.76 (dd, J = 8.3, 2.6 Hz, 1H), 6.67 (d, J = 2.5 Hz, 1H), 3.79 (s, 3H), 3.56 (s, 
2H), 3.00 (t, J = 6.7 Hz, 2H), 2.56 – 2.52 (m, 2H) ppm; 13C NMR (100 MHz, CDCl3): 
δ = 210.8, 158.7, 134.6, 128.9, 128.7, 113.6, 112.5, 55.5, 45.4, 38.7, 27.6 ppm; IR (ATR): 
ߥmax = 2968 (w), 2958 (w), 2903 (w), 2840 (w), 1712 (s), 1607 (m), 1585 (m), 1501 (s), 
1464 (m), 1455 (m), 1442 (m), 1393 (m), 1342 (m), 1315 (m), 1253 (s), 1234 (m), 1207 (m), 
1186 (m), 1155 (s), 1118 (m), 1103 (m), 1032 (s), 976 (m), 942 (m), 896 (m), 870 (m), 
833 (s), 821 (s), 771 (m), 737 (m), 692 (m) cm−1; melting point: 24.5 °C (semisolid at r.t.; lit.: 
23.0 – 24.0 °C)157; HRMS (EI): calc. for C11H12O2 [M]+: 204.1145, found:204.1152. 
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7-Methoxy-1,1-dimethyl-3,4-dihydronaphthalen-2-one (2.47) To a stirred solution of 
ketone 2.45 (6.58 g, 37.3 mmol, 1.0 eq), tetrabutylammonium hydrogensulfate (2.03 g, 
5.97 mmol, 0.16 eq) and MeI (7.00 mL, 112 mmol, 3.0 eq) in THF (30 mL) was carefully 
added aq. KOH solution (50 wt%, 44 mL) at r.t. and the resulting reaction mixture was stirred 
for 30 min. The reaction was quenched by addition of H2O (100 mL). The layers were 
separated and the aqueous layer was extracted with Et2O (3 × 150 mL). The combined 
organic layers were washed with sat. aq. NH4Cl solution (150 mL) and dried over Na2SO4. 
After filtration and concentration in vacuo, the crude product was purified by flash column 
chromatography (hexanes:EtOAc 14:1) on silica to afford dimethylated ketone 2.47 (7.02 g, 
34.4 mmol, 92%) as a white solid. Compound 2.47 has been reported in the literature.106c 
 
Data for 2.47: Rf: 0.43 (hexanes:EtOAc 9:1); 1H NMR (400 MHz, CDCl3): δ = 7.10 (d, 
J = 8.3 Hz, 1H), 6.88 (d, J = 2.6 Hz, 1H), 6.75 (dd, J = 8.3, 2.6 Hz, 1H), 3.81 (s, 3H), 3.10 – 
2.97 (m, 2H), 2.71 – 2.59 (m, 2H), 1.42 (s, 6H) ppm; 13C NMR (100 MHz, CDCl3): δ = 214.8, 
158.8, 145.0, 129.2, 127.5, 112.3, 111.4, 55.5, 48.0, 37.6, 27.8, 26.9 ppm; IR (ATR): 
ߥmax = 2997 (w), 2933 (w), 2835 (w), 1708 (s), 1609 (m), 1577 (m), 1503 (m), 1494 (m), 
1462 (m), 1422 (w), 1380 (m), 1359 (w), 1343 (w), 1315 (m), 1285 (m), 1264 (s), 1217 (s), 
1201 (m), 1178 (m), 1096 (m), 1075 (s), 1041 (s), 881 (m), 847 (m), 808 (s), 718 (m) cm−1; 
melting point: 58.7 – 59.5 °C; HRMS (EI): calc. for C13H16O2 [M]+: 176.0832, found: 
176.0826. 
 
 
 
6-Bromo-7-methoxy-1,1-dimethyl-3,4-dihydronaphthalen-2-one (S1) To a stirred solution 
of ketone 2.47 (3.00 g, 14.7 mmol, 1.0 eq) in MeCN (60 mL) was added NBS (2.88 g, 
16.2 mmol, 1.1 eq) at r.t. and the resulting reaction mixture was stirred for 14 h. The reaction 
was quenched by addition of H2O (100 mL). The layers were separated and the aqueous 
layer was extracted with Et2O (3 × 100 mL). The combined organic layers were washed with 
brine (100 mL) and dried over Na2SO4. After filtration and concentration in vacuo, the crude 
product was purified by flash column chromatography (hexanes:EtOAc 10:1) on silica to 
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afford bromide S1 (4.14 g, 14.6 mmol, 99%) as a white solid. Compound S1 has been 
reported in the literature.107a 
 
Data for S1: Rf: 0.33 (hexanes:EtOAc 9:1); 1H NMR (400 MHz, CDCl3): δ = 7.35 (s, 1H), 
6.83 (s, 1H), 3.90 (s, 3H), 3.10 – 2.95 (m, 2H), 2.71 – 2.60 (m, 2H), 1.43 (s, 6H) ppm; 
13C NMR (100 MHz, CDCl3): δ = 213.9, 155.1, 144.2, 132.8, 129.0, 109.9, 109.7, 56.5, 48.0, 
37.2, 27.5, 26.9 ppm; IR (ATR): ߥmax = 2969 (w), 2933 (w), 2837 (w), 1710 (s), 1594 (m), 
1510 (w), 1490 (m), 1459 (m), 14651 (m), 1418 (m), 1389 (m), 1383 (w), 1330 (s), 1304 (m), 
1274 (m), 1264 (m), 1240 (m), 1220 (m), 1194 (m), 1093 (s), 1045 (s), 865 (s), 843 (m), 
795 (m), 751 (m), 724 (m) cm−1; melting point: 99.1 – 99.8 °C HRMS (EI): calc. for 
C13H15O2Br79 [M]+: 282.0250, found: 282.0245. 
 
 
 
7-Methoxy-1,1,6-trimethyl-3,4-dihydronaphthalen-2-one (2.48) To a stirred solution of 
bromide S1 (1.70 g, 6.00 mmol, 1.0 eq) and Pd(dppf)Cl2∙CH2Cl2 (131 mg, 180 μmol, 0.16 eq) 
in 1,4-dioxane (24 mL) was added Me2Zn (0.8 M, 9.00 mL, 7.20 mmol, 1.2 eq) at r.t. and the 
resulting reaction mixture was refluxed for 2 h. The reaction was quenched by addition of 
H2O (100 mL) and aq. HCl solution (1.0 M, 50 mL). The layers were separated and the 
aqueous layer was extracted with Et2O (3 × 100 mL) and EtOAc (3 × 100 mL). The combined 
organic layers were washed with brine (150 mL) and dried over Na2SO4. After filtration and 
concentration in vacuo, the crude product was purified by flash column chromatography 
(hexanes:EtOAc 15:1) on silica to afford ketone 2.48 (1.27 g, 5.82 mmol, 97%) as a white 
solid. 
 
Data for 2.48: Rf: 0.50 (hexanes:EtOAc 9:1); 1H NMR (400 MHz, CDCl3): δ = 6.94 (s, 1H), 
6.76 (s, 1H), 3.84 (s, 3H), 3.10 – 2.93 (m, 2H), 2.73 – 2.60 (m, 2H), 2.20 (s, 3H), 1.43 (s, 6H) 
ppm; 13C NMR (100 MHz, CDCl3): δ = 215.0, 156.9, 141.8, 130.4, 126.7, 124.9, 107.6, 55.5, 
47.7, 37.5, 27.8, 27.0, 15.7 ppm; IR (ATR): ߥmax = 2967 (w), 2930 (w), 2852 (w), 2833 (w), 
1709 (s), 1615 (m), 1579 (w), 1501 (s), 1461 (m), 1406 (m), 1379 (m), 1328 (m), 1317 (m), 
1271 (m), 1247 (s), 1228 (m), 1220 (m), 1153 (m), 1132 (m), 1100 (m), 1059 (s), 1017 (m), 
1001 (m), 959 (w), 880 (m), 848 (m), 819 (m), 758 (w), 716 (w), 666 (w) cm−1; melting point: 
45.6 – 46.1 °C; HRMS (EI): calc. for C14H18O2 [M]+: 218.1301, found: 218.1300. 
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7-Methoxy-1,1,6-trimethyl-1,2,3,4-tetrahydronaphthalen-2-ol (2.57) To a stirred solution 
of ketone 2.47 (1.27 g, 5.82 mmol, 1.0 eq) in MeOH (35 mL) was added NaBH4 (330 mg, 
8.73 mmol, 1.5 eq) at 0 °C and the resulting reaction mixture was allowed to warm to r.t. over 
2 h. After concentration in vacuo, the crude product was purified by flash column 
chromatography (hexanes:EtOAc 5:13:1) on silica to afford alcohol 2.57 (1.24 g, 5.63 
mmol, 97%) as a white solid. 
 
Data for 2.57: Rf: 0.40 (hexanes:EtOAc 3:1); 1H NMR (400 MHz, C6D6): δ = 6.73 (s, 1H), 
6.70 (s, 1H), 3.49 (dd, J = 9.1, 3.0 Hz, 1H), 3.41 (s, 3H), 2.69 (dt, J = 16.5, 5.8 Hz, 1H), 2.57 
(ddd, J = 16.1, 8.7, 6.5 Hz, 1H), 2.30 (s, 3H), 1.82 – 1.62 (m, 2H), 1.32 (s, 3H), 1.28 (s, 3H), 
0.94 (s, 1H) ppm; 13C NMR (100 MHz, C6D6): δ = 156.9, 143.2, 131.2, 126.2, 124.4, 108.0, 
75.6, 54.8, 39.5, 29.0, 27.9, 27.0, 25.3, 16.1 ppm; IR (ATR): ߥmax = 3408 (br w), 2957 (w), 
2929 (m), 2863 (w), 2357 (w), 1720 (br w), 1614 (w), 1497 (s), 1461 (m), 1451 (m), 1400 (w), 
1375 (m), 1312 (m), 1247 (s), 1237 (m), 1208 (m), 1184 (m), 1141 (m), 1046 (s), 1009 (m), 
997 (m), 956 (m), 849 (m), 780 (m), 634 (m) cm−1; melting point: 72.3 – 73.3 °C; HRMS 
(EI): calc. for C14H20O2 [M]+: 220.1458, found: 220.1463. 
 
 
 
1,4-Cyclohexadiene 2.42 To a stirred solution of alcohol 2.57 (700 mg, 3.18 mmol, 1.0 eq) 
in a mixture of liquid ammonia (~40 mL, condensed at −78 °C), EtOH (12 mL) and THF 
(12 mL) in a three-necked 500 mL-flask equipped with a dry-ice condenser at −30 °C was 
added granulated lithium (1.10 g, 159 mmol, 50 eq) portionwise and the resulting dark blue 
reaction mixture was stirred for 30 min. The reaction was quenched by careful addition of 
NH4Cl (4 g) and the reaction flask was left open while stirring at r.t. for 1.5 h followed by the 
addition of H2O (150 mL) and sat. aq. NH4Cl solution (150 mL). The layers were separated 
and the aqueous layer was extracted with Et2O (3 × 100 mL) and the combined organic 
layers were washed with brine (100 mL) and dried over Na2SO4. After filtration and 
concentration in vacuo, the crude product was purified by flash column chromatography 
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(hexanes:EtOAc 9:1) on silica to afford cyclohexadiene 2.42 (605 mg, 2.72 mmol, 86%) as a 
colorless oil. 
 
Data for 2.42: Rf: 0.40 (hexanes:EtOAc 3:1); 1H NMR (400 MHz, C6D6): δ = 3.37 (dd, J = 
7.1, 5.6 Hz, 1H), 3.32 (s, 3H), 2.82 – 2.70 (m, 2H), 2.49 – 2.26 (m, 2H), 1.84 – 1.74 (m, 2H), 
1.73 (s, 3H), 1.66 – 1.58 (m, 2H), 1.16 (s, 1H), 1.00 (s, 6H) ppm; 13C NMR (100 MHz, C6D6): 
δ = 146.3, 130.8, 124.8, 110.2, 75.5, 56.0, 39.1, 39.0, 28.1, 27.1, 25.9, 25.5, 21.2, 14.7 ppm; 
IR (ATR): ߥmax = 3422 (br w), 2966 (m), 2934 (m), 2906 (m), 2871 (m), 2829 (m), 1718 (m), 
1461 (m), 1438 (m), 1201 (s), 1142 (s), 1108 (m), 1023 (w), 1001 (m) cm−1; HRMS (EI): calc. 
for C14H22O2 [M]+: 222.1614, found: 222.1609. 
 
 
 
Azide 2.50 To a stirred solution of alcohol 2.42 (240 mg, 1.08 mmol, 1.0 eq), EDC∙HCl 
(311 mg, 1.62 mmol, 1.5 eq) and DMAP (145 mg, 1.19 mmol, 1.1 eq) in CH2Cl2 (3.0 mL) at 
0 °C was added a solution of azide 2.49 (153 mg, 1.51 mmol, 1.4 eq) in CH2Cl2 (1.0 mL) and 
the resulting reaction mixture was stirred at r.t. for 2.5 h. The reaction was quenched by 
addition of H2O (10 mL). The layers were separated and the aqueous layer was extracted 
with CH2Cl2 (3 × 25 mL). The combined organic layers were dried over Na2SO4. After 
filtration and concentration in vacuo, the crude product was purified by flash column 
chromatography (hexanes:EtOAc 8:1) on silica to afford ester 2.50 (291 mg, 953 μmol, 88%) 
as a colorless oil. 
 
Data for 2.50: Rf: 0.73 (hexanes:EtOAc 3:1); 1H NMR (400 MHz, C6D6): δ = 4.94 (dd, J = 
8.0, 3.8 Hz, 1H), 3.30 (s, 3H), 3.13 (s, 2H), 2.68 (t, J = 7.2 Hz, 2H), 2.35 (t, J = 7.2 Hz, 2H), 
1.77 – 1.65 (m, 7H), 0.95 (s, 3H), 0.84 (s, 3H) ppm; 13C NMR (100 MHz, C6D6): δ = 168.0, 
146.0, 130.0, 125.2, 110.4, 80.0, 56.0, 50.12, 38.9, 37.7, 27.5, 25.7, 25.2, 23.6, 21.9, 
14.7 ppm; IR (ATR): ߥmax = 2970 (w), 2932 (w), 2904 (w), 2876 (w), 2827 (w), 2102 (s), 
1738 (s), 1716 (m), 1461 (w), 1358 (m), 1287 (m), 1196 (s), 1173 (m), 1142 (s), 1101 (m), 
1089 (m), 1022 (m), 994 (m), 972 (m), 933 (w), 733 (w) cm−1; HRMS (EI): calc. for 
C16H23O3N3 [M]+: 305.1734, found: 305.1737. 
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Diazoester 2.41 To a stirred solution of azide 2.50 (290 mg, 950 μmol, 1.0 eq) in THF/H2O 
(20:3, 3.45 mL) at 0 °C was added phosphine 2.51111b (424 mg, 998 μmol, 1.05 eq) and the 
resulting reaction mixture was allowed to warm up to 15 °C over 3 h. Sat. aq. NaHCO3 
solution (3 mL) was added and the resulting reaction mixture was stirred at r.t. for 30 min. 
The reaction was quenched by addition of H2O (40 mL). The layers were separated and the 
aqueous layer was extracted with CH2Cl2 (3 × 30 mL). The combined organic layers were 
dried over Na2SO4. After filtration and concentration in vacuo, the crude product was purified 
by flash column chromatography (hexanes:EtOAc 15:1) on silica to afford diazo compound 
2.41 (224 mg, 771 μmol, 81%) as a yellow oil. 
 
The 13C-shift of the carbonyl atom is not visible in the 13C-data or the HMBC-data. 
Data for 2.41: Rf: 0.70 (hexanes:EtOAc 3:1); 1H NMR (400 MHz, C6D6): δ = 5.09 (d, J = 
8.5 Hz, 1H), 4.04 (s, 1H), 3.29 (s, 3H), 2.69 (t, J = 6.5 Hz, 2H), 2.34 (q, J = 6.8 Hz, 2H), 1.91 
– 1.64 (m, 7H), 1.01 (s, 3H), 0.92 (s, 3H) ppm; 13C NMR (100 MHz, C6D6): δ = 146.0, 130.2, 
125.2, 110.3, 78.3, 55.9, 45.8, 38.9, 37.9, 27.8, 25.7, 25.3, 24.1, 21.8, 14.7 ppm; IR (ATR): 
ߥmax = 3097 (w), 2970 (w), 2935 (w), 2910 (w), 2876 (w), 2830 (w), 2105 (s), 1685 (s), 
1462 (w), 1378 (s), 1361 (m), 1335 (m), 1243 (m), 1186 (s), 1144 (s), 1102 (m), 1090 (m), 
1021 (m), 997 (m), 960 (m), 847 (w), 810 (w), 738 (m) cm−1; HRMS (EI): calc. for C16H22O3N2 
[M]+: 290.1625, found: 290.1618. 
 
 
 
Azide S2 To a stirred solution of alcohol 2.57 (350 mg, 1.59 mmol, 1.0 eq), EDC∙HCl 
(458 mg, 2.39 mmol, 1.5 eq) and DMAP (214 mg, 1.75 mmol, 1.1 eq) in CH2Cl2 (3.0 mL) at 
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0 °C was added a solution of azide 2.49 (225 mg, 2.23 mmol, 1.4 eq) in CH2Cl2 (2.5 mL) and 
the resulting reaction mixture was stirred for 2 h. The reaction was quenched by addition of 
H2O (10 mL). The layers were separated and the aqueous layer was extracted with 
CH2Cl2 (3 × 15 mL). The combined organic layers were dried over Na2SO4. After filtration and 
concentration in vacuo, the crude product was purified by flash column chromatography 
(hexanes:EtOAc 20:115:1) on silica to afford ester S2 (470 mg, 1.55 mmol, 97%) as a 
colorless oil. 
 
Data for S2: Rf: 0.75 (hexanes:EtOAc 3:1); 1H NMR (400 MHz, C6D6): δ = 6.69 (s, 1H), 6.61 
(s, 1H), 5.10 (t, J = 6.0 Hz, 1H), 3.40 (s, 3H), 3.11 (s, 2H), 2.62 (dt, J = 16.5, 6.7 Hz, 1H), 
2.53 (dt, J = 16.6, 6.8 Hz, 1H), 2.26 (s, 3H), 1.84 (q, J = 6.3 Hz, 2H), 1.25 (s, 3H), 1.16 (s, 
3H) ppm; 13C NMR (100 MHz, C6D6): δ = 168.0, 157.0, 141.7, 131.3, 125.8, 124.9, 107.5, 
79.6, 54.8, 50.1, 38.2, 29.4, 26.1, 26.0, 24.3, 16.0 ppm; IR (ATR): ߥmax = 2947 (w), 2104 (s), 
1739 (s), 1618 (w), 1501 (m), 1464 (m), 1404 (w),1366 (m), 1289 (m), 1248 (m), 1205 (s), 
1188 (s), 1147 (m), 1059 (m), 1038 (m), 1004 (m), 887 (m), 848 (m), 776 (w), 661 (w) cm−1; 
HRMS (EI): calc. for C16H21O3N3 [M]+: 303.1577, found: 303.1573. 
 
 
 
Diazoester 2.58 To a stirred solution of azide S2 (208 mg, 686 μmol, 1.0 eq) in THF/H2O 
(20:3, 2.99 mL) at 0 °C was added phosphine 2.51111b (306 mg, 720 μmol, 1.05 eq) and the 
resulting reaction mixture was allowed to warm up to 15 °C over 5 h. Sat. aq. NaHCO3 
solution (2.6 mL) was added and the resulting reaction mixture was stirred at r.t. for 30 min. 
The reaction was quenched by addition of H2O (15 mL). The layers were separated and the 
aqueous layer was extracted with CH2Cl2 (3 × 25 mL). The combined organic layers were 
dried over Na2SO4. After filtration and concentration in vacuo, the crude product was purified 
by flash column chromatography (hexanes:EtOAc 15:1) on silica to afford diazo compound 
2.58 (172 mg, 597 μmol, 87%) as a yellow oil. 
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The 13C-shift of the carbonyl atom is not visible in the 13C-data or the HMBC-data. 
Data for 2.58: Rf: 0.70 (hexanes:EtOAc 3:1); 1H NMR (400 MHz, C6D6): δ = 6.68 (s, 1H), 
6.62 (s, 1H), 5.26 (t, J = 5.6 Hz, 1H), 4.00 (s, 1H), 3.38 (s, 3H), 2.68 (dt, J = 16.5, 6.6 Hz, 
1H), 2.57 (dt, J = 16.5, 6.8 Hz, 1H), 2.26 (s, 3H), 1.94 (q, J = 6.6 Hz, 2H), 1.32 (s, 3H), 
1.23 (s, 3H) ppm; 13C NMR (100 MHz, C6D6): δ = 156.9, 142.1, 131.3, 126.0, 124.7, 107.6, 
78.2, 54.8, 45.8, 38.5, 29.5, 26.2, 26.0, 24.7, 16.0 ppm; IR (ATR): ߥmax = 3100 (w), 2967 (w), 
2945 (w), 2851 (w), 2105 (s), 1684 (s), 1618 (w), 1501 (s), 1464 (m), 1378 (s), 1362 (s), 
1338 (s), 1243 (s), 1174 (s), 1147 (s), 1059 (s), 1038 (s), 1004 (s), 918 (m), 888 (m), 
848 (m), 838 (m), 737 (s) cm−1; HRMS (EI): calc. for C16H20O3N2 [M]+: 288.1468, found: 
288.1470. 
 
 
 
Amide 2.62 To a stirred solution of alcohol 2.42 (230 mg, 1.03 mmol, 1.0 eq) in DME 
(5.0 mL) at −10 °C was added NaH (60% dispersion in mineral oil, 103 mg, 2.58 mmol, 
2.5 eq) and the resulting reaction mixture was stirred for 20 min. Chloride 2.61 (213 μL, 
1.55 mmol, 1.5 eq) in DME (1.0 mL) was added dropwise and the resulting reaction mixture 
was allowed to warm up to r.t. over 7.5 h. The reaction was quenched by addition of sat. aq. 
NH4Cl solution (5 mL) and H2O (10 mL). The layers were separated and the aqueous layer 
was extracted with Et2O (3 × 10 mL). The combined organic layers were dried over Na2SO4. 
After filtration and concentration in vacuo, the crude product was purified by flash column 
chromatography (hexanes:EtOAc 6:13:1) on silica to afford amide 2.62 (271 mg, 808 μmol, 
78%) as a colorless oil. 
 
Data for 2.62: Rf: 0.28 (hexanes:EtOAc 3:1); 1H NMR (400 MHz, C6D6): δ = 4.06 (d, 
J = 12.4 Hz, 1H), 4.00 (d, J = 12.4 Hz, 1H), 3.32 (s, 3H), 3.31 – 3.21 (m, 2H), 3.20 – 3.01 (m, 
2H), 2.98 – 2.85 (m, 1H), 2.83 – 2.74 (m, 2H), 2.49 – 2.32 (m, 2H), 1.91 – 1.63 (m, 7H), 1.14 
(s, 3H), 1.08 (s, 3H), 0.99 (t, J = 7.1 Hz, 3H), 0.77 (t, J = 7.1 Hz, 3H) ppm; 13C NMR 
(100 MHz, C6D6): δ = 168.3, 146.3, 130.9, 124.8, 110.2, 84.3, 69.9, 55.9, 41.2, 39.8, 39.1, 
39.0, 28.4, 25.8, 25.6, 22.4, 21.8, 14.7, 14.4, 13.1 ppm; IR (ATR): ߥmax = 2969 (m), 2934 (m), 
2905 (w), 2831 (w), 1717 (w), 1641 (s), 1462 (m), 1434 (m), 1380 (m), 1358 (m), 1311 (w), 
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1265 (w), 1221 (m), 1202 (m), 1144 (m), 1083 (s), 1026 (m), 1002 (m), 793 (w), 736 (w) 
cm−1; HRMS (EI): calc. for C20H33O3N [M]+: 335.2455, found: 335.2449. 
 
 
 
7-Methoxy-1,1-dimethyl-1,2,3,4-tetrahydronaphthalen-2-ol (S3) To a stirred solution of 
ketone 2.45 (200 mg, 980 μmol, 1.0 eq) in MeOH (5 mL) was added NaBH4 (55.6 mg, 
1.47 mmol, 1.5 eq) at 0 °C and the resulting reaction mixture was allowed to warm to r.t. over 
1 h. After concentration in vacuo, the crude product was purified by flash column 
chromatography (hexanes:EtOAc 8:15:1) on silica to afford alcohol S3 (200 mg, 970 μmol, 
99%) as a white solid. This compound has been reported in the literature.158 
 
Data for S3: Rf: 0.10 (hexanes:EtOAc 3:1); 1H NMR (400 MHz, CDCl3): δ = 6.99 (d, 
J = 8.4 Hz, 1H), 6.88 (d, J = 2.7 Hz, 1H), 6.70 (dd, J = 8.4, 2.7 Hz, 1H), 3.80 (s, 3H), 3.75 
(dd, J = 8.7, 2.9 Hz, 1H), 2.90 (dt, J = 16.7, 6.3 Hz, 1H), 2.84 – 2.74 (m, 1H), 2.00 (dddd, 
J = 12.4, 9.3, 6.2, 3.0 Hz, 1H), 1.96 – 1.86 (m, 1H), 1.60 (s, 1H), 1.34 (s, 3H), 1.29 (s, 3H) 
ppm; 13C NMR (100 MHz, CDCl3): δ = 158.0, 145.6, 129.6, 126.7, 112.4, 111.4, 75.6, 55.3, 
39.3, 29.0, 27.0, 26.1, 25.0 ppm; IR (ATR): ߥmax = 3367 (br w), 2962 (m), 2930 (m), 2859 (w), 
2836 (w), 1610 (m), 1580 (w), 1570 (w), 1488 (m), 1457 (w), 1441 (w), 1434 (w), 1421 (w), 
1382 (w), 1355 (w), 1314 (w), 1288 (m), 1281 (s), 1240 (s), 1229 (s), 1187 (m), 1169 (m), 
1136 (w), 1079 (m), 1058 (s), 1043 (s), 967 (m), 949 (m), 867 (s), 809 (m), 711 (m), 695 (m), 
662 (m) cm−1; melting point: 82.5 – 83.7 °C (lit.: 85.0 – 88.0 °C)159; HRMS (EI): calc. for 
C13H18O2 [M]+: 206.1301, found: 206.1299. 
 
 
 
1,4-Cyclohexadiene 2.67 To a stirred solution of alcohol S3 (200 mg, 970 μmol, 1.0 eq) in a 
mixture of liquid ammonia (~10 mL, condensed at −78 °C), EtOH (3 mL) and THF (3 mL) in a 
three-necked 100 mL-flask equipped with a dry-ice condenser at −35 °C was added 
granulated lithium (202 mg, 29.1 mmol, 30 eq) portionwise and the resulting dark blue 
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reaction mixture was stirred for 35 min. The reaction was quenched by careful addition of 
NH4Cl (2 g) and the reaction flask was left open while stirring at r.t. for 1.5 h followed by the 
addition of H2O (50 mL) and sat. aq. NH4Cl solution (50 mL). The layers were separated and 
the aqueous layer was extracted with Et2O (3 × 50 mL) and the combined organic layers 
were dried over Na2SO4. After filtration and concentration in vacuo, the crude product was 
purified by flash column chromatography (hexanes:EtOAc 9:1) on silica to afford 
cyclohexadiene 2.67 (130 mg, 624 μmol, 64%) as a colorless oil. 
 
Data for 2.67: Rf: 0.37 (hexanes:EtOAc 3:1); 1H NMR (400 MHz, C6D6): δ = 4.46 (t, 
J = 3.4 Hz, 1H), 3.35 – 3.30 (m, 4H), 2.90 – 2.81 (m, 2H), 2.68 – 2.54 (m, 2H), 1.92 – 1.76 
(m, 2H), 1.66 – 1.52 (m, 2H), 0.94 (s, 6H) ppm; 13C NMR (100 MHz, C6D6): δ = 154.1, 130.7, 
124.7, 89.6, 75.4, 53.6, 38.9, 32.8, 28.7, 28.2, 27.1, 25.3, 20.9 ppm; IR (ATR): 
ߥmax = 3397 (br w), 2965 (w), 2936 (m), 2874 (m), 2830 (m), 1698 (m), 1665 (w), 1465 (m), 
1440 (m), 1389 (m), 1361 (m), 1257 (w), 1231 (m), 1212 (s), 1168 (s), 1128 (m), 1112 (m), 
1062 (m), 1032 (s), 1011 (s), 980 (m), 908 (m), 858 (w), 834 (m), 782 (m), 706 (m), 
680 (m) cm−1; melting point: 76.0 – 77.8 °C; HRMS (EI): calc. for C13H20O2 [M]+: 208.1458, 
found: 208.1460. 
 
 
 
Ketal S4 To a stirred solution of enol ether 2.67 (237.0 mg, 1.14 mmol, 1.0 eq) and ethylene 
glycol (1.59 mL, 28.5 mmol, 25 eq) in CH2Cl2 (8.0 mL) at r.t. was added pTsOH∙H2O (2.0 mg, 
11.4 μmol, 0.01 eq) and the resulting reaction mixture was stirred for 1 h. The reaction was 
quenched by addition of half-sat. aq. NaHCO3 solution (20 mL). The layers were separated 
and the aqueous layer was extracted with CH2Cl2 (3 × 20 mL). The combined organic layers 
were dried over Na2SO4. After filtration and concentration in vacuo, the crude product was 
purified by flash column chromatography (hexanes:EtOAc 3:1) on silica to afford ketal S4 
(227 mg, 952 μmol, 84%) as a white solid. 
 
Data for S4: Rf: 0.15 (hexanes:EtOAc 3:1); 1H NMR (400 MHz, C6D6): δ = 3.67 – 3.49 (m, 
4H), 3.35 (dd, J = 8.9, 3.6 Hz, 1H), 2.37 (d, J = 17.0 Hz, 1H), 2.31 (d, J = 17.4 Hz, 1H), 2.11 
(dt, J = 15.1, 7.4 Hz, 1H), 2.00 (dt, J = 16.9, 5.9 Hz, 1H), 1.89 – 1.77 (m, 2H), 1.77 – 1.65 (m, 
2H), 1.65 – 1.44 (m, 2H), 1.01 (s, 3H), 1.01 (s, 3H), 0.93 (s, 1H) ppm; 13C NMR (100 MHz, 
C6D6): δ = 131.7, 125.9, 109.1, 75.5, 64.3 (2C), 39.2, 35.3, 31.4, 30.2, 28.6, 27.2, 25.3, 
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20.8 ppm; IR (ATR): ߥmax = 3319 (br w), 2970 (w), 2934 (m), 2876 (m), 2830 (w), 2361 (w), 
2337 (w), 1734 (w), 1466 (w), 1438 (w), 1362 (m), 1217 (m), 1122 (m), 1105 (m), 1084 (m), 
1058 (m), 1034 (s), 997 (m), 946 (m), 875 (w), 851 (m), 709 (m) cm−1; melting point: 77.0 – 
79.5 °C; HRMS (EI): calc. for C14H22O3 [M]+: 238.1563, found: 238.1564. 
 
 
 
Protected ketal 2.68 To a stirred solution of alcohol S4 (175 mg, 734 μmol, 1.0 eq) in 
CH2Cl2 (5.0 mL) at 0 °C was added 2,6-lutidine (256 μL, 2.20 mmol, 3.0 eq) and TIPSOTf 
(507 μL, 1.88 mmol, 2.5 eq) and the resulting reaction mixture was stirred at r.t. for 1 h. The 
reaction was quenched by addition of H2O (30 mL). The layers were separated and the 
aqueous layer was extracted with CH2Cl2 (3 × 30 mL). The combined organic layers were 
dried over Na2SO4. After filtration and concentration in vacuo, the crude product was purified 
by flash column chromatography (hexanes:EtOAc 25:1) on silica to afford ketal 2.68 
(220 mg, 557 μmol, 76%) as a white solid. A crystal, suitable for single crystal X-ray 
diffraction analysis, was obtained by crystallization from acetone. 
 
Data for 2.68: Rf: 0.70 (hexanes:EtOAc 3:1); 1H NMR (400 MHz, C6D6): δ = 3.77 (dd, 
J = 10.9, 3.6 Hz, 1H), 3.71 – 3.49 (m, 4H), 2.48 (d, J = 16.8 Hz, 1H), 2.37 (d, J = 16.7 Hz, 
1H), 2.22 (dt, J = 16.3, 8.0 Hz, 1H), 1.99 (dt, J = 17.1, 5.0 Hz, 1H), 1.94 – 1.67 (m, 6H), 1.21 
– 1.03 (m, 24H) ppm; 13C NMR (100 MHz, C6D6): δ = 132.6, 125.5, 109.1, 77.5, 64.4, 64.3, 
40.4, 35.6, 31.5, 30.2, 29.9, 28.2, 25.1, 20.5, 18.6, 13.4 ppm; IR (ATR): ߥmax = 2956 (w), 
2938 (m), 2892 (w), 2864 (m), 1462 (w), 1454 (w), 1378 (w), 1363 (w), 1262 (w), 1231 (w), 
1144 (m), 1116 (s), 1081 (m), 1069 (m), 1059 (m), 1043 (s), 1013 (s), 1006 (m), 945 (m), 
918 (w), 883 (s), 862 (m), 827 (m), 778 (w), 706 (w), 682 (s) cm−1; melting point: 63.9 –
 65.5 °C; HRMS (EI): calc. for C23H42O3Si [M]+: 394.2898, found: 394.2894. 
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Iron tricarbonyl complex 2.78 A stirred solution of pyrone 2.76 (2.00 g, 13.0 mmol, 1.0 eq) 
in benzene (130 mL, degassed by sparging with argon for 30 min) in a Duran® cylinder at r.t 
was irradiated for 43 h using a Rayonet lamp (350 nm, 250 W). The reaction was removed 
from the lamp and transferred into a round-bottom flask. Fe2(CO)9 (11.3 g, 31.2 mmol, 
2.4 eq) was added and the resulting reaction mixture was heated to 50 °C for 2 h . Additional 
Fe2(CO)9 (1.88 g, 5.19 mmol, 0.4 eq) was added followed by heating for 1h. After 
evaporation of the solvent, the crude product was purified by flash column chromatography 
(1st column: pentane:Et2O 9:12:3, 2nd column: pentane:Et2O 20:14:1) on silica to afford 
iron tricarbonyl complex 2.78 (1.77 g, 7.08 mmol, 55%) as a yellow solid. Compound 2.78 
has been reported in the literature.122b 
 
Data for 2.78: Rf: 0.80 (hexanes:EtOAc 4:1); 1H NMR (400 MHz, CDCl3): δ = 4.51 (s, 2H), 
4.29 (s, 1H), 3.68 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3): δ = 212.2, 167.7,* 67.9, 65.1, 
62.3, 51.9 ppm; IR (ATR): ߥmax = 3117 (w), 2956 (w), 2361 (w), 2341 (w), 2052 (s), 1955 (s), 
1707 (s), 1455 (s), 1416 (m), 1310 (m), 1198 (s), 1174 (s), 1117 (m), 1047 (m), 951 (m), 
930 (m), 826 (m), 798 (w), 759 (m) cm−1; melting point: 34.7 – 36.0 °C (lit.: 33.0 – 
34.0 °C)122b; HRMS (EI): calc. for C9H6Fe56O5 [M]+: 249.9559, found: 249.9565. 
* The shift of the ester carbonyl was not visible in the 13C spectra, but was extracted from the 
HMBC data showing corresponding correlations at 167.7 ppm. 
 
 
 
Iron tricarbonyl complex 2.79 To a stirred solution of ester 2.78 (500 mg, 2.00 mmol, 
1.0 eq) and BF3∙OEt2 (7 mL) in Et2O (5.4 mL) in a pressure tube at 0 °C was added LiAlH4 
(1.0 M in Et2O, 6.00 mL, 6.0 mmol, 3.0 eq) and the resulting reaction mixture was stirred at 
0 °C for 1.5 h followed by heating to 40 °C for 5 h. The reaction was quenched by addition of 
ice-water (150 mL). The layers were separated and the aqueous layer was extracted with 
Et2O (4 × 40 mL). The organic layer was dried over Na2SO4. After filtration and concentration 
in vacuo, the crude product was purified by flash column chromatography (pentane) on silica 
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to afford iron tricarbonyl complex 2.79 (391 mg, 1.89 mmol, 95%) as a yellow oil. Compound 
2.79 has been reported in the literature.122b 
 
Data for 2.79: Rf: 0.66 (pentane); 1H NMR (400 MHz, CDCl3): δ = 4.00 (s, 2H), 3.86 (s, 1H), 
1.75 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3): δ = 215.2, 85.5, 65.0, 58.2, 13.7 ppm; IR 
(ATR): ߥmax = 2980 (w), 2924 (w), 2861 (w), 2361 (w), 2333 (w), 2036 (s), 1935 (s), 1448 (s), 
1375 (w), 1286 (w), 1147 (w), 1061 (w), 1028 (w), 947 (w), 933 (w), 831 (w), 775 (w), 668 (w) 
cm−1; HRMS (EI): calc. for C8H6Fe56O3 [M]+: 205.9661, found: 205.9661. 
 
 
 
Aldehyde 2.80 and 2.81 Under vigorous stirring of PhMeNCHO (1.11 mL, 9.00 mmol, 
5.0 eq) was added POCl3 (821 μL, 9.00 mmol, 5.0 eq) at r.t. and the resulting reaction 
mixture was stirred for 1 h. Iron tricarbonyl complex 2.79 (370 mg , 1.80 mmol, 1.0 eq) was 
added followed by heating to 42 °C for 3.5 h. The reaction was quenched by addition of ice-
water (100 mL). The layers were separated and the aqueous layer was extracted with Et2O 
(3 × 50 mL). The organic layer was dried over Na2SO4. After filtration and concentration in 
vacuo, the crude product was purified by flash column chromatography (pentane:Et2O 6:1) 
on silica to afford aldehyde 2.81 (247 mg, 1.06 mmol, 59%) as yellow needles and 
regioisomeric aldehyde 2.80 (63.4 mg, 271 μmol, 15%) as a yellow solid. Compound 2.81 
was suitable for single crystal X-ray diffraction analysis. 
 
Data for 2.81 (major regioisomer): Rf: 0.39 (hexanes:EtOAc 4:1); 1H NMR (400 MHz, 
C6D6): δ = 8.87 (s, 1H), 3.77 (s, 2H), 1.00 (s, 3H) ppm; 13C NMR (100 MHz, C6D6): δ = 211.9, 
186.5, 93.2, 65.4, 65.0, 12.0 ppm; IR (ATR): ߥmax = 3085 (w), 2990 (w), 2965 (w), 2921 (w), 
2044 (m), 1956 (s), 1638 (s), 1467 (m), 1427 (m), 1384 (m), 1190 (m), 1112 (m), 1085 (m), 
1042 (m), 1027 (m), 994 (m), 854 (m), 794 (m), 781 (m), 677 (m), 656 (m) cm−1; melting 
point: 76.5 – 77.3 °C; HRMS (EI): calc. for C9H6Fe56O4 [M]+: 233.9610, found: 233.9614. 
 
Data for 2.80 (minor regioisomer): Rf: 0.49 (hexanes:EtOAc 4:1); 1H NMR (400 MHz, 
C6D6): δ = 8.90 (s, 1H), 3.57 (s, 1H), 3.36 (s, 1H), 1.41 (s, 3H) ppm; 13C NMR (100 MHz, 
C6D6): δ = 212.6, 187.0, 87.7, 71.9, 71.0, 60.3, 11.8 ppm; IR (ATR): ߥmax = 3115 (w), 
3102 (w), 2980 (w), 2960 (w), 2926 (w), 2860 (w), 2048 (m), 1948 (s), 1658 (s), 1476 (m), 
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1461 (m), 1451 (m), 1433 (m), 1384 (m), 1410 (m), 1380 (m), 1354 (m), 1297 (m), 1192 (m), 
1101 (m), 1030 (m), 989 (m), 946 (w), 860 (m), 821 (m), 776 (s), 690 (w) cm−1; melting 
point: 35.1 – 35.8 °C; HRMS (EI): calc. for C9H6Fe56O4 [M]+: 233.9610, found: 233.9613. 
 
 
 
Alkene 2.74 To a stirred solution of Mo(O)Cl3(THF)2128a (246 mg, 683 μmol, 1.3 eq) in THF 
(5.0 mL) at −78 °C was added MeLi (1.6 M in Et2O, 800 μL, 1.28 mmol, 2.5 eq) and the 
resulting reaction mixture was stirred for 1 h. Aldehyde 2.81 (120 mg, 513 mmol, 1.0 eq) in 
THF (2.0 mL) was added dropwise and the reaction mixture was allowed to warm up to r.t. 
overnight. The reaction was quenched by addition of H2O (10 mL). The layers were 
separated and the aqueous layer was extracted with Et2O (3 × 15 mL). The combined 
organic layers were dried over Na2SO4. After filtration and concentration in vacuo, the crude 
product was purified by flash column chromatography (pentane) on silica to afford alkene 
2.74 (93.0 mg, 401 μmol, 78%) as a yellow liquid. 
 
Data for 2.74: Rf: 0.55 (pentane); 1H NMR (400 MHz, C6D6): δ = 5.56 (dd, J = 17.3, 10.7 Hz, 
1H), 4.92 (d, J = 17.3 Hz, 1H), 4.77 (d, J = 10.7 Hz, 1H), 3.66 (s, 2H), 1.23 (s, 3H) ppm; 
13C NMR (100 MHz, C6D6): δ = 215.1, 129.8, 113.5, 84.6, 75.9, 64.2, 12.5 ppm; IR (ATR): 
ߥmax = 3097 (w), 2973 (w), 2924 (w), 2032 (s), 1936 (s), 1620 (w), 1445 (w), 1373 (w), 
1264 (w), 1046 (w), 1026 (w), 978 (m), 898 (m), 827 (w), 735 (w), 708 (m), 604 (m), 
575 (s) cm−1; HRMS (EI): calc. for C10H9Fe56O3 [M+H]+: 232.9896, found: 232.9905. 
 
 
 
Alkene 2.75 To a stirred suspension of CrCl2 (420 mg, 3.42 mmol, 8.0 eq) in THF (5.5 mL) at 
r.t. was added a mixture of aldehyde 2.81 (100 mg, 427 μmol, 1.0 eq) and 1,1-diiodoethane 
(240 mg, 854 μmol, 2.0 eq) in THF (2.0 mL) and the resulting reaction mixture was stirred for 
6.5 h. The reaction was quenched by addition of H2O (60 mL). The layers were separated 
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and the aqueous layer was extracted with Et2O (3 × 30 mL). The combined organic layers 
were dried over Na2SO4. After filtration and concentration in vacuo, the crude product was 
purified by flash column chromatography (pentane) on silica to afford alkene 2.75 (80.6 mg, 
328 μmol, 77%) as a yellow oil in an inseparable 2.5:1 mixture of the (E)- and (Z)-isomer. 
 
NMR shifts which could be clearly assigned to the major diastereomer are marked with an 
asterisk * and shifts which could be clearly assigned to the minor diastereomer are marked 
with a hash #. Due to the ratio of the two diastereomer the integrals in the 1H-NMR differ from 
the expected values. 
Data for 2.75: Rf: 0.80 (pentane); 1H NMR (400 MHz, C6D6): δ = 5.45 – 5.19 (m, 2H),*# 3.71 
(s, 2H),*# 1.37 (d, J = 6.4 Hz, 2H),* 1.33 (d, J = 5.8 Hz, 1H),# 1.29 (s, 2H),* 1.26 (s, 1H)# ppm; 
13C NMR (100 MHz, C6D6): δ = 215.2,* 215.1,# 126.4,# 126.0,* 122.6,* 121.5,# 84.4,# 82.8,* 
77.7,* 75.3,# 66.0,# 63.5,* 17.8,* 13.9,# 12.3,* 12.3# ppm; IR (ATR): ߥmax = 3021 (w), 2972 (w), 
2921 (w), 2853 (w), 2031 (s), 1944 (s), 1444 (m), 1435 (m), 1374 (w); 1045 (w), 1026 (w), 
955 (m), 931 (w), 827 (w), 733 (w) cm−1; HRMS (EI): calc. for C11H10Fe56O3 [M]+: 245.9979, 
found: 245.9990. 
 
 
 
Ethyl 3,3-dimethylpent-4-enoate (2.83) A stirred solution of prenol (2.82, 19.5 mL, 
191 mmol, 1.0 eq) and propionic acid (715 μL, 9.55 mmol, 0.05 eq) in triethylorthoacetate 
(700 mL, 3.82 mol, 20 eq) was refluxed for 10 h. The reaction mixture was poured into a 
solution of conc. H2SO4 (50 mL) in ice-water (800 mL) and the resulting mixture was stirred 
for 24 h at r.t. The layers were separated and the aqueous layer was extracted with Et2O 
(3 × 500 mL). The combined organic layers were washed with sat. aq. Na2CO3 solution 
(5 × 400 mL), brine (500 mL) and dried over Na2SO4. After filtration and concentration in 
vacuo, the crude product was purified by distillation under reduced pressure (80 – 90 °C, 75 
– 89 mbar) to afford ethyl ester 2.83 (21.5 g, 138 mmol, 72%) as a colorless liquid. 
Compound 2.83 has been reported in the literature.130 
 
Data for 2.83: Rf: 0.71 (hexanes:EtOAc 7:1); 1H NMR (400 MHz, CDCl3): δ = 5.89 (dd, 
J = 17.4, 10.7 Hz, 1H), 5.01 – 4.90 (m, 2H), 4.10 (q, J = 7.1 Hz, 2H), 2.28 (s, 2H), 1.24 (t, 
J = 7.1 Hz, 3H), 1.13 (s, 6H) ppm; 13C NMR (100 MHz, CDCl3): δ = 171.9, 147.0, 110.9, 
60.2, 47.0, 36.3, 27.1, 14.5 ppm; IR (ATR): ߥmax = 3086 (w), 2966 (w), 2932 (w), 2873 (w), 
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1731 (s), 1641 (w), 1465 (w), 1447 (w), 1416 (w), 1367 (m), 1325 (w), 1236 (m), 1207 (m), 
1126 (m), 1096 (w), 1033 (w), 999 (w), 913 (m), 845 (w), 792 (w), 715 (w), 678 (w) cm−1; 
HRMS (EI): calc. for C9H16O2 [M]+: 156.1145, found: 156.1150. 
 
 
 
Epoxide 2.85 To a stirred solution of alkene 2.83 (12.5 g, 80.0 mmol, 1.0 eq) in CH2Cl2 
(500 mL) at 0 °C was added carefully mCPBA (77% purity, 26.9 g, 120 mmol, 1.5 eq) and the 
resulting reaction mixture was stirred at r.t. for 14 h. The reaction was quenched by addition 
of sat. aq. NaHCO3 solution (300 mL) and sat. aq. Na2S2O3 solution (300 mL). The layers 
were separated and the aqueous layer was extracted with CH2Cl2 (3 × 300 mL). The 
combined organic layers were dried over Na2SO4. After filtration and concentration in vacuo, 
the crude product was purified by flash column chromatography (pentane:Et2O 7:1) on silica 
to afford epoxide 2.85 (11.6 g, 67.4 mmol, 84%) as a colourless liquid. 
 
Data for 2.85: Rf: 0.51 (hexanes:EtOAc 6:1); 1H NMR (400 MHz, CDCl3): δ = 4.13 (q, 
J = 7.1 Hz, 2H), 2.94 – 2.89 (m, 1H), 2.68 (t, J = 4.3 Hz, 1H), 2.64 (dd, J = 4.4, 3.0 Hz, 1H), 
2.30 (q, J = 13.7 Hz, 2H), 1.26 (t, J = 7.1 Hz, 3H), 1.02 (s, 3H), 0.99 (s, 3H) ppm; 13C NMR 
(100 MHz, CDCl3): δ = 171.6, 60.3, 58.8, 44.4, 44.2, 33.5, 23.8, 22.2, 14.3 ppm; IR (ATR): 
ߥmax = 2960 (w), 2935 (w), 2855 (w), 1730 (s), 1704 (m), 1681 (w), 1589 (w), 1474 (m), 
1440 (w), 1407 (w), 1382 (w), 1367 (m), 1330 (w), 1258 (m), 1233 (m), 1174 (m), 1166 (m), 
1114 (s), 1037 (s), 957 (m), 912 (m), 832 (s), 810 (m), 794 (m), 774 (m), 688 (w), 672 (w) 
cm−1; HRMS (EI): calc. for C9H17O3 [M+H]+: 173.1172, found: 173.1165. 
 
 
 
Lactone 2.84 To a stirred solution of (R,R)-salen-Co(II) (525 mg, 870 μmol, 0.03 eq) in 
toluene (20 mL) at r.t. was added AcOH (249 μL, 4.35 mmol, 0.15 eq) and the resulting 
reaction mixture was stirred open to air for 1 h. The solvent was evaporated and epoxide 
2.85 (5.00 g, 29.0 mmol, 1.0 eq) was added to the reaction mixture followed by cooling to 
0 °C. H2O (365 μL, 20.3 mmol, 0.70 eq) was added and the reaction mixture was stirred at 
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r.t. for 10.5 h. After cooling to −20 °C, TFA (4 mL) was added and the resulting reaction 
mixture was allowed to warm up to −5 °C over 15 min. The reaction was quenched by 
addition of benzene (100 mL). After concentration in vacuo, the crude product was purified 
by flash column chromatography (hexanes:EtOAc 2:1) on silica. The obtained material was 
dissolved in CH2Cl2 (150 mL) and stirred with powdered activated charcoal (50 g) overnight 
to afford lactone 2.84 (2.54 g, 17.6 mmol, 61%) as a white solid. A crystal, suitable for single 
crystal X-ray diffraction analysis, was obtained by crystallization from Et2O. 
 
Data for 2.84: Rf: 0.25 (hexanes:EtOAc 1:1); 1H NMR (400 MHz, CDCl3): δ = 4.18 (t, 
J = 4.6 Hz, 1H), 3.82 (d, J = 5.6 Hz, 2H), 2.48 (d, J = 17.0 Hz, 1H), 2.36 (d, J = 17.0 Hz, 1H), 
1.76 (t, J = 6.2 Hz, 1H), 1.23 (s, 3H), 1.13 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3): 
δ = 176.3, 88.6, 61.9, 44.3, 38.3, 27.3, 21.9 ppm; IR (ATR): ߥmax = 3433 (m), 2968 (w), 
2933 (w), 2880(w), 1774 (m), 1730 (s); 1467 (w), 1416 (m), 1391 (w), 1368 (m), 1290 (m), 
1263 (m), 1238 (m), 1200 (m), 1151 (m), 1130 (m), 1096 (m), 1041 (s), 1016 (s), 983 (s), 
940 (s), 905 (m), 830 (m), 674 (m) cm−1; melting point: 65.3 – 68.7 °C HRMS (EI): calc. for 
C7H12O3 [M]+: 144.0781, found: 144.0837; optical rotation: [α]D21 = +49.4° (c = 1.00, MeOH). 
 
 
The ee value of the reaction was determined by formation of the corresponding Mosher 
ester: 
 
 
Mosher ester S5 To a stirred solution of alcohol 2.84 (7.5 mg, 52.0 μmol, 1.0 eq), NEt3 
(10.9 μL, 78.0 μmol, 1.5 eq) and DMAP (cat.) in CH2Cl2 (1.0 mL) at 0 °C was added (R)-(−)-
α-methoxy-α-(trifluoromethyl)phenylacetyl chloride (12.7 μL, 67.6 μmol, 1.3 eq) and the 
resulting reaction mixture was stirred at r.t. for 30 min. The reaction was quenched by 
addition of sat. aq. NaHCO3 (5 mL). The layers were separated and the aqueous layer was 
extracted with Et2O (5 mL). The organic layer was dried over Na2SO4. After filtration and 
concentration in vacuo, the crude product was purified by flash column chromatography 
(pentane:acetone 9:1) on silica to afford ester S5 (13.4 mg, 37.2 μmol, 72%) as a colourless 
liquid in a 95:5 diastereomeric mixture. 
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For clarity just the 1H-NMR and 13C-shifts of the major diastereomer are reported. 
Data for S5: Rf: 0.66 (hexanes:acetone 3:2); 1H NMR (400 MHz, CDCl3): δ = 7.60 – 7.47 (m, 
2H), 7.42 (d, J = 6.3 Hz, 3H), 4.58 – 4.39 (m, 2H), 4.36 – 4.25 (m, 1H), 3.53 (s, 3H), 2.34 (s, 
2H), 1.20 (s, 3H), 1.07 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3): δ = 175.2, 166.5, 131.8, 
123.0, 128.7, 127.4, 123.3 (q, J = 288 Hz), 84.8 (q, J = 27.9 Hz), 84.4, 64.4, 55.7, 43.8, 38.5, 
26.7, 21.6 ppm; 19F NMR (375 MHz, CDCl3): δ = −71.5 (s, major), −71.6 (s, minor) ppm; IR 
(ATR): ߥmax = 2965 (w), 2885 (w), 2851 (w), 1786 (m), 1750 (m); 1452 (w), 1422 (m), 
1271 (m), 1229 (m), 1158 (s), 1120 (m), 1082 (m), 1067 (m), 1021 (m), 1001 (m), 940 (m), 
766 (m), 720 (m), 698 (m) cm−1; HRMS (ESI): calc. for C17H23O5NF3 [M+NH4]+: 378.1523, 
found: 378.1520; optical rotation: [α]D21 = +10.8° (c = 0.50, CHCl3). 
 
 
 
Alkene 2.73 To a stirred solution of alcohol 2.84 (250 mg, 1.73 mmol, 1.0 eq) in CH2Cl2 
(8.0 mL) at r.t. was added PhI(OAc)2 (725 mg, 2.25 mmol, 1.3 eq) and TEMPO (108 mg, 
692 μmol, 0.4 eq) and the resulting reaction mixture was stirred at r.t. for 7.5 h. The reaction 
was quenched by addition of sat. aq. Na2S2O3 (30 mL). The layers were separated and the 
aqueous layer was extracted with CH2Cl2 (3 × 30 mL). The combined organic layers were 
dried over Na2SO4. After filtration and careful concentration in vacuo (30 °C, 650 mbar), 
crude aldehyde 2.88 was obtained and used in the next step without further purification.  
To a stirred solution of Mo(O)Cl3(THF)2128a (1.68 g, 4.67 mmol, 2.7 eq) in THF (8.0 mL) at 
−78 °C was added MeLi (1.6 M in Et2O, 5.19 mL, 8.30 mmol, 4.8 eq) and the resulting 
reaction mixture was stirred for 1 h. Crude aldehyde 2.88 in THF (8.0 mL) was added 
dropwise and the reaction mixture was allowed to warm up to r.t. overnight. The reaction was 
quenched by addition of H2O (40 mL). The layers were separated and the aqueous layer was 
extracted with Et2O (4 × 20 mL). The combined organic layers were washed with brine 
(40 mL) and dried over Na2SO4. After filtration and concentration in vacuo, the crude product 
was purified by flash column chromatography (pentane:Et2O 6:1) on silica to afford alkene 
2.73 (125 mg, 891 μmol, 52%) as a colourless liquid. 
 
Data for 2.73: Rf: 0.47 (hexanes:EtOAc 4:1); 1H NMR (400 MHz, CDCl3): δ = 5.81 (ddd, 
J = 17.3, 10.6, 6.7 Hz, 1H), 5.45 – 5.30 (m, 2H), 4.50 (d, J = 6.7 Hz, 1H), 2.42 (d, 
J = 16.9 Hz, 1H), 2.35 (d, J = 16.8 Hz, 1H), 1.18 (s, 3H), 1.01 (s, 3H) ppm; 13C NMR 
(100 MHz, CDCl3): δ = 176.1, 131.6, 119.2, 89.1, 44.0, 40.2, 25.3, 22.2 ppm; IR (ATR): 
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ߥmax = 2964 (w), 2933 (w), 2876 (w), 1776 (s), 1466 (w), 1420 (w), 1392 (w), 1374 (w), 
1322 (w), 1287 (m), 1230 (m), 1198 (m), 1162 (m), 1112 (m), 1031 (m), 989 (s), 948 (m), 
927 (s), 890 (m), 800 (w), 715 (w), 592 (w) cm−1; HRMS (EI): calc. for C8H12O2 [M]+: 
140.0832, found: 140.0837; optical rotation: [α]D22 = +55.6° (c = 1.00, CHCl3). 
 
 
 
Alkene (E)-2.89 To a stirred solution of lactone 2.73 (36.4 mg, 260 μmol, 4.0 eq) and iron 
tricarbonyl complex 2.75 (16.0 mg, 65.0 μmol, 1.0 eq) in benzene (0.5 mL, degassed by 
sparging with argon for 20 min) at r.t. was added nitro-Grela catalyst (2.93, 2.2 mg, 
3.25 μmol, 0.05 eq) and the resulting reaction mixture was stirred for 1.5 h at 40 °C followed 
by addition of catalyst 2.93 (2.2 mg, 3.25 μmol, 0.05 eq). After 4 h the solvent was 
evaporated and the crude product was purified by flash column chromatography 
(pentane:Et2O 4:1) on silica to afford alkene (E)-2.89 (6.7 mg, 19.5 μmol, 30%) as a yellow 
oil. 
 
Data for (E)-2.89: Rf: 0.23 (hexanes:EtOAc 4:1); 1H NMR (400 MHz, C6D6): δ = 5.49 (d, 
J = 15.7 Hz, 1H), 5.27 (dd, J = 15.7, 7.2 Hz, 1H), 3.82 (d, J = 7.2 Hz, 1H), 3.68 (d, J = 9.2 Hz, 
1H), 3.63 (d, J = 9.2 Hz, 1H), 1.86 (d, J = 16.6 Hz, 1H), 1.74 (d, J = 16.6 Hz, 1H), 1.25 (s, 
3H), 0.57 (s, 3H), 0.54 (s, 3H) ppm; 13C NMR (100 MHz, C6D6): δ = 214.9, 174.3, 126.5, 
123.0, 87.7, 85.3, 73.9, 65.2, 63.7, 43.8, 40.0, 24.5, 21.6, 12.5 ppm; IR (ATR): 
ߥmax = 3099 (w), 2964 (w), 2928 (w), 2875 (w), 2031 (s), 1941 (s), 1774 (s), 1646 (m), 
1465 (m), 1451 (m), 1438 (m), 1373 (m); 1284 (m), 1228 (m), 1195 (m), 1158 (m), 1116 (m), 
1022 (m), 993 (m), 961 (s), 928 (m), 837 (m) cm−1; HRMS (EI): calc. for C16H16Fe56O5 [M]+: 
344.0342, found: 344.0342; optical rotation: [α]D21 = −65.7° (c = 0.35, CH2Cl2). 
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Alkyne 2.95 To a stirred solution of aldehyde 2.81 (340 mg, 1.45 mmol, 1.0 eq) in MeOH 
(11.0 mL) at 0 °C was added K2CO3 (422 mg, 3.05 mmol, 2.1 eq) and Bestmann-Ohira 
reagent (2.94, 279 mg, 1.45 μmol, 1.0 eq) in MeOH (2.0 mL) and the resulting reaction 
mixture was stirred at r.t. for 1 h. Additional K2CO3 (422 mg, 3.05 mmol, 2.1 eq) and 
Bestmann−Ohira reagent (2.94, 279 mg, 1.45 μmol,1.0 eq) was added and the reaction was 
stirred for 3 h. The reaction was quenched by addition of H2O (30 mL) and sat. aq. NaHCO3 
solution (30 mL). The layers were separated and the aqueous layer was extracted with Et2O 
(3 × 30 mL). The combined organic layers were dried over Na2SO4. After filtration and 
concentration in vacuo, the crude product was purified by flash column chromatography 
(pentane) on silica to afford alkyne 2.95 (265 mg, 1.15 μmol, 79%) as a yellow oil. 
 
Data for 2.95: Rf: 0.71 (hexanes:EtOAc 4:1); 1H NMR (400 MHz, C6D6): δ = 3.66 (s, 2H), 
2.42 (s, 1H), 1.00 (s, 3H) ppm; 13C NMR (100 MHz, C6D6): δ = 214.0, 87.3, 79.1, 77.0, 68.0, 
54.0, 12.1 ppm; IR (ATR): ߥmax = 3305 (m), 2041 (s), 1951 (s), 1447 (w), 1405 (w), 1376 (w), 
1044 (w), 1027 (w), 826 (w), 724 (w), 659 (w) cm−1; HRMS (EI): calc. for C10H6Fe56O3 [M]+: 
229.9661, found: 229.9653. 
 
 
 
Ethyl 3,3-dimethyl-4-oxobutanoate (2.96) Ozone was bubbled through a stirred solution of 
ester 2.83 (21.5 g, 138 mmol, 1.0 eq) in CH2Cl2/MeOH (500 mL, 4:1) at –78 °C. After a 
slightly blue color persisted (2 h), N2 was bubbled through the reaction mixture for 15 min 
followed by addition of PPh3 (61.3 g, 234 mmol, 1.7 eq). The resulting mixture was stirred at 
r.t. for 14 h. After concentration in vacuo, the crude product was purified by flash column 
chromatography (pentane:Et2O 9:1) on silica to afford aldehyde 2.96 (20.7 g, 131 mmol, 
95%) as a colorless liquid. 2.96 was stored as solution in THF (72 mL) at –20 °C. Compound 
2.96 has been reported in the literature.130,160 
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Data for 2.96: Rf: 0.77 (hexanes:EtOAc 4:1); 1H NMR (400 MHz, C6D6): δ = 9.33 (s, 1H), 
3.84 (q, J = 7.1 Hz, 2H), 2.17 (s, 2H), 0.89 (t, J = 7.1 Hz, 3H), 0.82 (s, 6H) ppm; 13C NMR 
(100 MHz, C6D6): δ = 202.9, 170.7, 60.4, 44.0, 42.0, 21.7, 14.2 ppm; IR (ATR): 
ߥmax = 2980 (w), 2938 (w), 2877 (w), 2815 (w), 2713 (w), 1727 (s), 1472 (w), 1448 (w), 
1397 (w), 1370 (m), 1342 (m), 1207 (m), 1135 (m), 1097 (m), 1032 (m), 948 (w), 922 (w), 
888 (m), 860 (w), 808 (w), 733 (w) cm−1; HRMS (EI): calc. for C8H14O3 [M]+: 158.0937, found: 
158.0940. 
 
 
 
Lactone 2.97 To a stirred solution of alkyne 2.95 (250 mg, 1.09 mmol, 1.0 eq) in THF (7 mL) 
at −78 °C was added EtMgBr (1.0 M in MTBE, 1.25 mL, 1.25 mmol, 1.15 eq) and the 
resulting reaction mixture was stirred for 2.5 h at 0 °C. The reaction was cooled to −78 °C 
and aldehyde 2.96 (0.43 M in THF, 4.57 mL, 1.96 mmol, 1.8 eq) was added dropwise. The 
reaction mixture was allowed to warm up to r.t. over 1.5 h. The reaction was quenched by 
addition of H2O (40 mL) and sat. aq. NH4Cl solution (20 mL). The layers were separated and 
the aqueous layer was extracted with Et2O (3 × 30 mL). The combined organic layers were 
dried over Na2SO4. After filtration and concentration in vacuo, the crude product was 
dissolved in toluene (10 mL) and pTsOH∙H2O (20.7 mg, 109 μmol, 0.1 eq) was added and 
the resulting reaction mixture was stirred for 30 min at r.t. The reaction was quenched by 
addition of H2O (30 mL) and sat. aq. NaHCO3 solution (30 mL). The layers were separated 
and the aqueous layer was extracted with Et2O (3 × 20 mL). The combined organic layers 
were dried over Na2SO4. After filtration and concentration in vacuo, the crude product was 
purified by flash column chromatography (pentane:Et2O 5:12:1) on silica to afford lactone 
2.97 (293 mg, 857 μmol, 79%) as a yellow solid. 
 
Data for 2.97: Rf: 0.43 (hexanes:EtOAc 4:1); 1H NMR (400 MHz, C6D6): δ = 4.20 (s, 1H), 
3.70 (s, 2H), 1.88 (d, J = 16.7 Hz, 1H), 1.58 (d, J = 16.7 Hz, 1H), 1.04 (s, 3H), 0.84 (s, 3H), 
0.55 (s, 3H) ppm; 13C NMR (100 MHz, C6D6): δ = 213.9, 173.7, 88.1, 84.3, 83.0, 78.4, 68.2, 
68.1, 53.1, 42.5, 40.2, 24.5, 22.9, 12.2 ppm; IR (ATR): ߥmax = 2966 (w), 2931 (w), 2877 (w), 
2224 (w), 2040 (s), 1952 (s), 1781 (s), (m), 1465 (m), 1434 (m), 1375 (m), 1340 (w); 
1284 (m), 1230 (m), 1195 (m), 1146 (m), 1135 (m), 1112 (m), 1052 (m), 1025 (m), 988 (m), 
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966 (m), 952 (m), 925 (m), 888 (m), 857 (m), 844 (m), 727 (m), 658 (w) cm−1; melting point: 
82.0 – 83.8 °C; HRMS (EI): calc. for C16H14Fe56O5 [M]+: 342.0185, found: 342.0179.	
 
 
 
Iron tricarbonyl complex 2.98 To a stirred solution of alkyne 2.97 (250 mg, 731 μmol, 
1.0 eq) in THF/H2O (1:1, 15 mL) at r.t. was added p-toluenesulfonyl hydrazide (5.43 g, 
29.2 mmol, 40 eq) and NaOAc∙3H2O (3.97 g, 29.2 mmol, 40 eq) and the resulting reaction 
mixture was stirred for 12 h at 70 °C. The reaction was quenched by addition of H2O 
(120 mL) and sat. aq. NaHCO3 solution (120 mL). The layers were separated and the 
aqueous layer was extracted with Et2O (3 × 50 mL) and EtOAc (50 mL). The combined 
organic layers were dried over Na2SO4. After filtration and concentration in vacuo, the crude 
product was purified by flash column chromatography (pentane:Et2O 3:1) on silica to afford 
iron tricarbonyl complex 2.98 (238 mg, 688 μmol, 94%) as a yellow solid. 
 
Data for 2.98: Rf: 0.43 (hexanes:EtOAc 3:1); 1H NMR (400 MHz, C6D6): δ = 3.56 (d, 
J = 9.3 Hz, 1H), 3.51 (d, J = 9.3 Hz, 1H), 3.37 (dd, J = 10.6, 1.6 Hz, 1H), 2.05 (ddd, J = 15.1, 
10.1, 4.9 Hz, 1H), 1.82 (d, J = 16.7 Hz, 1H), 1.77 (d, J = 13.9 Hz, 1H), 1.71 (td, J = 9.7, 
4.9 Hz, 1H), 1.32 (s, 3H), 1.31 – 1.18 (m, 1H), 1.16 – 1.05 (m, 1H), 0.51 (s, 3H), 0.49 (s, 
3H) ppm; 13C NMR (100 MHz, C6D6): δ = 215.9, 174.3, 86.9, 82.3, 81.9, 65.9, 65.7, 44.2, 
38.5, 29.7, 24.7, 24.6, 20.9, 12.6 ppm; IR (ATR): ߥmax = 2969 (w), 2919 (w), 2874 (w), 
2033 (s), 1947 (s), 1777 (m), 1462 (w), 1451 (m), 1420 (w), 1391 (w), 1372 (w), 1289 (w), 
1227 (w), 1197 (w), 1145 (w), 947 (w), 928 (w), 614 (m), 589 (m) cm−1; melting point: 59.7 – 
61.2 °C; HRMS (ESI): calc. for C16H22Fe56NO5 [M+NH4]+: 364.0842, found: 364.0843.	
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Enone 2.72 To a stirred solution of lactone 2.98 (140 mg, 404 μmol, 1.0 eq) in THF (5 mL) at  
–78 °C was added LHMDS (1.0 M in THF, 888 μL, 888 μmol, 2.2 eq) and the resulting 
mixture was allowed to warm up to –45 °C within 1 h. Eschenmoser’s salt (247 mg, 
1.33 mmol, 3.3 eq) was added to the reaction mixture in one portion at –78 °C and the 
resulting reaction mixture was allowed to warm up to r.t. over 1 h. The solvent was 
evaporated and the crude material was dissolved in MeOH (3 mL). Methyliodide (3 mL) was 
added and the reaction was stirred at r.t. overnight. The solvent was evaporated and the 
crude material was dissolved in CH2Cl2 (2 mL). Aq. NaHCO3 solution (5 wt%, 1 mL) and DBU 
(0.5 mL, 3.35 mmol, 8.3 eq) were added and the resulting reaction mixture was stirred at r.t. 
for 3.5 h followed by addition of H2O (5 mL) and sat. aq. NH4Cl solution (5 mL). The layers 
were separated and the aqueous layer was extracted with CH2Cl2 (4 × 5 mL). The combined 
organic layers were dried over Na2SO4. After filtration and concentration in vacuo, the crude 
product was purified by flash column chromatography (pentane:Et2O 4:1) on silica to afford 
enone 2.72 (99.9 mg, 279 μmol, 69%) as a slightly yellow solid. A crystal, suitable for single 
crystal X-ray diffraction analysis, was obtained by crystallization from acetone. 
 
Data for 2.72: Rf: 0.60 (hexanes:EtOAc 3:1); 1H NMR (400 MHz, C6D6): δ = 6.05 (s, 1H), 
4.85 (s, 1H), 3.53 – 3.41 (m, 3H), 2.04 (ddd, J = 15.1, 9.7, 5.0 Hz, 1H), 1.70 (ddd, J = 15.6, 
9.3, 6.6 Hz, 1H), 1.31 (s, 3H), 1.26 – 1.09 (m, 2H), 0.67 (s, 3H), 0.60 (s, 3H) ppm; 13C NMR 
(100 MHz, C6D6): δ = 215.8, 169.0, 146.4, 118.5, 85.5, 82.1, 82.0, 65.9, 65.7, 41.6, 30.6, 
25.3, 24.1, 22.2, 12.6 ppm; IR (ATR): ߥmax = 2967 (w), 2927 (w), 2869 (w), 2031 (s), 1943 (s), 
1765 (m), 1465 (w), 1445 (m), 1410 (w), 1371 (w), 1348 (w), 1296 (m), 1194 (m), 1127 (w), 
1106 (w), 1023 (w), 940 (w), 815 (w), 612 (m), 589 (m) cm−1; melting point: 43.2 – 45.5 °C; 
HRMS (ESI): calc. for C17H22Fe56NO5 [M+NH4]+: 376.0842, found: 376.0844.	
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Cyclohexadiene 2.100 To a stirred solution of enone 2.72 (5.0 mg, 14.0 μmol, 1.0 eq) in 
benzene (14 mL) at r.t. was added trimethylamine N-oxide (4.2 mg, 55.9 μmol, 4.0 eq) and 
the resulting mixture was heated to 85 °C for 5.5 h. Additional trimethylamine N-oxide 
(4.2 mg, 55. mmol, 4.0 eq) was added and the resulting reaction mixture was heated over 
12.5 h. The reaction was quenched by addition of sat. aq NaHCO3 solution (14 mL) and sat. 
aq Na2S2O3 solution (7 mL). The layers were separated and the aqueous layer was extracted 
with CH2Cl2 (3 × 30 mL). The combined organic layers were dried over Na2SO4. After 
filtration and concentration in vacuo, the crude product was purified by flash column 
chromatography (pentane:Et2O 5:1) on silica to afford cyclohexadiene 2.100 (1.2 mg, 
5.50 μmol, 39%) as a colourless oil. 
 
Data for 2.100: Rf: 0.57 (hexanes:EtOAc 3:1); 1H NMR (400 MHz, C6D6): δ = 5.39 (s, 1H), 
5.10 (s, 1H), 3.62 (d, J = 4.2 Hz, 1H), 3.20 (d, J = 19.5 Hz, 1H), 2.44 – 2.32 (m, 1H), 2.05 
(dd, J = 19.2, 5.7 Hz, 1H), 1.76 (dd, J = 15.0, 6.9 Hz, 1H), 1.53 (s, 3H), 1.49 (dd, J = 8.0, 
4.7 Hz, 1H), 1.28 (td, J = 13.4, 12.6, 7.0 Hz, 1H), 0.68 (s, 3H), 0.66 (s, 3H) ppm; 13C NMR 
(100 MHz, C6D6): δ = 178.3, 132.2, 128.0,* 124.0, 117.9, 83.9, 54.1, 46.3, 27.6, 25.9, 23.8, 
22.6, 21.3, 18.0 ppm; IR (ATR): ߥmax = 3030 (w), 2948 (w), 2876 (w), 2853 (w), 1776 (s), 
1761 (s), 1672 (w), 1612 (w), 1467 (w), 1452 (w), 1492 (w), 1372 (w), 1339 (m), 1290 (w), 
1264 (w), 1180 (w), 1167 (w), 1142 (m), 1100 (m), 1036 (m), 1011 (w), 981 (m), 964 (m), 
941 (w), 922 (m), 773 (w) cm−1; HRMS (EI): calc. for C14H18O2 [M]+: 218.1301, 
found:218.1306.	
* One alkene 13C-shift overlapped with the solvent peak, but could be extracted from the 
HMBC data showing corresponding correlations at 128.0 ppm. 
 
 
 
Alkene (Z)-2.89 To a stirred solution of alkyne 2.97 (43.3 mg, 127 μmol, 1.0 eq) in EtOH 
(4 mL) at r.t. was added Pd/C (10% Pd on activated charcoal, 21.7 mg, 20.5 μmol, 0.2 eq) 
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and the reaction vessel was backfilled three times with H2 followed by sparging with H2 for 
1 min. After 2.5 h the reaction was filtered over Celite (EtOAc) and the crude product was 
purified by flash column chromatography (pentane:Et2O 5:1) on silica to afford alkene 
(Z)-2.89 (21.8 mg, 63.3 μmol, 50%) as a yellow oil.  
 
For clarity just the 1H-NMR and 13C-shifts of the major diastereomer are reported. 
Data for (Z)-2.89: Rf: 0.38 (hexanes:EtOAc 4:1); 1H NMR (400 MHz, C6D6): δ = 5.29 (d, 
J = 11.4 Hz, 1H), 5.00 (dd, J = 10.7, 9.7 Hz, 1H), 4.31 (d, J = 9.4 Hz, 1H), 3.79 (d, J = 9.2 Hz, 
1H), 3.61 (d, J = 9.2 Hz, 1H), 1.87 (d, J = 16.9 Hz, 1H), 1.82 (d, J = 16.5 Hz, 1H), 1.24 (s, 
3H), 0.64 (s, 3H), 0.55 (s, 3H) ppm; 13C NMR (100 MHz, C6D6): δ = 214.7, 174.5, 127.7, 
123.7, 86.0, 83.1, 71.8, 66.8, 66.7, 43.9, 39.8, 25.4, 21.7, 12.6 ppm; IR (ATR): 
ߥmax = 2965 (w), 2936 (w), 2877 (w), 2038 (s), 1956 (s), 1782 (s), 1468 (w), 1445 (w), 
1374 (w), 1287 (w), 1232 (w), 1198 (w), 1151 (w), 1116 (w), 1024 (w), 995 (w), 969 (w), 
928 (w) cm−1; HRMS (EI): calc. for C16H16Fe56O5 [M]+: 344.0342, found: 344.0339.	
 
 
 
Enone 2.106 To a stirred solution of alkene (Z)-2.89 (20.0 mg, 58.1 μmol, 1.0 eq) in THF 
(1 mL) at –78 °C was added LHMDS (1.0 M in THF, 128 μL, 128 μmol, 2.2 eq) and the 
resulting mixture was allowed to warm up to –45 °C within 1 h. Eschenmoser’s salt (35.5 mg, 
192 μmol, 3.3 eq) was added to the reaction mixture in one portion at –78 °C and the 
resulting reaction mixture was allowed to warm up to r.t. over 2 h. The solvent was 
evaporated and the crude material was dissolved in MeOH (1 mL). Methyliodide (0.5 mL) 
was added and the reaction was stirred at r.t. overnight. The solvent was evaporated and the 
crude material was dissolved in CH2Cl2 (1 mL). Aq. 5% NaHCO3 solution (0.5 mL) and DBU 
(0.2 mL, 1.34 mmol, 23 eq) were added and the resulting reaction mixture was stirred at r.t. 
for 30 min followed by addition of aq. phosphate buffer (pH = 7.0, 15 ml). The layers were 
separated and the aqueous layer was extracted with CH2Cl2 (3 × 15 mL). The combined 
organic layers were dried over Na2SO4. After filtration and concentration in vacuo, the crude 
product was purified by flash column chromatography (pentane:Et2O 3:1) on silica to afford 
enone 2.106 (16.6 mg, 46.6 μmol, 80%) as a slightly yellow oil. 
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For clarity just the 1H-NMR shifts of the major diastereomer are reported. In the 13C-data 
shifts of the minor isomer are marked by an asterisk *. 
Data for 2.106: Rf: 0.53 (hexanes:EtOAc 4:1); 1H NMR (400 MHz, C6D6): δ = 6.09 (s, 1H), 
5.28 (d, J = 11.3 Hz, 1H), 4.98 (t, J = 10.5 Hz, 1H), 4.88 (s, 1H), 4.39 (d, J = 9.7 Hz, 1H), 
3.68 (d, J = 9.1 Hz, 1H), 3.55 (d, J = 9.1 Hz, 1H), 1.22 (s, 3H), 0.82 (s, 3H), 0.68 (s, 3H) ppm; 
13C NMR (100 MHz, C6D6): δ = 214.9,* 214.7, 169.2, 169.1,* 146.1, 145.9,* 127.7,# 127.1,* 
123.8, 123.2,* 118.8, 86.5,* 86.2, 85.4,* 81.7, 73.7,* 71.6, 66.8, 66.6, 65.4,* 63.6,* 42.9,* 
42.6, 25.6, 24.8,* 23.3,* 23.1, 12.6, 12.5* ppm; IR (ATR): ߥmax = 2968 (w), 2932 (w), 
2869 (w), 2038 (s), 1957 (s), 1766 (s), 1465 (w), 1446 (w), 1407 (w), 1371 (w), 1295 (w), 
1193 (w), 1169 (w), 1131 (w), 1111 (w), 985 (w), 814 (w) cm−1; HRMS (EI): calc. for 
C17H16Fe56O5 [M]+: 356.0342, found: 356.0344.	
# One alkene 13C-shift overlapped with the solvent peak, but could be extracted from the 
HMBC data showing corresponding correlations at 127.7 ppm. 
 
 
 
Amide 2.114 To a stirred suspension of AlCl3 (26.9 mg, 202 μmol, 1.0 eq) in DCE (2 mL) at 
r.t. was added pyrrolidine (33.2 μL, 408 μmol, 4.0 eq) and the resulting mixture was stirred 
for 20 min. Lactone 2.98 (35.0 mg, 101 μmol, 1.0 eq) in DCE (2 mL) was added and the 
resulting reaction mixture was stirred for 8 h. The reaction was quenched by addition of H2O 
(10 mL). The layers were separated and the aqueous layer was extracted with CH2Cl2 
(3 × 30 mL). The combined organic layers were dried over Na2SO4. After filtration and 
concentration in vacuo, the crude product was purified by flash column chromatography 
(EtOAc) on silica to afford amide 2.114 (41.3 mg, 99.0 μmol, 98%) as a yellow oil. 
 
Data for 2.114: Rf: 0.55 (EtOAc); 1H NMR (400 MHz, C6D6): δ = 5.84 (d, J = 6.5 Hz, 1H), 
3.66 (d, J = 9.3 Hz, 1H), 3.63 (d, J = 9.3 Hz, 1H), 3.48 (ddd, J = 9.5, 6.7, 3.0 Hz, 1H), 3.24 (t, 
J = 6.4 Hz, 2H), 2.73 – 2.53 (m, 3H), 2.32 (d, J = 14.7 Hz, 1H), 2.15 – 2.02 (m, 1H), 1.89 (d, 
J = 14.7 Hz, 1H), 1.62 – 1.47 (m, 2H), 1.30 (s, 3H), 1.22 – 1.07 (m, 4H), 1.03 (s, 3H), 0.94 (s, 
3H) ppm; 13C NMR (100 MHz, C6D6): δ = 216.4, 171.1, 85.5, 81.3, 77.0, 66.4, 66.3, 47.1, 
46.0, 44.6, 38.9, 32.7, 26.0, 25.9, 25.3, 24.8, 24.2, 12.7 ppm; IR (ATR): ߥmax = 3336 (br w), 
2964 (w), 2928 (w), 2875 (w), 2031 (s), 1946 (s), 1612 (m), 1470 (w), 1447 (w), 1260 (w), 
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1076 (w), 1025 (w), 799 (w) cm−1; HRMS (EI): calc. for C19H27Fe56NO4 [M-CO]+: 389.1284, 
found: 389.1283.	
 
 
 
Protected amide 2.115 To a stirred solution of amide 2.114 (20.0 mg, 47.9 μmol, 1.0 eq) in 
DMF (1 mL) at r.t. was added TBSCl (21.7 mg, 144 μmol, 3.0 eq), imidazole (19.5 mg, 
287 μmol, 6.0 eq) and DMAP (cat.) and the resulting mixture was stirred for 6 h. The reaction 
was quenched by addition of H2O (10 mL). The layers were separated and the aqueous layer 
was extracted with Et2O (3 × 10 mL). The combined organic layers were dried over Na2SO4. 
After filtration and concentration in vacuo, the crude product was purified by flash column 
chromatography (pentane:EtOAc 4:1) on silica to afford protected amide 2.115 (21.0 mg, 
39.5 μmol, 82%) as a yellow oil. 
 
Data for 2.115: Rf: 0.65 (hexanes:EtOAc 1:1); 1H NMR (400 MHz, C6D6): δ = 4.23 (dd, 
J = 7.0, 3.1 Hz, 1H), 3.78 (d, J = 9.3 Hz, 1H), 3.66 (d, J = 9.3 Hz, 1H), 3.38 (t, J = 6.7 Hz, 
2H), 2.87 (t, J = 6.7 Hz, 2H), 2.30 (d, J = 15.5 Hz, 1H), 2.18 (ddd, J = 15.5, 10.7, 5.2 Hz, 1H), 
2.05 (d, J = 15.7 Hz, 1H), 1.98 (td, J = 10.4, 5.3 Hz, 1H), 1.70 (tdd, J = 15.9, 7.6, 4.8 Hz, 1H), 
1.50 (td, J = 15.6, 13.2, 5.9 Hz, 1H), 1.32 (s, 3H), 1.30 – 1.21 (m, 4H), 1.20 (s, 6H), 1.03 (s, 
9H), 0.18 (s, 3H), 0.13 (s, 3H) ppm; 13C NMR (100 MHz, C6D6): δ = 216.1, 169.5, 84.0, 81.7, 
77.5, 66.1, 65.9, 46.7, 45.7, 42.7, 39.2, 33.7, 26.5, 26.3, 25.3, 24.4, 24.4, 24.4, 18.7, 12.7, 
−3.4, −3.7 ppm; IR (ATR): ߥmax = 2954 (w), 2929 (w), 2857 (w), 2031 (s), 1943 (s), 1638 (m), 
1423 (m), 1383 (w), 1361 (w), 1341 (w), 1252 (w), 1192 (w), 1168 (w), 1081 (m), 1046 (w), 
1005 (w), 834 (m), 773 (w), 719 (m), 664 (w) cm−1; HRMS (EI): calc. for C26H41Fe56NSiO5 
[M]+: 531.2098, found:531.2095.	
 
 
 
Diol 2.109 To a stirred solution of lactone 2.72 (30.0 mg, 83.8 μmol, 1.0 eq) in toluene (1 mL) 
at 0 °C was added DIBAL-H (1.0 M in toluene, 629 μL, 629 μmol, 7.5 eq) and the resulting 
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mixture was allowed to warm up to r.t. overnight. The reaction was quenched by addition of 
aq. sat. K+-Na+-tartrate solution (3 mL) and Et2O (2 mL) and the biphasic mixture was 
vigorously stirred for 30 min. The layers were separated and the aqueous layer was 
extracted with Et2O (2 × 20 mL) and EtOAc (20 mL). The combined organic layers were dried 
over Na2SO4. After filtration and concentration in vacuo, the crude product was purified by 
flash column chromatography (hexanes:EtOAc 2:1) on silica to afford diol 2.109 (26.1 mg, 
72.1 μmol, 86%) as a yellow oil. 
 
Data for 2.109: Rf: 0.50 (hexanes:EtOAc 1:1); 1H NMR (400 MHz, C6D6): δ = 5.10 (s, 1H), 
4.95 (s, 1H), 3.93 (d, J = 11.2 Hz, 1H), 3.85 – 3.69 (m, 1H), 3.69 – 3.52 (m, 2H), 3.23 (d, 
J = 9.5 Hz, 1H), 2.30 (ddd, J = 14.8, 10.0, 4.8 Hz, 1H), 1.87 (ddd, J = 15.5, 9.8, 6.6 Hz, 1H), 
1.51 – 1.34 (m, 2H), 1.32 (s, 3H), 0.99 (s, 3H), 0.96 (s, 3H) ppm; 13C NMR (100 MHz, C6D6): 
δ = 215.8, 153.1, 114.5, 84.0, 81.0, 76.6, 65.8, 65.6, 63.9, 43.1, 32.0, 24.6, 23.9, 22.5, 12.3 
ppm; IR (ATR): ߥmax = 3295 (br w), 2967 (w), 2925 (w), 2880 (w), 2029 (s), 1938 (s), 
1634 (w), 1445 (w), 1384 (w), 1372 (w), 1331 (w), 1198 (w), 1107 (w), 1069 (w), 1046 (w), 
1025 (w), 907 (w), 829 (w), 770 (w), 729 (w) cm−1; HRMS (EI): calc. for C17H22Fe56O5 [M]+: 
362.0811, found:362.0786.	
 
 
 
Monoprotected diol 2.110 To a stirred solution of diol 2.109 (19.0 mg, 52.5 μmol, 1.0 eq) in 
DMF (1 mL) at r.t. was added TBSCl (15.8 mg, 105 μmol, 2.0 eq), imidazole (14.3 mg, 
210 μmol, 4.0 eq) and DMAP (cat.) and the resulting mixture was stirred for 2 h. The reaction 
was quenched by addition of H2O (10 mL). The layers were separated and the aqueous layer 
was extracted with Et2O (2 × 5 mL) and EtOAc (5 mL). The combined organic layers were 
dried over Na2SO4. After filtration and concentration in vacuo, the crude product was purified 
by flash column chromatography (hexanes:EtOAc 9:1) on silica to afford monoprotected diol 
2.110 (20.0 mg, 42.0 μmol, 80%) as a yellow oil. 
 
Data for 2.110: Rf: 0.53 (hexanes:EtOAc 9:1); 1H NMR (400 MHz, C6D6): δ = 5.25 (s, 1H), 
5.02 (s, 1H), 4.14 (d, J = 12.3 Hz, 1H), 3.97 (d, J = 12.4 Hz, 1H), 3.63 (d, J = 9.3 Hz, 1H), 
3.58 (d, J = 9.3 Hz, 1H), 3.36 (dd, J = 9.4, 4.0 Hz, 1H), 2.64 (d, J = 4.9 Hz, 1H), 2.39 (ddd, 
J = 15.1, 10.1, 4.9 Hz, 1H), 1.94 (ddd, J = 15.6, 10.1, 6.1 Hz, 1H), 1.54 – 1.35 (m, 2H), 1.32 
(s, 3H), 1.05 (s, 3H), 1.01 (s, 3H), 0.95 (s, 9H), 0.04 (s, 6H) ppm; 13C NMR (100 MHz, C6D6): 
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δ = 216.1, 153.2, 114.7, 84.4, 81.3, 76.7, 66.1, 65.9, 64.9, 43.6, 32.3, 26.0, 25.1, 24.2, 22.4, 
18.5, 12.7, −5.3, −5.4 ppm; IR (ATR): ߥmax = 3417 (br w), 2956 (w), 2930 (w), 2884 (w), 
2858 (w), 2033 (s), 1950 (s), 1636 (w), 1471 (w), 1445 (w), 1390 (w), 1362 (w), 1256 (w), 
1083 (m), 1046 (w), 1005 (w), 837 (m), 777 (w), 679 (w) cm−1; HRMS (EI): calc. for 
C22H36Fe56SiO4 [M-CO]+: 448.1727, found: 448.1728. 
 
  
116  Supporting information for Chapter 2.2.1.1–2.2.1.5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6.1.2 1H and 13C NMR spectra 
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6.1.3 X-ray crystallographic data 
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Ketal 2.68 
 
Figure 6.1 ORTEP of the molecular structure of ketal 2.68. 
 
net formula C23H42O3Si 
Mr/g mol−1 394.663 
crystal size/mm 0.510 × 0.382 × 0.152 
T/K 173(2) 
radiation MoKα 
diffractometer 'Oxford XCalibur' 
crystal system triclinic 
space group 'P -1' 
a/Å 8.1169(3) 
b/Å 13.7341(7) 
c/Å 21.3233(9) 
α/° 92.039(4) 
β/° 95.567(3) 
γ/° 90.004(4) 
V/Å3 2364.36(18) 
Z 4 
calc. density/g cm−3 1.10874(8) 
μ/mm−1 0.118 
absorption correction 'multi-scan' 
transmission factor range 0.57289–1.00000 
Table 6.1 Crystallographic data for ketal 2.68. 
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refls. measured 13675 
Rint ? 
mean σ(I)/I 0.0515 
θ range 4.192–28.305 
observed refls. 9506 
x, y (weighting scheme) 0.1225, 
hydrogen refinement constr 
refls in refinement 13675 
parameters 504 
restraints 0 
R(Fobs) 0.0636 
Rw(F2) 0.1853 
S 0.987 
shift/errormax 0.001 
max electron density/e Å−3 0.544 
min electron density/e Å−3 −0.376 
 
BASF 0.42. 
 
 
Iron tricarbonyl complex 2.81 
 
Figure 6.2 ORTEP of the molecular structure of iron tricarbonyl complex 2.81. 
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net formula C9H6FeO4 
Mr/g mol−1 233.99 
crystal size/mm 0.120 × 0.060 × 0.010 
T/K 100(2) 
radiation MoKα 
diffractometer 'Bruker D8Venture' 
crystal system monoclinic 
space group 'C 2/c' 
a/Å 14.4029(7) 
b/Å 6.2050(3) 
c/Å 20.8861(10) 
α/° 90 
β/° 92.2073(16) 
γ/° 90 
V/Å3 1865.21(16) 
Z 8 
calc. density/g cm−3 1.667 
μ/mm−1 1.599 
absorption correction multi-scan 
transmission factor range 0.6933–0.7454 
refls. measured 16100 
Rint 0.0389 
mean σ(I)/I 0.0234 
θ range 3.376–26.45 
observed refls. 1643 
x, y (weighting scheme) 0.0252, 1.5046 
hydrogen refinement refall 
refls in refinement 1917 
parameters 151 
restraints 0 
R(Fobs) 0.0236 
Rw(F2) 0.0532 
S 1.063 
shift/errormax 0.001 
max electron density/e Å−3 0.348 
min electron density/e Å−3 −0.191 
Table 6.2 Crystallographic data for iron tricarbonyl complex 2.81. 
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Lactone 2.84 
 
Figure 6.3 ORTEP of the molecular structure of lactone 2.84. 
 
 
net formula C7H12O3 
Mr/g mol−1 144.17 
crystal size/mm 0.100 × 0.030 × 0.020 
T/K 100(2) 
radiation MoKα 
diffractometer 'Bruker D8Venture' 
crystal system monoclinic 
space group 'P 21' 
a/Å 6.6788(3) 
b/Å 6.2350(3) 
c/Å 9.0525(4) 
α/° 90 
β/° 96.602(3) 
γ/° 90 
V/Å3 374.47(3) 
Z 2 
calc. density/g cm−3 1.279 
μ/mm−1 0.099 
absorption correction multi-scan 
Table 6.3 Crystallographic data for lactone 2.84. 
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transmission factor range 0.7765–0.9582 
refls. measured 3507 
Rint 0.0245 
mean σ(I)/I 0.1000 
θ range 3.070–26.39 
observed refls. 1068 
x, y (weighting scheme) 0.00, 0.00 
hydrogen refinement mixed 
Flack parameter −0.4(10) 
refls in refinement 1176 
parameters 97 
restraints 1 
R(Fobs) 0.0382 
Rw(F2) 0.1069 
S 0.943 
shift/errormax 0.001 
max electron density/e Å−3 0.189 
min electron density/e Å−3 −0.186 
 
C-H: constr, O-H: refall. 
 
 
Iron tricarbonyl complex 2.72 
 
Figure 6.4 ORTEP of the molecular structure of iron tricarbonyl complex 2.72. 
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net formula C17H18FeO5 
Mr/g mol−1 358.16 
crystal size/mm 0.090 × 0.030 × 0.010 
T/K 100(2) 
radiation MoKα 
diffractometer 'Bruker D8Venture' 
crystal system monoclinic 
space group 'P 21/c' 
a/Å 11.8594(9) 
b/Å 18.1861(14) 
c/Å 7.7976(7) 
α/° 90 
β/° 94.188(2) 
γ/° 90 
V/Å3 1677.3(2) 
Z 4 
calc. density/g cm−3 1.418 
μ/mm−1 0.920 
absorption correction multi-scan 
transmission factor range 0.6646–0.7452 
refls. measured 28158 
Rint 0.0660 
mean σ(I)/I 0.0373 
θ range 3.229–25.12 
observed refls. 2342 
x, y (weighting scheme) 0.0314, 1.9213 
hydrogen refinement constr 
refls in refinement 2981 
parameters 211 
restraints 0 
R(Fobs) 0.0357 
Rw(F2) 0.0878 
S 1.033 
shift/errormax 0.001 
max electron density/e Å−3 0.611 
min electron density/e Å−3 −0.405 
Table 6.4 Crystallographic data for iron tricarbonyl complex 2.72. 
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6.2 Supporting information for Chapter 2.2.1.6 
6.2.1 Experimental procedures 
 
 
Ethyl 3,3-dimethylpent-4-enoate (8) A stirred solution of prenol (S1, 19.5 mL, 191 mmol, 
1.0 eq) and propionic acid (715 μL, 9.55 mmol, 0.05 eq) in triethylorthoacetate (700 mL, 
3.82 mol, 20 eq) was refluxed for 10 h. The reaction mixture was poured into a solution of 
conc. H2SO4 (50 mL) in ice-water (800 mL) and the resulting mixture was stirred for 24 h at 
r.t. The layers were separated and the aqueous layer was extracted with Et2O (3 × 500 mL). 
The combined organic layers were washed with sat. aq. Na2CO3 solution (5 × 400 mL), brine 
(500 mL) and dried over Na2SO4. After filtration and concentration in vacuo, the crude 
product was purified by distillation under reduced pressure (80 – 90 °C, 75 – 89 mbar) to 
afford ethyl ester 8 (21.5 g, 138 mmol, 72%) as a colorless liquid. Compound 8 has been 
reported in the literature.130 
 
Data for 8: Rf: 0.71 (hexanes:EtOAc 7:1); 1H NMR (400 MHz, CDCl3): δ = 5.89 (dd, J = 17.4, 
10.7 Hz, 1H), 5.01 – 4.90 (m, 2H), 4.10 (q, J = 7.1 Hz, 2H), 2.28 (s, 2H), 1.24 (t, J = 7.1 Hz, 
3H), 1.13 (s, 6H) ppm; 13C NMR (100 MHz, CDCl3): δ = 171.9, 147.0, 110.9, 60.2, 47.0, 36.3, 
27.1, 14.5 ppm; IR (ATR): ߥmax = 3086 (w), 2966 (w), 2932 (w), 2873 (w), 1731 (s), 1641 (w), 
1465 (w), 1447 (w), 1416 (w), 1367 (m), 1325 (w), 1236 (m), 1207 (m), 1126 (m), 1096 (w), 
1033 (w), 999 (w), 913 (m), 845 (w), 792 (w), 715 (w), 678 (w) cm−1; HRMS (EI): calc. for 
C9H16O2 [M]+: 156.1145, found: 156.1150. 
 
 
 
Ethyl 3,3-dimethyl-4-oxobutanoate (S2) Ozone was bubbled through a stirred solution of 
ester 8 (21.5 g, 138 mmol, 1.0 eq) in CH2Cl2/MeOH (500 mL, 4:1) at –78 °C. After a slightly 
blue color persisted (2 h), N2 was bubbled through the reaction mixture for 15 min followed 
by addition of PPh3 (61.3 g, 234 mmol, 1.7 eq). The resulting mixture was stirred at r.t. for 
14 h. After concentration in vacuo, the crude product was purified by flash column 
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chromatography (pentane:Et2O 9:1) on silica to afford aldehyde S2 (20.7 g, 131 mmol, 95%) 
as a colorless liquid. S2 was stored as solution in THF (72 mL) at –20 °C. Compound S2 has 
been reported in the literature.130,160 
 
Data for S2: Rf: 0.77 (hexanes:EtOAc 4:1); 1H NMR (400 MHz, C6D6): δ = 9.33 (s, 1H), 3.84 
(q, J = 7.1 Hz, 2H), 2.17 (s, 2H), 0.89 (t, J = 7.1 Hz, 3H), 0.82 (s, 6H) ppm; 13C NMR 
(100 MHz, C6D6): δ = 202.9, 170.7, 60.4, 44.0, 42.0, 21.7, 14.2 ppm; IR (ATR): ߥmax = 
2980 (w), 2938 (w), 2877 (w), 2815 (w), 2713 (w), 1727 (s), 1472 (w), 1448 (w), 1397 (w), 
1370 (m), 1342 (m), 1207 (m), 1135 (m), 1097 (m), 1032 (m), 948 (w), 922 (w), 888 (m), 
860 (w), 808 (w), 733 (w) cm−1; HRMS (EI): calc. for C8H14O3 [M]+: 158.0937, found: 
158.0940. 
 
 
 
Lactone S3 Zn powder (16.0 g) was activated by stirring with aq. 2% HCl (200 mL) for 5 min 
at r.t. After filtration, the grey powder was washed with EtOH (100 mL), acetone (100 mL) 
and Et2O (100 mL) and then dried under high vacuum at 80 °C for 15 min. To a stirred 
suspension of activated Zn powder (9.58 g, 147 mmol, 1.12 eq) in THF (50 mL) at 0 °C was 
added allyl bromide (12.6 mL, 147 mmol, 1.12 eq) in THF (50 mL) via canula. After 45 min at 
r.t., S2 (20.7 g, 131 mmol, 1.00 eq) in THF (50 mL) was added via canula at 0 °C and the 
resulting reaction mixture was stirred for 1 h at r.t. The reaction was quenched by addition of 
H2O (200 mL) and then filtered over Celite (Et2O), followed by extraction with Et2O 
(2 × 200 mL). The combined organic layers were dried over Na2SO4. After filtration and 
concentration in vacuo, the crude product was purified by flash column chromatography 
(pentane:Et2O 9:13:1) on silica to afford lactone S3 (17.8 g, 115 mmol, 88%) as a colorless 
liquid. 
 
Data for S3: Rf: 0.48 (hexanes:EtOAc 4:1); 1H NMR (400 MHz, C6D6): δ = 5.77 – 5.63 (m, 
1H), 5.03 – 4.95 (m, 2H), 3.50 (dd, J = 9.5, 3.9 Hz, 1H), 2.07 – 1.92 (m, 1H), 1.84 – 1.69 (m, 
3H), 0.47 (s, 3H), 0.46 (s, 3H) ppm; 13C NMR (100 MHz, C6D6): δ = 174.4, 134.5, 117.5, 
86.9, 44.4, 38.6, 33.9, 24.8, 20.9 ppm; IR (ATR): ߥmax = 3079 (w), 2964 (w), 2936 (w), 
2876 (w), 1772 (s), 1643 (w), 1467 (w), 1421 (w), 1373 (w), 1345 (w), 1287 (m), 1229 (m), 
1197 (m), 1160 (m), 1116 (m), 1078 (w), 1026 (m), 992 (s), 974 (s), 949 (w), 923 (s), 913(s), 
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866 (w), 826 (w), 800 (w), 672 (w) cm−1; HRMS (EI): calc. for C9H14O2 [M]+: 154.0988, found: 
154.0941. 
 
 
S4
O3, CH2Cl2/MeOH, 78 °C,20 min then PPh3 (1.7 eq),78 °C to r.t., 2 h then
NaBH4 (3.0 eq), 0 °C to r.t., 2 h O
O
S3
O
O
OH
 
Alcohol S4 Ozone was bubbled through a stirred solution of lactone S3 (2.98 g, 19.3 mmol, 
1.0 eq) in CH2Cl2/MeOH (64 mL, 4:1) at –78 °C. After a slightly blue color persisted (20 min), 
N2 was bubbled through the reaction mixture for 15 min followed by addition of PPh3 (8.60 g, 
32.8 mmol, 1.7 eq). The resulting mixture was stirred at r.t. for 2 h. NaBH4 (2.19 g, 
57.9 mmol, 3.0 eq) was added portionwise at 0 °C and the resulting reaction mixture was 
stirred at r.t. for 2 h. The reaction was quenched by addition of sat. aq. NH4Cl solution 
(75 mL) and H2O (25 mL) at 0 °C and the resulting mixture was stirred for 20 min. The layers 
were separated and the aqueous layer was extracted with CH2Cl2 (100 mL) and EtOAc 
(6 × 30 mL). The combined organic layers were dried over Na2SO4. After filtration and 
concentration in vacuo, the crude product was purified by flash column chromatography 
(Et2O) on silica to afford alcohol S4, inseparable from PPh3O impurities. Crude S4 was used 
without further purification in the next step. 
 
Data for S4: Rf: 0.20 (hexanes:EtOAc 1:1); 1H NMR (400 MHz, C6D6): δ = 3.71 (dd, J = 10.4, 
2.7 Hz, 1H), 3.47 – 3.35 (m, 2H), 1.78 (d, J = 16.6 Hz, 1H), 1.72 (d, J = 16.7 Hz, 1H), 1.29 – 
1.11 (m, 2H), 0.82 (s, 1H), 0.46 (s, 3H), 0.43 (s, 3H) ppm; 13C NMR (100 MHz, C6D6): δ = 
174.9, 84.7, 59.6, 44.3, 38.4, 31.9, 24.4, 21.0 ppm; HRMS (ESI): calc. for C8H18NO3 
[M+NH4]+: 176.1281, found: 176.1281. 
 
 
 
Protected lactone 9 To a stirred solution of crude alcohol S4 in CH2Cl2 (120 mL) at 0 °C 
was added DIPEA (5.58 mL, 32.8 mmol, 1.7 eq) and SEMCl (5.13 mL, 29.0 mmol, 1.5 eq). 
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The resulting reaction mixture was allowed to warm up to r.t. overnight and was quenched by 
addition of H2O (200 mL). The layers were separated and the aqueous layer was extracted 
with CH2Cl2 (50 mL) and EtOAc (5 × 50 mL). The combined organic layers were dried over 
Na2SO4. After filtration and concentration in vacuo, the crude product was purified by flash 
column chromatography (pentane:Et2O 3:1) on silica to afford SEM protected lactone 9 
(4.44 g, 15.4 mmol, 80% over 2 steps) as a colorless oil. 
 
Data for 9: Rf: 0.44 (hexanes:EtOAc 4:1); 1H NMR (400 MHz, C6D6): δ = 4.61 (s, 2H), 3.92 
(dd, J = 10.6, 2.6 Hz, 1H), 3.70 – 3.56 (m, 4H), 1.85 – 1.71 (m, 2H), 1.53 – 1.33 (m, 2H), 1.04 
– 0.93 (m, 2H), 0.52 (s, 3H), 0.46 (s, 3H), 0.02 (s, 9H) ppm; 13C NMR (100 MHz, C6D6): δ = 
174.5, 95.3, 84.2, 65.3, 64.6, 44.4, 38.3, 29.8, 24.6, 21.0, 18.3, –1.3 ppm; IR (ATR): ߥmax = 
2955 (w), 2932 (w), 2877 (w), 1778 (s), 1467 (w), 1422 (w), 1395 (w), 1374 (w), 1350 (w), 
1287 (w), 1247 (m), 1231 (m), 1197 (m), 1163 (m), 1143 (w), 1111 (m), 1057 (s), 1033 (s), 
968 (m), 955 (m), 927 (m), 959 (s), 764 (w), 694 (w) cm−1; HRMS (ESI): calc. for 
C14H32NO4Si [M+NH4]+: 306.2095, found: 306.2099. 
 
 
 
Enone S5 The following procedure was performed in two separate flasks with identical 
amounts of substrate and reagents and the reactions were combined for work up and 
purification. To a stirred solution of lactone 9 (3.00 g, 10.4 mmol, 1.0 eq) in THF (130 mL) at 
–78 °C was added LHMDS (1.0 M in THF, 13.5 mL, 13.5 mmol, 1.3 eq) and the resulting 
mixture was allowed to warm up to –50 °C within 2.5 h. Eschenmoser’s salt (3.27 g, 
17.7 mmol, 1.7 eq) was added to the reaction mixture in one portion at –78 °C and the 
resulting reaction mixture was allowed to warm up to r.t. over 3 h. The solvent was 
evaporated and the crude material was dissolved in MeOH (30 mL). Methyliodide (13 mL) 
was added dropwise at 0 °C and the reaction was allowed to warm up to r.t. overnight. The 
solvent was evaporated and the crude material was dissolved in CH2Cl2 (150 mL). Aq. 5% 
NaHCO3 solution (115 mL) and DBU (15.5 mL, 104 mmol, 10 eq) were added at 0 °C and the 
resulting reaction mixture was stirred at r.t. for 1 h followed by addition of H2O (100 mL). The 
separate reactions were combined and the layers were separated. The aqueous layer was 
extracted with CH2Cl2 (100 mL) and Et2O (3 × 100 mL). The combined organic layers were 
dried over Na2SO4. After filtration and concentration in vacuo, the crude product was purified 
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by flash column chromatography (pentane:Et2O 4:1) on silica to afford enone S5 (5.76 g, 
19.2 mmol, 92%) as a colorless oil. 
 
Data for S5: Rf: 0.39 (hexanes:EtOAc 4:1); 1H NMR (400 MHz, C6D6): δ = 6.03 (s, 1H), 4.84 
(s, 1H), 4.59 (s, 2H), 4.00 (dd, J = 11.0, 2.5 Hz, 1H), 3.72 – 3.62 (m, 3H), 3.62 – 3.54 (m, 
1H), 1.58 – 1.46 (m, 1H), 1.42 – 1.32 (m, 1H), 1.03 – 0.94 (m, 2H), 0.69 (s, 3H), 0.58 (s, 3H), 
0.02 (s, 9H) ppm; 13C NMR (100 MHz, C6D6): δ = 169.1, 146.7, 118.2, 95.3, 83.0, 65.3, 64.2, 
41.4, 30.7, 25.0, 22.4, 18.3, –1.3 ppm; IR (ATR): ߥmax = 2955 (w), 2923 (w), 2876 (w), 
1765 (s), 1661 (w), 1465 (w), 1410 (w), 1370 (w), 1345 (w), 1295 (m), 1248 (m), 1192 (m), 
1109 (m), 1055 (s), 1030 (s), 967 (m), 937 (m), 858 (s), 833 (s), 758 (w), 692 (m) cm−1; 
HRMS (ESI): calc. for C15H32NO4Si [M+NH4]+: 318.2095, found: 318.2099. 
 
 
 
Diol S6 The following procedure was performed in two separate flasks with identical 
amounts of substrate and reagents and the reactions were combined for work up and 
purification. To a stirred solution of enone S5 (2.88 g, 9.58 mmol, 1.0 eq) in THF (120 mL) at 
0 °C was slowly added DIBAL-H (1.0 M in THF, 33.5 mL, 33.5 mmol, 3.5 eq). The resulting 
reaction mixture was allowed to warm up to r.t. over 3 h. The reaction mixture was poured in 
a mixture of ice-water (200 mL), Et2O (200 mL) and aq. sat. K+-Na+-tartrate solution (600 mL) 
and stirred at r.t. for 2 h. The separate reactions were combined and the layers were 
separated. The aqueous layer was extracted with EtOAc (3 × 200 mL). The combined 
organic layers were dried over Na2SO4. After filtration and concentration in vacuo, the crude 
product was purified by flash column chromatography (hexanes:EtOAc 2:1) on silica to afford 
diol S6 (5.50 g, 18.1 mmol, 94%) as a colorless oil. 
 
Data for S6: Rf: 0.33 (hexanes:EtOAc 2:1); 1H NMR (400 MHz, C6D6): δ = 5.17 (d, J = 
1.2 Hz, 1H), 4.95 (d, J = 1.4 Hz, 1H), 4.48 (s, 2H), 4.13 (dd, J = 12.8, 1.0 Hz, 1H), 3.97 (dd, 
J = 12.8, 1.0 Hz, 1H), 3.73 – 3.55 (m, 5H), 1.63 – 1.55 (m, 2H), 1.06 (s, 3H), 1.04 (s, 3H), 
0.97 – 0.90 (m, 2H), 0.01 (s, 9H) ppm; 13C NMR (100 MHz, C6D6): δ = 154.3, 113.6, 95.2, 
76.7, 67.2, 65.4, 64.4, 43.1, 31.9, 23.9, 23.7, 18.3, –1.3 ppm; IR (ATR): ߥmax = 3361 (br w) 
2954 (w), 2877 (w), 1635 (w), 1469 (w), 1409 (w), 1380 (w), 1248 (m), 1191 (w), 1152 (w), 
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1109 (m), 1054 (s), 1023 (s), 971 (w), 936 (m), 919 (m), 905 (m), 857 (s), 833 (s), 757 (m), 
692 (w), 664 (w) cm−1; HRMS (ESI): calc. for C15H33O4Si [M+H]+: 305.2143, found: 305.2145. 
 
 
 
Protected triol S7 The following procedure was performed in two separate flasks with 
identical amounts of substrate and reagents and the reactions were combined for work up 
and purification. To a stirred solution of diol S6 (2.00 g, 6.57 mmol, 1.0 eq) in THF (15 mL) at 
0 °C was slowly added NaH (60% dispersion in mineral oil, 892 mg, 22.3 mmol, 3.4 eq). The 
resulting reaction mixture was allowed to warm up to r.t. for 40 min followed by the addition 
of benzyl bromide (3.13 mL, 26.3 mmol, 4.0 eq) and TBAI (971 mg, 2.63 mmol, 0.4 eq). The 
resulting reaction mixture was heated to 50 °C overnight and was poured afterwards in     
ice-water (200 mL). The separate reactions were combined and the layers were separated. 
The aqueous layer was extracted with EtOAc (3 × 200 mL). The combined organic layers 
were dried over Na2SO4. After filtration and concentration in vacuo, the crude product was 
purified by flash column chromatography (hexanes:EtOAc 30:1) on silica to afford protected 
triol S7 (5.70 g, 11.8 mmol, 90%) as colorless oil. 
 
Data for S7: Rf: 0.56 (hexanes:EtOAc 9:1); 1H NMR (400 MHz, CDCl3): δ = 7.40 – 7.27 (m, 
10H), 5.30 (d, J = 1.3 Hz, 1H), 5.11 (s, 1H), 4.68 – 4.55 (m, 4H), 4.52 (s, 2H), 4.16 – 4.07 (m, 
2H), 3.66 – 3.55 (m, 4H), 3.52 (dd, J = 9.8, 2.1 Hz, 1H), 1.87 – 1.75 (m, 1H), 1.67 – 1.58 (m, 
1H), 1.18 (s, 3H), 1.14 (s, 3H), 0.96 – 0.88 (m, 2H), 0.00 (s, 9H) ppm; 13C NMR (100 MHz, 
CDCl3): δ = 150.8, 139.1, 138.7, 128.5, 128.4, 127.7, 127.6, 127.6, 127.5, 112.2, 95.0, 82.7, 
75.3, 72.5, 71.2, 65.5, 65.3, 43.7, 32.1, 25.3, 22.5, 18.3, –1.3 ppm; IR (ATR): ߥmax = 
3089 (w), 3064 (w), 3031 (w), 2953 (w), 2925 (w), 2871 (w), 1635 (w), 1496 (w), 1453 (w), 
1378 (w), 1361 (w), 1306 (w), 1248 (m), 1204 (w), 1155 (w), 1093 (s), 1058 (s), 1027 (s), 
935 (m), 918 (m), 857 (s), 833 (s), 732 (s), 695 (s), 605 (m) cm−1; HRMS (ESI): calc. for 
C29H48NO4Si [M+NH4]+: 502.3347, found: 502.3355. 
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Primary alcohol S8 To a stirred solution of alkene S7 (3.90 g, 8.05 mmol, 1.0 eq) in Et2O 
(150 mL) at r.t. was added nBuSH (7.35 mL, 68.4 mmol, 8.5 eq), magnesium bromide diethyl 
etherate (15.6 g, 60.4 mmol, 7.5 eq) and potassium carbonate (11.1 g, 80.5 mmol, 10 eq). 
The resulting reaction mixture was stirred for 14 h followed by addition of H2O (500 mL). The 
layers were separated and the aqueous layer was extracted with EtOAc (3 × 100 mL). The 
combined organic layers were dried over Na2SO4. After filtration and concentration in vacuo, 
the crude product was purified by flash column chromatography (hexanes:EtOAc 7:2) on 
silica to afford alcohol S8 (2.84 g, 8.01 mmol, quant.) as a colorless oil. 
 
Data for S8: Rf: 0.45 (hexanes:EtOAc 2:1); 1H NMR (400 MHz, CDCl3): δ = 7.39 – 7.26 (m, 
10H), 5.29 (s, 1H), 5.13 (s, 1H), 4.65 (d, J = 11.1 Hz, 1H), 4.58 (d, J = 11.0 Hz, 1H), 4.56 (d, 
J = 11.0 Hz, 1H), 4.52 (d, J = 11.9 Hz, 1H), 4.13 (d, J = 12.9 Hz, 1H), 4.08 (d, J = 12.8 Hz, 
1H), 3.76 – 3.59 (m, 3H), 1.73 (dddd, J = 13.8, 8.1, 5.4, 2.6 Hz, 1H), 1.66 – 1.58 (m, 2H), 
1.19 (s, 3H), 1.14 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3): δ = 150.7, 138.9, 138.4, 128.5, 
128.5, 127.9, 127.8, 127.8, 127.7, 113.2, 83.2, 75.4, 72.6, 71.3, 60.9, 44.0, 34.4, 25.4, 
22.1 ppm; IR (ATR): ߥmax = 3413 (br w), 3088 (w), 3063 (w), 3030 (w), 2964 (w), 2928 (w), 
2873 (w), 1635 (w), 1496 (w), 1453 (m), 1399 (w), 1380 (w), 1360 (m), 1307 (w), 1250 (w), 
1206 (w), 1138 (w), 1086 (s), 1071 (s), 1054 (s), 1027 (s), 967 (w), 906 (m), 964 (w), 841 (w), 
733 (s), 695 (s) cm−1; HRMS (ESI): calc. for C23H31O3 [M+H]+: 355.2268, found: 355.2271. 
 
 
 
Primary bromide 10 The following procedure was performed in two separate flasks with 
identical amounts of substrate and reagents and the reactions were combined for work up 
and purification. To a stirred solution of alcohol S8 (2.08 g, 5.87 mmol, 1.0 eq) in CH2Cl2 
(35 mL) at 0 °C was added PPh3 (2.46 g, 9.39 mmol, 1.6 eq) and N-bromosuccinimide 
(1.67 g, 9.39 mmol, 1.6 eq). The resulting reaction mixture was stirred for 1 h at r.t. followed 
by addition of H2O (100 mL). The separate reactions were combined and the layers were 
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separated. The aqueous layer was extracted with CH2Cl2 (100 mL) and EtOAc (3 × 150 mL) 
and the combined organic layers were dried over Na2SO4. After filtration and concentration in 
vacuo, the crude product was purified by flash column chromatography (pentane:Et2O 30:1) 
on silica to afford bromide 10 (4.60 g, 11.0 mmol, 94%) as a colorless oil. 
 
Data for 10: Rf: 0.60 (hexanes:EtOAc 9:1); 1H NMR (400 MHz, CDCl3): δ = 7.43 – 7.27 (m, 
10H), 5.31 (d, J = 1.3 Hz, 1H), 5.12 (s, 1H), 4.71 (d, J = 11.2 Hz, 1H), 4.61 (d, J = 11.2 Hz, 
1H), 4.55 (s, 2H), 4.16 – 4.08 (m, 2H), 3.63 (dd, J = 7.5, 4.5 Hz, 1H), 3.51 (dt, J = 10.5, 
5.2 Hz, 1H), 3.47 – 3.38 (m, 1H), 2.01 – 1.88 (m, 2H), 1.20 (s, 3H), 1.15 (s, 3H) ppm; 
13C NMR (100 MHz, CDCl3): δ = 150.5, 138.8, 138.5, 128.5 (2C), 127.8, 127.7, 127.7, 127.6, 
112.6, 83.4, 75.9, 72.6, 71.1, 43.7, 35.1, 32.2, 25.6, 22.2 ppm; IR (ATR): ߥmax = 3088 (w), 
3064 (w), 3030 (w), 2970 (w), 2859 (w), 1635 (w), 1605 (w), 1496 (w), 1453 (m), 1398 (w), 
1381 (w), 1360 (m), 1306 (w), 1264 (w), 1208 (w), 1092 (s), 1068 (s), 1028 (s), 969 (w), 
909 (m), 733 (s), 696 (s) cm−1; HRMS (ESI): calc. for C23H33Br79NO2 [M+NH4]+: 434.1690, 
found: 434.1693. 
 
 
S10
AcOH (1.38 eq), MeOH,
reflux, 12 h
O O
Ts
SO2Na
(1.38 eq)
S9
 
3-Tosylcyclopentan-1-one (S10) To a stirred solution of cyclopentenone (S9, 4.43 mL, 
52.9 mmol, 1.00 eq) in MeOH (60 mL) at r.t. was added sodium p-toluenesulfinate (13.0 g, 
73.0 mmol, 1.38 eq) and acetic acid (4.17 mL, 73.0 mmol, 1.38 eq). The resulting reaction 
mixture was refluxed for 12 h. The reaction was quenched by addition of H2O (300 mL) and 
the layers were separated. The aqueous layer was extracted with EtOAc (3 × 100 mL) and 
the combined organic layers were dried over Na2SO4. After filtration and concentration in 
vacuo, the crude ketone S10 (10.8 g) was obtained as a colorless oil and was used in the 
next step without further purification. Compound S10 has been reported in the literature.161 
 
Data for S10: Rf: 0.40 (hexanes:EtOAc 1:1); 1H NMR (400 MHz, CDCl3): δ = 7.78 (d, 
J = 8.3 Hz, 2H), 7.38 (d, J = 7.9 Hz, 2H), 3.74 (quint, J = 7.3 Hz, 1H), 2.66 (dd, J = 18.9, 
8.1 Hz, 1H), 2.58 – 2.37 (m, 6H), 2.32 – 2.17 (m, 2H) ppm; 13C NMR (100 MHz, CDCl3): δ = 
213.1, 145.5, 134.5, 130.3, 128.7, 60.9, 38.8, 37.1, 23.3, 21.8 ppm; HRMS (EI): calc. for 
C12H14O3S [M]+: 238.0658, found: 238.0656. 
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Sulfone 11 To a stirred solution of crude ketone S10 in benzene (50 mL) at r.t. was added 
glycol (3.40 mL, 60.8 mmol, 1.15 eq) and p-toluenesulfonic acid monohydrate (91.1 mg, 
529 μmol, 0.01 eq). The resulting reaction mixture was refluxed for 2 h in a Dean-Stark 
apparatus. The reaction was poured in aq. half-sat. NaHCO3 solution (300 mL) at 0 °C and 
the layers were separated. The aqueous layer was extracted with EtOAc (3 × 100 mL) and 
the combined organic layers were dried over Na2SO4. After filtration and concentration in 
vacuo, the crude product was purified by flash column chromatography (hexanes:EtOAc 2:3) 
on silica to afford sulfone 11 (9.80 g, 34.7 mmol, 66% over 2 steps) as a white solid. 
Compound 11 has been reported in the literature.161 
 
Data for 11: Rf: 0.52 (hexanes:EtOAc 1:1); 1H NMR (400 MHz, C6D6): δ = 7.69 (d, 
J = 8.2 Hz, 2H), 6.77 – 6.70 (m, 2H), 3.43 (quint, J = 8.4 Hz, 1H), 3.37 – 3.19 (m, 4H), 2.47 
(dd, J = 13.4, 10.1 Hz, 1H), 2.31 – 2.17 (m, 1H), 2.04 – 1.90 (m, 2H), 1.86 (s, 3H), 1.79 – 
1.68 (m, 1H), 1.64 – 1.53 (m, 1H) ppm; 13C NMR (100 MHz, C6D6): δ = 144.0, 136.8, 129.8, 
128.9, 116.6, 64.8, 64.1, 61.8, 37.1, 35.3, 24.3, 21.2 ppm; IR (ATR): ߥmax = 3093 (w), 
3056 (w), 2986 (w), 2961 (w), 2948 (w), 2900 (w), 1597 (w), 1504 (w), 1475 (w), 1432 (w), 
1352 (w), 1338 (w), 1309 (m), 1281 (s), 1208 (w), 1177 (w), 1150 (s), 1110 (s), 1087 (s), 
1065 (m), 1008 (m), 966 (w), 946 (m), 915 (w), 887 (m), 833 (m), 803 (w), 752 (w), 714 (w), 
660 (m), 604 (w) cm−1; melting point: 72.6 – 76.0 °C (lit.: 61.5 – 62 °C)161; HRMS (ESI): 
calc. for C14H22O4NS [M+NH4]+: 300.1264, found: 300.1266. 
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Enone 7 The following procedure was performed in two separate flasks with identical 
amounts of substrate and reagents and the reactions were combined for work up and 
purification after the hydrolysis step. To a stirred solution of sulfone 11 (2.54 g, 8.98 mmol, 
1.25 eq) in THF (60 mL) at –78 °C was added LDA (0.45 M in THF, 20.0 mL, 8.98 mmol, 
1.25 eq) and the resulting reaction mixture was stirred for 1.5 h. Bromide 10 (3.00 g, 
7.18 mmol, 1.0 eq) dissolved in THF (20 mL) was added dropwise. The resulting reaction 
mixture was stirred at –78 °C for 15 min and r.t. for 2 h. The reaction was quenched by 
addition of H2O (200 mL) and the layers were separated. The aqueous layer was extracted 
with EtOAc (3 × 100 mL) and the combined organic layers were dried over Na2SO4. After 
filtration and concentration in vacuo, the crude alkylated sulfone S11 was obtained as a 
colorless oil and was used in the next step without further purification. 
To a stirred solution of crude sulfone S11 in THF (60 mL) was added aq. 5% HCl solution 
(60 mL) and the resulting reaction mixture was heated to 60 °C for 7 h followed by addition of 
H2O (300 mL). The two separate reactions were combined and the layers were separated. 
The aqueous layer was extracted with EtOAc (3 × 200 mL) and the combined organic layers 
were dried over Na2SO4. After filtration and concentration in vacuo, the crude product was 
purified by flash column chromatography (hexanes:EtOAc 5:14:1) on silica to afford 
enone 7 (5.58 g, 13.3 mmol, 93% over 2 steps) as a colorless oil. 
 
Data for 7: Rf: 0.45 (hexanes:EtOAc 2:1); 1H NMR (400 MHz, CDCl3): δ = 7.38 – 7.27 (m, 
10H), 5.86 (s, 1H), 5.29 (s, 1H), 5.12 (s, 1H), 4.67 (d, J = 11.3 Hz, 1H), 4.52 (s, 2H), 4.49 (d, 
J = 11.3 Hz, 1H), 4.13 (d, J = 12.8 Hz, 1H), 4.07 (d, J = 12.7 Hz, 1H), 3.40 (dd, J = 9.5, 
2.4 Hz, 1H), 2.55 – 2.39 (m, 3H), 2.38 – 2.23 (m, 3H), 1.79 – 1.59 (m, 2H), 1.20 (s, 3H), 1.15 
(s, 3H) ppm; 13C NMR (100 MHz, CDCl3): δ = 210.2, 183.2, 150.7, 138.9, 138.5, 129.5, 
128.5 (2C), 127.8, 127.8, 127.7, 127.5, 113.4, 85.7, 75.7, 72.6, 71.6, 44.2, 35.4, 31.6, 31.2, 
29.3, 25.6, 22.1 ppm; IR (ATR): ߥmax = 3091 (w), 3063 (w), 3030 (w), 2956 (w), 2926 (w), 
2871 (w), 1703 (s), 1675 (m), 1614 (m), 1496 (w), 1453 (m), 1437 (w), 1407 (w), 1358 (w), 
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1306 (w), 1282 (w), 1234 (w), 1184 (m), 1089 (s), 1067 (s), 1028 (m), 907 (w), 840 (m), 
734 (s), 696 (w) cm−1; HRMS (ESI): calc. for C28H35O3 [M+H]+: 419.2581, found: 419.2589. 
 
 
 
Cyclobutane 6 A stirred solution of enone 7 (3.00 g, 
7.17 mmol, 1.0 eq) in EtOAc (300 mL, degassed by 
sparging with argon for 30 min) at –78 °C was irradiated 
for 11 h using a medium pressure mercury lamp (150W) in 
an immersion well photoreactor containing a Pyrex® filter. 
After evaporation of the solvent, the crude product was 
purified by flash column chromatography (pentane:Et2O 
10:16:1) on silica to afford cyclobutane 6 (1.65 g, 
3.94 mmol, 55%, d.r. 13:1) as a colorless oil. 
 
Data for 6 (major diastereomer): Rf: 0.56 
(hexanes:EtOAc 3:1); 1H NMR (800 MHz, CDCl3): δ = 7.40 
– 7.26 (m, 10H), 4.65 (d, J = 11.8 Hz, 1H), 4.48 (d, 
J = 12.0 Hz, 1H), 4.46 (d, J = 12.0 Hz, 1H), 4.35 
(d, J = 11.8 Hz, 1H), 3.51 (d, J = 10.0 Hz, 1H), 3.43 (d, 
J = 10.1 Hz, 1H), 3.27 (dd, J = 7.2, 4.2 Hz, 1H), 2.73 (dd, J = 12.2, 11.2 Hz, 1H), 2.64 – 2.56 
(m, 2H), 2.37 (ddd, J = 14.4, 10.0, 5.1 Hz, 1H), 2.26 (dddd, J = 18.1, 10.9, 5.1, 1.7 Hz, 1H), 
2.08 (dtd, J = 14.6, 7.2, 3.4 Hz, 1H), 1.90 (dddd, J = 14.9, 11.4, 7.4, 4.2 Hz, 1H), 1.86 (dd, 
J = 12.4, 5.3 Hz, 1H), 1.81 (ddd, J = 14.5, 10.9, 7.3 Hz, 1H), 1.63 –1.59 (m, 1H), 1.51 (ddd, 
J = 14.0, 10.9, 8.0 Hz, 1H), 1.01 (s, 3H), 0.94 (s, 3H) ppm; 13C NMR (200 MHz, CDCl3): δ = 
223.4, 139.3, 138.3, 128.5, 128.4, 127.7, 127.7, 127.4, 127.4, 84.1, 73.4, 72.9, 72.0, 46.5, 
46.3, 46.2, 39.5, 39.0, 31.7, 31.4, 27.2, 25.7, 24.5, 22.3 ppm; IR (ATR): ߥmax = 3071 (w), 
3030 (w), 2928 (w), 2856 (w), 1730 (s), 1604 (w), 1496 (w), 1454 (m), 1403 (w), 1383 (w), 
1363 (m), 1306 (w), 1252 (w), 1205 (w), 1174 (w), 1088 (s), 1066 (s), 1027 (m), 987 (w), 
941 (w), 884 (w), 836 (m), 775 (w), 733 (s), 696 (s) cm−1; HRMS (ESI): calc. for C28H38NO3 
[M+NH4]+: 436.2846, found: 436.2851. 
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Diazo ketone 13 In a two-neck 100 mL flask equipped with 
an open Vigreux column (20 cm) a stirred solution of 
ketone 6 (800 mg, 1.91 mmol, 1.0 eq) and MeOCH(NMe2)2 
(7.5 mL) in THF (19 mL) was heated to 60 °C for 30 h with a 
weak stream of N2 bubbling through the reaction mixture. 
After evaporation of the solvent, the crude product was 
dissolved in 1,4-dioxane (45 mL) followed by addition of 
pABSA (1.38 g, 5.73 mmol, 3.0 eq) in one portion. The 
resulting reaction mixture was heated to 70 °C for 2.5 h. 
After evaporation of the solvent the crude product was 
purified by flash column chromatography (hexanes:EtOAc 
9:1) on silica to afford diazo ketone 13 (515 mg, 1.16 mmol, 
61%) as a yellow oil.  
 
Data for 13: Rf: 0.44 (hexanes:EtOAc 3:1); 1H NMR (600 MHz, CD2Cl2): δ = 7.38 – 7.24 (m, 
10H), 4.64 (d, J = 11.7 Hz, 1H), 4.48 (d, J = 11.9 Hz, 1H), 4.44 (d, J = 11.9 Hz, 1H), 4.35 (d, 
J = 11.7 Hz, 1H), 3.63 (d, J = 10.5 Hz, 1H), 3.59 (d, J = 10.5 Hz, 1H), 3.54 (d, J = 14.2 Hz, 
1H), 3.31 (dd, J = 8.0, 4.2 Hz, 1H), 2.88 (dd, J = 12.5, 10.8 Hz, 1H), 2.69 (dd, J = 10.8, 
4.3 Hz, 1H), 2.60 (d, J = 14.2 Hz, 1H), 2.27 – 2.19 (m, 1H), 1.99 – 1.87 (m, 2H), 1.77 – 1.66 
(m, 2H), 1.06 (s, 3H), 0.99 (s, 3H) ppm; 13C NMR (150 MHz, CD2Cl2): δ = 203.5, 139.9, 
139.0, 128.8, 128.7, 128.1 (2C), 127.9, 127.8, 84.4, 73.8, 73.8, 72.4, 60.2, 47.7, 47.6, 44.2, 
40.2, 34.1, 31.6, 29.1, 26.9, 25.7, 22.6 ppm; IR (ATR): ߥmax = 3063 (w), 3029 (w), 2929 (w), 
2863 (w), 2075 (s), 1744 (w), 1661 (w), 1496 (w), 1453 (m), 1383 (w), 1361 (m), 1325 (s), 
1294 (m), 1269 (m), 1245 (m), 1224 (m), 1190 (m), 1156 (w), 1090 (s), 1059 (s), 1027 (s), 
982 (m), 912 (m), 888 (m), 806 (m), 733 (s), 696 (s) cm−1; HRMS (ESI): calc. for C28H33N2O3 
[M+H]+: 445.2486, found: 445.2487. 
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[2]-Ladderane 14 A stirred solution of diazo ketone 13 (480 mg, 1.08 mmol, 1.0 eq) in 
MeOH (130 mL, degassed by sparging with argon for 25 min) and triethylamine (74.9 μL, 
540 μmol, 0.5 eq) in a Duran® cylinder at r.t was irradiated for 45 min using a Rayonet lamp 
(300 nm, 250 W). After evaporation of the solvent, the crude product was purified by flash 
column chromatography (pentane:Et2O 9:18:1) on silica to afford [2]-ladderane 14 
(375 mg, 836 μmol, 77%, d.r. 3:1) as a colorless oil. 
 
For clarity just the 1H-NMR shifts of the major diastereomer are reported. In the 13C-data 
shifts of the minor isomer are marked by an asterisk *. 
Data for 14: Rf: 0.79 (hexanes:EtOAc 3:1); 1H NMR (600 MHz, CD2Cl2): δ = 7.36 – 7.22 (m, 
10H), 4.56 (d, J = 11.6 Hz, 1H), 4.44 – 4.39 (m, 2H), 4.37 (d, J = 11.7 Hz, 1H), 3.78 (d, 
J = 10.0 Hz, 1H), 3.66 – 3.62 (m, 1H), 3.61 (s, 3H), 3.54 (d, J = 10.4 Hz, 1H), 3.32 – 3.24 (m, 
1H), 2.99 (dd, J = 13.0, 8.7 Hz, 1H), 2.77 – 2.70 (m, 1H), 2.14 (dd, J = 13.2, 7.7 Hz, 1H), 
1.93 – 1.83 (m, 2H), 1.83 – 1.75 (m, 1H), 1.75 – 1.58 (m, 2H), 1.52 (dd, J = 20.5, 13.6 Hz, 
1H), 1.10 (s, 3H), 1.02 (s, 3H) ppm; 13C NMR (150 MHz, CD2Cl2): δ = 176.8*, 174.8, 140.5, 
139.7, 139.6*, 128.7, 128.6, 128.1, 127.9, 127.8, 127.6, 83.6*, 83.0, 74.1*, 73.7, 73.5, 72.3, 
72.3*, 52.0*, 51.7, 49.5, 47.9*, 47.0*, 45.3, 42.9*, 40.1, 39.9*, 39.6, 38.2, 33.3*, 32.9, 32.1*, 
31.8, 31.5*, 26.8, 24.7, 24.3*, 24.2, 20.9*, 20.6 ppm; IR (ATR): ߥmax = 3091 (w), 3063 (w), 
3027 (w), 2946 (m), 2900 (w), 2865 (w), 1730 (s), 1496 (w), 1476 (w), 1453 (m), 1434 (w), 
1377 (w), 1358 (w), 1224 (m), 1196 (m), 1175 (m), 1091 (s), 1072 (s), 1028 (m), 975 (m), 
907 (w), 792 (w), 735 (m), 697 (m) cm−1; HRMS (ESI): calc. for C29H40NO4 [M+NH4]+: 
466.2952, found: 466.2959. 
 
 
 
Methyl ester 5 [2]-Ladderane 14 (375 mg, 836 μmol, 1.0 eq, d.r. 3:1) dissolved in THF 
(18 mL) was added to a solution of LDA (0.45M in THF, 2.78 mL, 1.25 mmol, 1.5 eq) in THF 
(2.0 mL) at –78 °C and the resulting reaction mixture was stirred for 45 min. Methyl iodide 
(99.0 μL, 1.59 mmol, 1.9 eq) in THF (0.5 mL) was added dropwise and the reaction mixture 
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was allowed to warm up to –50 °C within 1 h. The reaction was quenched by addition of H2O 
(50 mL) and the layers were separated. The aqueous layer was extracted with Et2O 
(3 × 30 mL) and the combined organic layers were dried over Na2SO4. After filtration and 
concentration in vacuo, the crude product was purified by flash column chromatography 
(pentane:Et2O 9:1) on silica to afford methyl ester 5 (333 mg, 720 μmol, 86%, d.r. 20:1) as a 
colorless oil. 
 
Data for 5 (major diastereomer): Rf: 0.78 (hexanes:EtOAc 4:1); 1H NMR (400 MHz, 
CD2Cl2): δ = 7.39 – 7.20 (m, 10H), 4.55 (d, J = 11.7 Hz, 1H), 4.40 (s, 2H), 4.36 (d, 
J = 11.7 Hz, 1H), 3.69 (d, J = 10.0 Hz, 1H), 3.66 (dd, J = 9.2, 4.1 Hz, 1H), 3.60 (s, 3H), 3.50 
(d, J = 10.0 Hz, 1H), 3.16 (d, J = 13.2 Hz, 1H), 2.41 (ddd, J = 7.6, 4.8, 2.7 Hz, 1H), 2.18 (dd, 
J = 13.3, 7.8 Hz, 1H), 1.95 – 1.85 (m, 1H), 1.82 – 1.59 (m, 3H), 1.54 (dd, J = 13.2, 2.7 Hz, 
1H), 1.38 (s, 3H), 1.30 (dd, J = 13.4, 4.8 Hz, 1H), 1.09 (s, 3H), 1.00 (s, 3H) ppm; 13C NMR 
(100 MHz, CD2Cl2): δ = 177.5, 140.5, 139.6, 128.7, 128.6, 128.0, 127.9, 127.8, 127.6, 82.8, 
73.9, 73.4, 72.3, 51.8, 48.3, 45.9, 44.6, 42.8, 40.1, 40.0, 33.7, 27.9, 25.6, 24.9, 24.1, 
20.4 ppm; IR (ATR): ߥmax = 3091 (w), 3063 (w), 3031 (w), 2935 (m), 2904 (m), 2869 (m), 
1728 (s), 1496 (w), 1480 (w), 1453 (m), 1434 (m), 1359 (m), 1299 (m), 1216 (m), 1196 (m), 
1179 (m), 1144 (s), 1131 (s), 1092 (s), 1028 (m), 989 (m), 907 (w), 734 (s), 697 (s) cm−1; 
HRMS (ESI): calc. for C30H42NO4 [M+NH4]+: 480.3108, found: 480.3109. 
 
 
 
Diol 15 To a stirred solution of 5 (55.0 mg, 119 μmol, 1.0 eq) in MeOH (6 mL) at r.t. was 
added Pd/C (10% Pd on activated charcoal, 25.0 mg, 23.5 μmol, 0.2 eq) and the reaction 
vessel was backfilled three times with H2 followed by sparging with H2 for 2 min. After 8 h 
Pd/C (10% Pd on activated charcoal, 25.0 mg, 23.5 μmol, 0.2 eq) and after 20 h additional 
Pd/C (10% Pd on activated charcoal, 100.0 mg, 94.0 μmol, 0.8 eq) was added. The reaction 
was filtered over Celite (EtOAc) after 24 h. After concentration in vacuo, the crude product 
was purified by flash column chromatography (pentane:EtOAc 1:1) on silica to afford diol 15 
(22.3 mg, 79.0 μmol, 66%) as a white solid. A crystal, suitable for single crystal X-ray 
diffraction analysis, was obtained by crystallization from Et2O/pentane. 
 
Data for 15: Rf: 0.20 (hexanes:EtOAc 1:1); 1H NMR (400 MHz, CD2Cl2): δ = 3.91 (dd, 
J = 11.6, 3.8 Hz, 1H), 3.85 – 3.78 (m, 1H), 3.69 (dd, J = 11.7, 5.3 Hz, 1H), 3.62 (s, 3H), 3.21 
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(d, J = 13.1 Hz, 1H), 2.41 (ddd, J = 7.7, 4.9, 2.7 Hz, 1H), 2.12 (dd, J = 13.4, 7.8 Hz, 1H), 1.92 
(dd, J = 12.5, 5.0 Hz, 1H), 1.73 – 1.53 (m, 4H), 1.42 (d, J = 4.3 Hz, 1H), 1.39 (s, 3H), 1.30 
(dd, J = 13.5, 4.9 Hz, 1H), 1.23 – 1.18 (m, 1H), 1.03 (s, 3H), 1.01 (s, 3H) ppm; 13C NMR 
(100 MHz, CD2Cl2): δ = 177.4, 74.6, 65.7, 51.9, 49.1, 45.7, 44.7, 42.6, 40.0, 39.9, 34.1, 28.8, 
27.5, 25.5, 23.7, 19.2 ppm; IR (ATR): ߥmax = 3514 (br w), 3439 (br w), 2932 (m), 2900 (m), 
2873 (w), 1727 (m), 1701(s), 1481 (w), 1457 (m), 1435 (m), 1408 (w),  1383 (w), 1371 (w), 
1360 (w), 1333 (w), 1295 (m), 1265 (m), 1227 (m), 1194 (s), 1180 (m), 1171 (m), 1144 (s), 
1103 (m), 1057 (m), 1036 (m), 1023 (m), 999 (s), 989 (s), 967 (m), 947 (w), 936 (w), 861 (w), 
768 (w), 722 (s), 683 (w) cm−1; melting point: 149.5 – 152.8 °C; HRMS (ESI): calc. for 
C16H27O4 [M+H]+: 283.1904, found: 283.1904. 
 
 
 
Secondary alcohol S12 To a stirred solution of 5 (315  mg, 681 μmol, 1.0 eq) in EtOH 
(25 mL) at r.t. was added Pd/C (10% Pd on activated charcoal, 250 mg, 23.5 μmol, 0.3 eq) 
and the reaction vessel was backfilled three times with H2 followed by sparging with H2 for 
2 min. To prevent overreduction the reaction was controlled by TLC every 20 min. The 
reaction was filtered over Celite (EtOAc) after 2 h 40 min. After concentration in vacuo crude 
alcohol S12 (250 mg) was used in the next step without further purification. 
 
Data for S12: Rf: 0.33 (hexanes:EtOAc 4:1); 1H NMR (400 MHz, CD2Cl2): δ = 7.38 – 7.21 
(m, 5H), 4.45 – 4.35 (m, 2H), 3.88 (d, J = 9.7 Hz, 1H), 3.68 (d, J = 10.0 Hz, 1H), 3.60 (s, 3H), 
3.49 (d, J = 10.0 Hz, 1H), 3.14 (d, J = 13.2 Hz, 1H), 2.40 (ddd, J = 7.7, 5.0, 2.8 Hz, 1H), 2.13 
(dd, J = 13.4, 7.8 Hz, 1H), 1.92 – 1.86 (m, 1H), 1.72 – 1.50 (m, 4H), 1.37 (s, 3H), 1.31 (dd, 
J = 13.4, 5.0 Hz, 2H), 1.04 (s, 3H), 0.96 (s, 3H) ppm; 13C NMR (100 MHz, CD2Cl2): δ = 
177.5, 139.5, 128.7, 127.9, 127.8, 74.2, 73.8, 73.5, 51.8, 48.4, 46.0, 44.7, 43.1, 40.2, 40.1, 
34.0, 28.9, 27.9, 25.4, 23.6, 19.0 ppm; HRMS (ESI): calc. for C23H33O4 [M+H]+: 373.2373, 
found: 373.2374. 
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Silylated alcohol S13 To a stirred solution of crude alcohol S12 in CH2Cl2 (10 mL) at 0 °C 
was added 2,6-lutidine (194 μL, 1.68 mmol, 2.5 eq) and TIPSOTf (325 μL, 1.21 mmol, 
1.8 eq) and the resulting reaction mixture was allowed to warm up to r.t. overnight. The 
reaction was quenched by addition of H2O (50 mL) and the layers were separated. The 
aqueous layer was extracted with Et2O (3 × 20 mL) and the combined organic layers were 
dried over Na2SO4. After filtration and concentration in vacuo, the crude product was purified 
by flash column chromatography (pentane:Et2O 60:130:1) on silica to afford silylated 
alcohol S13 (297 mg, 562 μmol, 83%) as a colorless oil. 
 
Data for S13: Rf: 0.73 (hexanes:EtOAc 4:1); 1H NMR (400 MHz, CD2Cl2): δ = 7.39 – 7.16 
(m, 5H), 4.41 (d, J = 11.8 Hz, 1H), 4.36 (d, J = 11.8 Hz, 1H), 4.11 (dd, J = 10.8, 3.7 Hz, 1H), 
3.68 (d, J = 9.9 Hz, 1H), 3.60 (s, 3H), 3.50 (d, J = 10.0 Hz, 1H), 3.14 (d, J = 13.2 Hz, 1H), 
2.40 (ddd, J = 7.7, 4.9, 2.8 Hz, 1H), 2.12 (dd, J = 13.3, 7.7 Hz, 1H), 1.92 – 1.83 (m, 1H), 1.80 
– 1.66 (m, 1H), 1.65 – 1.50 (m, 3H), 1.37 (s, 3H), 1.27 (dd, J = 13.3, 5.0 Hz, 1H), 1.07 (s, 
3H), 1.02 – 0.98 (m, 21H), 0.98 (s, 3H) ppm; 13C NMR (100 MHz, CD2Cl2): δ = 177.5, 139.5, 
128.6, 128.1, 127.7, 75.2, 73.9, 73.6, 51.8, 48.6, 46.2, 44.7, 43.1, 41.0, 40.2, 34.4, 29.7, 
27.8, 25.4, 24.4, 19.3, 18.6, 13.5 ppm; IR (ATR): ߥmax = 2941 (m), 2863 (m), 1730 (m), 
1494 (w), 1454 (m), 1433 (w), 1381 (w), 1357 (w), 1298 (m), 1216 (w), 1195 (w), 1173 (w), 
1143 (m), 1130 (m), 1089 (s), 1061 (s), 1023 (m), 1012 (m), 995 (m), 988 (m), 955 (w), 
919 (w), 881 (m), 849 (w), 806 (w), 733 (s), 696 (m), 674 (s) cm−1; HRMS (ESI): calc. for 
C32H56NO4Si [M+NH4]+: 546.3973, found: 546.3994. 
 
 
 
Primary alcohol S14 To a stirred solution of S13 (255 mg, 482 μmol, 1.0 eq) in MeOH 
(12 mL) at r.t. was added Pd(OH)2/C (10% Pd on activated charcoal, 120 mg, 113 μmol, 
0.2 eq) and the reaction vessel was backfilled three times with H2 followed by sparging with 
H2 for 2 min. The reaction was filtered over Celite (EtOAc) after 1 h. After concentration in 
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vacuo, the crude product was purified by flash column chromatography (pentane:Et2O 5:1) 
on silica to afford alcohol S14 (205 mg, 467 μmol, 97%) as a colorless oil. 
 
Data for S14: Rf: 0.48 (hexanes:EtOAc 4:1); 1H NMR (400 MHz, C6D6): δ = 4.23 (dd, 
J = 10.5, 3.9 Hz, 1H), 3.71 (d, J = 11.0 Hz, 1H), 3.46 – 3.40 (m, 2H), 3.39 (s, 3H), 2.35 (ddd, 
J = 7.6, 4.9, 2.7 Hz, 1H), 2.05 (dd, J = 13.3, 7.8 Hz, 1H), 1.79 – 1.64 (m, 2H), 1.63 – 1.48 (m, 
3H), 1.36 (s, 3H), 1.35 – 1.30 (m, 1H), 1.23 – 1.07 (m, 27H), 0.37 (s, 1H) ppm; 13C NMR 
(100 MHz, C6D6): δ = 176.6, 75.2, 65.4, 51.1, 49.0, 45.8, 44.6, 42.4, 40.8, 40.0, 34.4, 29.6, 
27.4, 25.2, 24.4, 19.4, 18.6, 13.5 ppm; IR (ATR): ߥmax = 3455 (br w), 2914 (m), 2865 (m), 
2849 (m), 1730 (s), 1470 (m), 1459 (m), 1435 (w), 1386 (m), 1301 (m), 1272 (m), 1254 (m), 
1225 (m), 1199 (m), 1176 (s), 1144 (s), 1129 (m), 1111 (s), 1090 (s), 1061 (m), 1015 (s), 
997 (m), 919 (w), 882 (m), 850 (w), 808 (w), 780 (w), 716 (w), 674 (m) cm−1; HRMS (ESI): 
calc. for C25H47O4Si [M+H]+:439.3238, found: 439.3240. 
 
 
 
Weinreb amide 16 To a stirred solution of alcohol S14 (189 mg, 431 μmol, 1.0 eq) in 
THF (16 mL) at –78 °C was added Me(OMe)NH2Cl (105 mg, 1.08 mmol, 2.5 eq) and LHMDS 
(1.0 M in THF, 2.37 mL, 2.37 mmol, 5.5 eq) and the resulting reaction mixture was stirred at 
0 °C for 1 h. The reaction was quenched by addition of H2O (60 mL) and the layers were 
separated. The aqueous layer was extracted with EtOAc (3 × 40 mL) and the combined 
organic layers were dried over Na2SO4. After filtration and concentration in vacuo, the crude 
product was purified by flash column chromatography (pentane:EtOAc 1:1) on silica to afford 
Weinreb amide 16 (175 mg, 374 μmol, 87%) as a white foam. 
 
Data for 16: Rf: 0.40 (hexanes:EtOAc 1:1); 1H NMR (400 MHz, C6D6): δ = 4.28 (dd, J = 10.5, 
3.7 Hz, 1H), 3.75 (d, J = 10.8 Hz, 1H), 3.57 (d, J = 13.2 Hz, 1H), 3.45 (dd, J = 10.8, 2.1 Hz, 
1H), 3.04 (s, 3H), 2.89 (s, 3H), 2.45 – 2.38 (m, 1H), 2.08 (dd, J = 13.1, 7.7 Hz, 1H), 1.88 – 
1.73 (m, 2H), 1.71 – 1.56 (m, 3H), 1.42 (s, 3H), 1.36 (dd, J = 13.1, 5.0 Hz, 1H), 1.25 – 1.17 
(m, 21H), 1.17 – 1.08 (m, 6H) ppm; 13C NMR (100 MHz, C6D6): δ = 177.8*, 75.3, 65.4, 60.1, 
48.9, 46.1, 45.7, 42.0, 41.7, 40.8, 34.6, 32.9, 29.7, 28.3, 24.7, 24.4, 19.4, 18.7, 13.5 ppm; IR 
(ATR): ߥmax = 3444 (br w), 2940 (s), 2865 (s), 1633 (br s), 1462 (m), 1381 (m), 1365 (m), 
1247 (w), 1226 (w), 1207 (w), 1171 (w), 1158 (w), 1129 (m), 1088 (s), 1068 (s), 1054 (s), 
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1011 (s), 952 (w), 918 (w), 881 (s), 864 (w), 850 (m), 830 (w), 792 (m), 743 (w), 675 (s) cm−1; 
HRMS (EI): calc. for C26H49NO4Si [M]+: 467.3425, found: 467.3417. 
* The shift of the amide carbonyl was not visible in the 13C spectra, but was extracted from 
the HMBC data showing corresponding correlations at 177.8 ppm. 
 
 
 
Iodide 17 To a stirred solution of alcohol 16 (25.0 mg, 53.4 μmol, 1.0 eq) in CH2Cl2 (1.9 mL) 
at –20 °C was added PPh3 (28.1 mg, 107 μmol, 2.0 eq), imidazole (15.2 mg, 224 μmol, 
4.2 eq) and iodine (27.2 mg, 107 μmol, 2.0 eq) and the resulting reaction mixture was 
allowed to warm up to –15 °C within 1 h. The reaction was cooled down to –20 °C and PPh3 
(28.1 mg, 107 μmol, 2.0 eq), imidazole (15.2 mg, 224 μmol, 4.2 eq) and iodine (27.2 mg, 
107 μmol, 2.0 eq) was added again. After warming up to –15 °C within 1 h, the reaction was 
cooled down to –20 °C again and additional PPh3 (28.1 mg, 107 μmol, 2.0 eq), imidazole 
(15.2 mg, 224 μmol, 4.2 eq) and iodine (27.2 mg, 107 μmol, 2.0 eq) was added followed by 
stirring for additional 30 min. The reaction was cooled to –78 °C and diluted with CH2Cl2 
(5 mL). Reaction quench was performed by cannulation of the reaction mixture into a 
vigorously stirred, cold (ice bath), aq. 10% Na2S2O4 solution. The layers were separated and 
the aqueous layer was extracted with CH2Cl2 (10 mL), Et2O (2 × 20 mL) and EtOAc (10 mL). 
The combined organic layers were dried over Na2SO4. After filtration and concentration in 
vacuo, the crude product was purified by flash column chromatography (pentane:Et2O 1:1) 
on Davisil® to afford iodide 17 (24.9 mg) as a colorless oil. Iodide 17 was immediately used 
in the next step.  
 
Data for 17: Rf: 0.61 (hexanes:EtOAc 1:1); 1H NMR (400 MHz, C6D6): δ = 4.64 (dd, J = 11.3, 
3.9 Hz, 1H), 3.43 (d, J = 13.5 Hz, 1H), 3.37 (d, J = 10.8 Hz, 1H), 3.15 (d, J = 10.8 Hz, 1H), 
3.02 (s, 3H), 2.88 (s, 3H), 2.41 (dd, J = 13.3, 7.7 Hz, 1H), 2.28 (ddd, J = 7.5, 4.8, 2.9 Hz, 1H), 
1.98 (td, J = 14.1, 5.9 Hz, 1H), 1.88 – 1.74 (m, 2H), 1.70 – 1.55 (m, 2H), 1.55 – 1.48 (m, 1H), 
1.36 (s, 3H), 1.23 – 1.08 (m, 27H) ppm. 
The iodination reaction was best performed on 20–40 mg scale and it was essential to keep 
the reaction at low temperature to suppress ring opening. Reverse quenching was more 
reproducible than direct quenching of the reaction at low temperature. The only side product 
observed was cyclopentene 18.  
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Data for 18: Rf: 0.69 (hexanes:EtOAc 1:1); 1H NMR 
(400 MHz, C6D6): δ = 5.33 (t, J = 2.0 Hz, 1H), 3.63 (dd, 
J = 3.2, 1.8 Hz, 1H), 3.12 (d, J = 11.9 Hz, 1H), 3.08 (s, 3H), 
2.86 (s, 3H), 2.72 (ddd, J = 17.0, 9.9, 2.0 Hz, 1H), 2.45 (d, 
J = 10.4 Hz, 1H), 2.38 (ddd, J = 17.1, 4.2, 2.0 Hz, 1H), 2.17 (td, J = 12.9, 3.7 Hz, 1H), 1.92 – 
1.83 (m, 2H), 1.82 – 1.74 (m, 1H), 1.58 (dq, J = 10.3, 3.3 Hz, 1H), 1.52 (s, 3H), 1.24 (s, 3H), 
1.17 – 1.01 (m, 21H), 0.97 (s, 3H) ppm; 13C NMR (100 MHz, C6D6): δ = 178.5*, 152.6, 122.1, 
77.5, 59.7, 53.8, 47.2, 45.2, 44.2, 40.3, 36.1, 33.0, 32.8, 27.3, 27.3, 26.8, 26.0, 18.6, 13.4 
ppm; IR (ATR): ߥmax = 2926 (s), 2866 (s), 1660 (br s), 1463 (m), 1381 (m), 1359 (m), 
1327 (w), 1289 (w), 1244 (w), 1178 (w), 1159 (w), 1110 (s), 1094 (m), 1079 (m), 1066 (m), 
1011 (s), 996 (m), 924 (w), 882 (m), 864 (w), 836 (w), 821 (w), 795 (w), 767 (w), 
679 (w) cm−1; HRMS (EI): calc. for C26H47NO3Si [M]+: 449.3320, found: 449.3311. 
* The shift of the amide carbonyl was not visible in the 13C-spectra, but was extracted from 
the HMBC data showing corresponding correlations at 178.5 ppm. 
 
 
20
tBuLi (2.2 eq)
pentane/Et2O,115 °C to 60 °C, 1 h
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Ketone 20 A solution of iodide 17 (24.9 mg, 43.1 μmol, 1.0 eq) in Et2O/pentane (2.8 mL, 1:1) 
at –78 °C was added dropwise to tBuLi (1.6M in pentane, 59.3 μL, 94.8 μmol, 2.2 eq) in 
pentane (2.8 mL) at –115 °C. The resulting reaction mixture was allowed to warm up to         
–60 °C within 1 h before cooling down to –80 °C. The reaction was quenched by addition of 
aq. half-sat. NH4Cl solution (5 mL) and H2O (5 mL) and the layers were separated. The 
aqueous layer was extracted with Et2O (3 × 10 mL) and the combined organic layers were 
dried over Na2SO4. After filtration and concentration in vacuo, the crude product was purified 
by flash column chromatography (pentane:Et2O 20:1) on silica to afford ketone 20 (8.8 mg, 
22.5 μmol, 42% over 2 steps) as a white solid. A crystal, suitable for single crystal X-ray 
diffraction analysis, was obtained by crystallization from Et2O/pentane. 
 
Data for 20: Rf: 0.37 (hexanes:EtOAc 20:1); 1H NMR (800 MHz, C6D6): δ = 3.58 – 3.55 (m, 
1H), 2.92 (ddd, J = 10.8, 5.5, 2.7 Hz, 1H), 2.57 (dd, J = 16.2, 2.6 Hz, 1H), 2.24 (d, 
J = 16.2 Hz, 1H), 2.17 (ddd, J = 14.2, 12.5, 6.8 Hz, 1H), 2.02 (d, J = 10.6 Hz, 1H), 1.96 (d, 
J = 5.4 Hz, 1H), 1.52 (d, J = 10.7 Hz, 1H), 1.43 – 1.40 (m, 2H), 1.36 – 1.31 (m, 2H), 1.22 (s, 
3H), 1.09 (d, J = 7.2 Hz, 18H), 1.05 – 0.96 (m, 3H), 0.80 (s, 3H), 0.48 (s, 3H) ppm; 13C NMR 
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(200 MHz, C6D6): δ = 211.8, 78.4, 49.4, 46.7, 44.0, 42.6, 41.0, 40.3, 37.0, 34.6, 26.5, 26.4, 
25.3, 21.3, 19.0, 18.6, 13.3 ppm; IR (ATR): ߥmax = 2922 (s), 2851 (m), 1722 (m), 1462 (w), 
1409 (w), 1378 (w), 1363 (w), 1259 (w), 1092 (m), 1057 (s), 1013 (m), 959 (w), 919 (w), 
883 (w), 802 (m), 719 (w), 680 (w) cm−1; melting point: 58.6 – 60.2 °C; HRMS (EI): calc. for 
C21H35O3Si [M-(CH3)2CH]+: 347.2401, found: 347.2393. 
 
 
 
Alcohol 21 To a stirred solution of ketone 20 (17.0 mg, 43.5 μmol, 1.0 eq) in THF (2.5 mL) at 
0 °C was added TBAF (1.0 M in THF, 435 μL, 435 μmol, 10 eq) and the resulting reaction 
mixture was allowed to warm up to r.t. overnight. The reaction was quenched by addition of 
H2O (10 mL) and the layers were separated. The aqueous layer was extracted with 
EtOAc (3 × 10 mL) and the combined organic layers were dried over Na2SO4. After filtration 
and concentration in vacuo, the crude product was purified by flash column chromatography 
(pentane:EtOAc 2:1) on silica to afford alcohol 21 (9.3 mg, 39.7 μmol, 91%) as a white solid.  
 
Data for 21: Rf: 0.60 (hexanes:EtOAc 1:1); 1H NMR (800 MHz, C6D6): δ = 3.07 (s, 1H), 2.88 
(ddd, J = 10.8, 5.5, 2.7 Hz, 1H), 2.54 (dd, J = 16.3, 2.7 Hz, 1H), 2.21 (d, J = 16.3 Hz, 1H), 
2.15 – 2.07 (m, 1H), 2.00 – 1.95 (m, 2H), 1.50 (d, J = 10.7 Hz, 1H), 1.37 – 1.29 (m, 3H), 1.27 
– 1.24 (m, 1H), 1.19 (s, 3H), 0.87 (d, J = 3.3 Hz, 1H), 0.63 (s, 3H), 0.42 (s, 3H) ppm; 13C 
NMR (200 MHz, C6D6): δ = 212.0, 76.6, 49.4, 46.7, 43.9, 42.7, 40.8, 40.4, 36.0, 34.8, 26.2, 
25.9, 25.0, 20.1, 18.9 ppm; IR (ATR): ߥmax = 3509 (br m), 2936 (m), 2905 (m), 2861 (w), 
1706 (s), 1465 (w), 1451 (w), 1410 (w), 1380 (w), 1360 (w), 1340 (w), 1321 (w), 1294 (w), 
1278 (w), 1242 (w), 1211 (w), 1196 (w), 1180 (w), 1167 (w), 1132 (w), 1116 (m), 1085 (w), 
1048 (w), 1036 (w), 994 (m), 950 (w), 909 (w), 891 (w), 880 (w), 799 (w), 695 (w) cm−1; 
melting point: 115.5 – 116.5 °C; HRMS (ESI): calc. for C15H23O2 [M+H]+: 235.1693, found: 
235.1694. 
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Imidazole 23 To a stirred solution of alcohol 21 (9.3 mg, 39.7 μmol, 1.0 eq) in THF (0.75 mL) 
was added 22 (177 mg, 993 μmol, 25 eq) and DMAP (24.3 mg, 199 μmol, 5.0 eq). The 
resulting reaction mixture was heated to 60 °C for 7 h followed by addition of H2O (10 mL) 
and EtOAc (2 mL). The layers were separated and the aqueous layer was extracted with 
EtOAc (4 × 10 mL). The combined organic layers were dried over Na2SO4. After filtration and 
concentration in vacuo, the crude product was purified by flash column chromatography 
(pentane:EtOAc 10:18:1) on silica to afford imidazole 23 (12.5 mg, 36.3 μmol, 91%) as a 
slightly yellow solid.  
 
Data for 23: Rf: 0.40 (hexanes:EtOAc 1:1); 1H NMR (400 MHz, C6D6): δ = 8.38 (s, 1H), 7.50 
(s, 1H), 6.98 (s, 1H), 5.37 (dd, J = 4.1, 2.9 Hz, 1H), 2.39 (dd, J = 16.3, 2.7 Hz, 1H), 2.16 
(ddd, J = 11.0, 5.6, 2.8 Hz, 1H), 2.05 (d, J = 16.3 Hz, 1H), 1.81 (d, J = 10.8 Hz, 1H), 1.71 (d, 
J = 5.6 Hz, 1H), 1.49 (dq, J = 13.6, 4.6 Hz, 1H), 1.44 – 1.34 (m, 2H), 1.32 – 1.22 (m, 1H), 
1.20 – 1.12 (m, 5H), 0.43 (s, 3H), 0.36 (s, 3H) ppm; 13C NMR (100 MHz, C6D6): δ = 210.6, 
184.3, 136.5, 131.9, 118.6, 88.8, 49.4, 45.7, 43.5, 42.0, 40.5, 40.2, 36.8, 34.7, 26.6, 24.6, 
22.6, 19.7, 18.8 ppm; IR (ATR): ߥmax = 3117 (w), 2965 (w), 2921 (w), 2852 (w), 1715 (s), 
1528 (w), 1478 (m), 1459 (w), 1383 (s), 1331 (s), 1282 (s), 1250 (s), 1234 (s), 1200 (m), 
1186 (m), 1194 (w), 1131 (w), 1115 (w), 1099 (m), 1093 (m), 1035 (w), 973 (s), 964 (s), 
951 (m), 927 (m), 888 (w), 880 (w), 853 (m), 839 (w), 731 (m) cm−1; melting point: 115.2 – 
117.4 °C; HRMS (EI): calc. for C19H24N2O2S [M]+: 344.1553, found: 344.1540. 
 
 
 
Aplydactone (1) and 8-epi-aplydactone (27) To a stirred solution of imidazole 23 (4.2 mg, 
12.2 μmol, 1.0 eq) and α-bromo acid 25 (10.2 mg, 61.0 μmol, 5.0 eq) in benzene (0.5 mL, 
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degassed by sparging with argon for 15 min) at 60 °C was added hyponitrite 24162 (8.5 mg, 
48.8 μmol, 4.0 eq) in benzene (0.5 mL, degassed by sparging with argon for 15 min) over 2 h 
by syringe pump followed by stirring for 30 min. The reaction was cooled to r.t. and filtered 
over a plug of silica (pentane:EtOAc 8:1). After concentration in vacuo, the crude product 
was purified by flash column chromatography (pentane:EtOAc 30:118:1) on silica to afford 
aplydactone (1, 1.3 mg, 4.37 μmol, 36%) and 8-epi-aplydactone (27, 0.8 mg, 2.69 μmol, 
22%).  
 
Data for 8-epi-aplydactone (27): Rf: 0.35 (hexanes:EtOAc 9:1); IR (ATR): ߥmax = 2921 (m), 
2852 (w), 1718 (s), 1464 (w), 1444 (w), 1407 (s), 1385 (w), 1367 (w), 1339 (w), 1274 (w), 
1264 (w), 1236 (w), 1228 (w), 1209 (w), 1149 (w), 1127 (w), 1105 (w), 1092 (w), 1070 (w), 
1024 (w), 977 (w), 963 (w), 949 (w), 899 (w), 866 (w), 804 (w), 704 (w), 691 (w) cm−1; HRMS 
(EI): calc. for C15H21Br79O [M]+: 296.0770 found: 296.0776. 
NMR-data: 
 
 
1H NMR (800 MHz, C6D6): δ = 3.86 (t, J = 3.4 Hz, 1H, H-8), 3.08 (ddd, J = 11.2, 5.6, 2.9 Hz, 
1H, H-12), 2.38 (dd, J = 16.2, 2.8 Hz, 1H, H’-5), 2.24 (td, J = 14.3, 4.7 Hz, 1H, H-10), 2.11 (d, 
J = 16.2 Hz, 1H, H-5), 1.90 (d, J = 5.6 Hz, 1H, H-11), 1.85 (d, J = 10.8 Hz, 1H, H’-2), 1.59 – 
1.55 (m, 1H, H-9), 1.41 (d, J = 10.8 Hz, 1H, H-2), 1.40 – 1.35 (m, 1H, H’-9), 1.33 – 1.30 (m, 
2H, H’-10, H’-12), 1.15 (s, 3H, H-13), 0.80 (s, 3H, H-15), 0.41 (s, 3H, H-14) ppm; 13C NMR 
(200 MHz, C6D6): δ = 210.9 (C-4), 66.3 (C-8), 49.1 (C-3), 45.6 (C-11), 44.1 (C-6), 43.0 (C-5), 
40.6 (C-1), 40.6 (C-2), 36.5 (C-7), 34.4 (C-12), 28.2 (C-9 or C-10), 28.1 (C-9 or C-10), 25.8 
(C-14), 25.0 (C-15), 18.7 (C-13) ppm; 
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Data for aplydactone (1): Rf: 0.41 (hexanes:EtOAc 1:9); IR (ATR): ߥmax = 2956 (m), 2918 
(m), 2845 (w), 1709 (s), 1470 (w), 1455 (w), 1437 (w), 1411 (s), 1389 (w), 1365 (w), 1341 
(w), 1302 (w), 1278 (w), 1250 (w), 1236 (w), 1189 (w), 1147 (w), 1131 (w), 1113 (w), 1092 
(w), 1062 (w), 1026 (w), 981 (w), 957 (w), 947 (w), 846 (w), 711 (w), 691 (w) cm−1; HRMS 
(EI): calc. for C15H21Br79O [M]+: 296.0770 found: 296.0768. 
NMR-data:95 
 
 
No. 
1H NMR Isolation  
300 MHz, C6D6 
[ppm] 
1H NMR Synthetic 
800 MHz, C6D6 
[ppm] 
13C NMR  
Isolation  
75 MHz, C6D6 
[ppm] 
13C NMR 
Synthetic 
200 MHz, C6D6 
[ppm] 
1   40.2 40.2 
2 1.29 (d, J = 11.0 Hz, 1H) 1.81 (d, J = 11.0 Hz, 1H) 
1.29 (d, J = 10.9 Hz, 1H) 
1.80 (d, J = 10.9 Hz, 1H) 40.6 40.6 
3   48.9 48.9 
4   210.4 210.5 
5 
2.12 (d, J = 16.5 Hz, 1H) 
2.51 (dd, J = 16.5, 2.7 Hz, 
1H) 
2.13 (d, J = 16.4 Hz, 1H) 
2.51 (dd, J = 16.4, 2.8 Hz, 
1H) 
42.9 42.9 
6   47.1 47.1 
7   38.2 38.2 
8 3.90 (m, 1H) 3.89 (dd, J = 11.9, 3.9 Hz, 1H) 65.7 65.8 
9 1.69 (m, 2H) 1.70 – 1.65 (m, 2H) 31.0 31.0 
10 1.30 (m, 2H) 1.35 – 1.25 (m, 2H) 33.8 33.9 
11 1.58 (d, J = 5.6 Hz, 1H) 1.58 (d, J = 5.6 Hz, 1H) 45.5 45.5 
12 
1.05 (d, J = 11.3 Hz, 1H) 
1.72 (ddd, J = 11.3, 5.6, 2.7 
Hz, 1H) 
1.04 (d, J = 11.3 Hz, 1H) 
1.73 – 1.70 (m, 1H) 31.7 31.7 
13 1.09 (s, 3H) 1.10 (s, 3H) 18.6 18.7 
14 0.75 (s, 3H) 0.75 (s, 3H) 18.3 18.3 
15 0.70 (s, 3H) 0.70 (s, 3H) 22.9 22.9 
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6.2.2 1H and 13C NMR spectra 
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1H-NMR, 800 MHz, CDCl3 
range: 4.7 – 0.7 ppm 
1H-NMR, 800 MHz, CDCl3 
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13C-NMR, 200 MHz, CDCl3 
13C-NMR, 200 MHz, CDCl3 
range: 90 – 20 ppm 
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1H-NMR, 600 MHz, CD2Cl2 
1H-NMR, 600 MHz, CD2Cl2 
range: 4.7 – 0.7 ppm 
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13C-NMR, 150 MHz, CD2Cl2 
13C-NMR, 150 MHz, CD2Cl2 
range: 90 – 20 ppm 
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1H-NMR, 600 MHz, CD2Cl2 
1H-NMR, 600 MHz, CD2Cl2 
range: 4.7 – 0.7 ppm 
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13C-NMR, 150 MHz, CD2Cl2 
13C-NMR, 150 MHz, CD2Cl2 
range: 90 – 20 ppm 
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1H-NMR, 400 MHz, CD2Cl2 
1H-NMR, 400 MHz, CD2Cl2 
range: 4.7 – 0.7 ppm 
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13C-NMR, 100 MHz, CD2Cl2 
13C-NMR, 100 MHz, CD2Cl2 
range: 90 – 20 ppm 
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1H-NMR, 400 MHz, CD2Cl2 
1H-NMR, 400 MHz, CD2Cl2 
range: 4.7 – 0.7 ppm 
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1H-NMR, 400 MHz, CD2Cl2 
range: 4.7 – 0.7 ppm 
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1H-NMR, 400 MHz, C6D6 
1H-NMR, 400 MHz, C6D6 
range: 4.7 – 0.7 ppm 
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13C-NMR, 100 MHz, C6D6 
13C-NMR, 100 MHz, C6D6 
range: 90 – 10 ppm 
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1H-NMR, 400 MHz, C6D6 
1H-NMR, 400 MHz, C6D6 
range: 4.7 – 0.7 ppm 
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13C-NMR, 100 MHz, C6D6 
13C-NMR, 100 MHz, C6D6 
range: 90 – 10 ppm 
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1H-NMR, 400 MHz, C6D6 
1H-NMR, 400 MHz, C6D6 
range: 4.7 – 0.7 ppm 
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13C-NMR, 100 MHz, C6D6 
13C-NMR, 100 MHz, C6D6 
range: 90 – 10 ppm 
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1H-NMR, 800 MHz, C6D6 
1H-NMR, 800 MHz, C6D6 
range: 4.5 – 0.3 ppm 
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13C-NMR, 200 MHz, C6D6 
13C-NMR, 200 MHz, C6D6 
range: 90 – 10 ppm 
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1H-NMR, 800 MHz, C6D6 
range: 3.5 – 0.3 ppm 
 
1H-NMR, 800 MHz, C6D6 
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13C-NMR, 200 MHz, C6D6 
13C-NMR, 200 MHz, C6D6 
range: 90 – 10 ppm 
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1H-NMR, 400 MHz, C6D6 
1H-NMR, 400 MHz, C6D6 
range: 3.5 – 0.3 ppm 
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13C-NMR, 100 MHz, C6D6 
13C-NMR, 100 MHz, C6D6 
range: 90 – 10 ppm 
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1H-NMR, 800 MHz, C6D6 
1H-NMR, 800 MHz, C6D6 
range: 3.5 – 0.3 ppm 
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13C-NMR, 200 MHz, C6D6 
13C-NMR, 200 MHz, C6D6 
range: 90 – 10 ppm 
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6.2.3 X-ray crystallographic data 
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1. Ladderane 15 
 
Figure 6.5 ORTEP of the molecular structure of ladderane 15. 
CCDC 1475334 contains the supplementary crystallographic data for ladderane 15. These 
data can be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
        
Table 6.5 Crystallographic data for ladderane 15. 
net formula C16H26O4 
Mr/g mol−1 282.37 
crystal size/mm 0.100 × 0.080 × 0.060 
T/K 100(2) 
radiation MoKα 
diffractometer 'Bruker D8Venture' 
crystal system monoclinic 
space group 'P 21' 
a/Å 7.4267(2) 
b/Å 10.8919(3) 
c/Å 9.6608(3) 
α/° 90 
β/° 111.1920(11) 
γ/° 90 
V/Å3 728.62(4) 
Z 2 
calc. density/g cm−3 1.287 
μ/mm−1 0.091 
absorption correction multi-scan 
transmission factor range 0.9233–0.9585 
refls. measured 8756 
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Rint 0.0264 
mean σ(I)/I 0.0269 
θ range 2.942–26.40 
observed refls. 2854 
x, y (weighting scheme) 0.0405, 0.1831 
hydrogen refinement mixed 
Flack parameter 1.7(11) 
refls in refinement 2973 
parameters 194 
restraints 1 
R(Fobs) 0.0304 
Rw(F2) 0.0788 
S 1.056 
shift/errormax 0.001 
max electron density/e Å−3 0.285 
min electron density/e Å−3 −0.170 
        
       C-H: constr, O-H: refall. Refined as inversion twin. 
 
2. Ketone 20 
 
Figure 6.6 ORTEP of the molecular structure of ketone 20. 
CCDC 1475333 contains the supplementary crystallographic data for ketone 20. These data 
can be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
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2-component twin refinement. 
Table 6.6 Crystallographic data for ketone 20. 
net formula C24H42O2Si 
Mr/g mol−1 390.66 
crystal size/mm 0.100 × 0.070 × 0.040 
T/K 100(2) 
radiation MoKα 
diffractometer 'Bruker D8 Venture TXS' 
crystal system triclinic 
space group 'P -1' 
a/Å 8.2947(12) 
b/Å 9.6655(13) 
c/Å 15.097(2) 
α/° 85.913(5) 
β/° 77.552(5) 
γ/° 75.220(5) 
V/Å3 1142.6(3) 
Z 2 
calc. density/g cm−3 1.135 
μ/mm−1 0.119 
absorption correction Multi-Scan 
transmission factor range 0.8992–0.9705 
refls. measured 8198 
mean σ(I)/I 0.0501 
θ range 3.180–25.39 
observed refls. 3796 
x, y (weighting scheme) 0.0000, 2.7536 
hydrogen refinement constr 
refls in refinement 4155 
parameters 254 
restraints 0 
R(Fobs) 0.0730 
Rw(F2) 0.1484 
S 1.215 
shift/errormax 0.001 
max electron density/e Å−3 0.466 
min electron density/e Å−3 −0.443 
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6.3 Supporting information for Chapter 2.2.2 
6.3.1 Experimental procedures 
 
S2S1
OMe OMe
Li (5.0 eq), NH3,
tBuOH/Et2O,78 °C, 3 h
oxalic acid
dihydrate (0.04 eq),
MeOH/H2O, r.t., 3 h
O
mCPBA (1.2 eq),
CH2Cl2, 0 °C to r.t.,16 h then NEt3 (2.5 eq),CH2Cl2, r.t., 3 h
O
OH
(66%, 4 steps)
S4S3  
4-Hydroxy-3-methylcyclohex-2-en-1-one (S4) To a stirred solution of 3-methylanisole (S1, 
20.0 mL, 159 mmol, 1.0 eq) in a mixture of liquid ammonia (~300 mL, condensed at −78 °C), 
tBuOH (140 mL) and Et2O (140 mL) in a three-necked 1 L-flask equipped with a dry-ice 
condenser at −78 °C was added granulated lithium (5.50 g, 793 mmol, 5.0 eq) portionwise 
and the resulting dark blue reaction mixture was stirred for 3 h. The reaction was quenched 
by careful addition of NH4Cl (50 g) and H2O (300 mL) and the reaction flask was left open 
while stirring at r.t. for 2 h. The layers were separated and the aqueous layer was extracted 
with pentane (5 × 130 mL) and the combined organic layers were dried over Na2SO4. After 
filtration, the solvent was removed by distillation with a Vigreux column (25 cm) at 
atmospheric pressure to obtain crude diene S2, which was used in the next step without 
further purification. 
To a stirred solution of crude diene S2 in a mixture of MeOH/H2O (360 mL, 3:1) at r.t. was 
added oxalic acid dihydrate (800 mg, 6.35 mmol, 0.04 eq) and the resulting reaction mixture 
was stirred for 3 h. The reaction was quenched by addition of H2O (500 mL). The aqueous 
layer was extracted with CH2Cl2 (5 × 100 mL) and the combined organic layers were dried 
over Na2SO4. After filtration, the solvent was removed by distillation with a Vigreux column 
(25 cm) at atmospheric pressure to obtain crude ketone S3, which was used in the next step 
without further purification. 
To a stirred solution of crude ketone S3 in CH2Cl2 (600 mL) at 0 °C was added mCPBA (77% 
purity, 42.8 g, 191 mmol, 1.2 eq) and the resulting reaction mixture was stirred at r.t. for 16 h. 
The reaction was quenched by addition of sat. aq. NaHCO3 solution (300 mL). The aqueous 
layer was extracted with CH2Cl2 (3 × 100 mL) and the combined organic layers were dried 
over Na2SO4. After filtration, NEt3 (55.0 mL, 396 mmol, 2.5 eq) was added to the CH2Cl2 
solution and the resulting reaction mixture was stirred at r.t. for 3h. The reaction was 
quenched by addition of brine (300 mL). The aqueous layer was extracted with CH2Cl2 
(3 × 100 mL) and the combined organic layers were dried over Na2SO4. After filtration and 
concentration in vacuo, the crude product was purified by flash column chromatography 
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(hexanes:EtOAc 1:1) on silica to afford enone S4 (13.2 g, 105 mmol, 66% over 4 steps) as a 
white solid. Compound S4 has been reported in the literature.163 
 
Data for S4: Rf: 0.30 (hexanes:EtOAc 1:1); 1H NMR (400 MHz, CDCl3): δ = 5.87 (s, 1H), 
4.39 (dd, J = 7.2, 6.7 Hz, 1H), 2.58 (dt, J = 15.9, 5.1 Hz, 1H), 2.44 – 2.24 (m, 2H), 2.06 (s, 
3H), 2.05 – 1.95 (m, 1H), 1.87 – 1.75 (m, 1H); 13C NMR (100 MHz, CDCl3): δ = 198.7, 162.8, 
127.3, 69.0, 35.0, 32.2, 20.7 ppm; IR (ATR): ߥmax = 3317 (w), 2970 (w), 2950 (w), 2927 (w), 
2870 (w), 2849 (w), 1641 (s), 1614 (m), 1442 (m), 1371 (m), 1342 (w), 1324 (m), 1299 (w), 
1253 (m), 1191 (m), 1178 (m), 1139 (w), 1079 (m), 1065 (m), 1046 (m), 1024 (m), 1007 (m), 
965 (m), 884 (m), 809 (m), 751 (m), 679 (m), 662 (m) cm−1; melting point: 43.6 – 46.4 °C; 
HRMS (EI): calc. for C7H10O2 [M]+: 126.0675, found: 126.0672. 
 
 
 
4-((tert-Butyldimethylsilyl)oxy)-3-methylcyclohex-2-enone (12) To a stirred solution of 
alcohol S4 (13.4 g, 106 mmol, 1.0 eq) in DMF (400 mL) at r.t. was added imidazole (11.6 g, 
170 mmol, 1.6 eq), DMAP (1.29 g, 10.6 mmol, 0.1 eq) and TBSCl (25.6 g, 170 mmol, 1.6 eq) 
and the resulting reaction mixture was stirred at r.t. for 12 h. The reaction was quenched by 
addition of H2O (400 mL) and brine (400 mL). The aqueous layer was extracted with Et2O 
(3 × 250 mL) and the combined organic layers were washed with H2O (4 × 250 mL) and dried 
over Na2SO4. After filtration and concentration in vacuo, the crude product was purified by 
flash column chromatography (hexanes:EtOAc 10:1) on silica to afford protected enone 12 
(22.0 g, 91.5 mmol, 86%) as a colorless oil. Compound 12 has been reported in the 
literature.164 
 
Data for 12: Rf: 0.85 (hexanes:EtOAc 1:1); 1H NMR (400 MHz, CDCl3): δ = 5.82 (s, 1H), 
4.35 (dd, J = 8.2, 4.5 Hz, 1H), 2.55 (dt, J = 16.8, 5.0 Hz, 1H), 2.32 (ddd, J = 16.7, 11.7, 
4.7 Hz, 1H), 2.17 (dq, J = 14.5, 4.9 Hz, 1H), 2.04 – 1.93 (m, 4H), 0.92 (s, 9H), 0.14 (s, 3H), 
0.13 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3): δ = 199.0, 164.5, 126.7, 69.8, 35.3, 32.7, 
25.9, 21.3, 18.2, −4.2, −4.8 ppm; IR (ATR): ߥmax = 2954 (w), 2929 (w), 2887 (w), 2857 (w), 
1673 (s), 1628 (w), 1472 (w), 1440 (w), 1374 (w), 1360 (m), 1324 (m), 1252 (m), 1195 (w), 
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1098 (s), 1004 (m), 989 (w), 972 (m), 938 (w), 895 (m), 879 (m), 855 (m), 835 (s), 803 (m), 
774 (s), 671 (m) cm−1; HRMS (EI): calc. for C13H24O2Si [M]+: 240.1540, found: 240.1541. 
 
 
CuBr·Me2S (1.5 eq),MeMgBr (1.5 eq), TMEDA (3.0 eq),
TMSCl (3.0 eq), THF, 78 °C to r.t., 4 h
O
OTBS
(87%)
12
OTMS
TBSO
S5  
Enol ether S5 To a stirred suspension of CuBr·Me2S (2.30 g, 11.3 mmol, 1.5 eq) in THF 
(50 mL) at −78 °C was added MeMgBr (1.0 M in dibutyl ether, 11.3 mL, 11.3 mmol, 1.5 eq) 
dropwise and the resulting reaction mixture was stirred at −78 °C for 1 h. A solution of enone 
12 (1.80 g, 7.49 mmol, 1.0 eq), TMEDA (3.37 mL, 22.5 mmol, 3.0 eq) and freshly distilled 
TMSCl (2.85 mL, 22.5 mmol, 3.0 eq) in THF (30 mL) was added dropwise and the resulting 
reaction mixture was warmed to r.t. over 4h. The reaction was quenched by addition of Et2O 
(50 mL), sat. aq. NaHCO3 solution (300 mL) and H2O (150 mL). The layers were separated 
and the aqueous layer was extracted with Et2O (4 × 30 mL) and the combined organic layers 
were washed with H2O (5 × 30 mL) and dried over Na2SO4. After filtration and concentration 
in vacuo, enol ether S5 (2.15 g, 6.54 mmol, 87%) was obtained as a colorless oil which was 
used in the next step without further purification. 
 
Data for S5: Rf: 0.40 (hexanes); 1H NMR (400 MHz, C6D6): δ = 4.74 (s, 1H), 3.50 (dd, J = 
9.8, 3.2 Hz, 1H), 2.17 – 2.06 (m, 2H), 1.82 – 1.70 (m, 1H), 1.70 – 1.58 (m, 1H), 1.12 (s, 3H), 
1.05 (s, 3H), 0.99 (s, 9H), 0.20 (s, 9H), 0.04 (s, 3H), 0.03 (s, 3H) ppm; 13C NMR (100 MHz, 
C6D6): δ = 148.6, 114.0, 75.7, 37.0, 29.7, 28.9, 28.3, 26.1, 24.5, 18.4, 0.4, −4.0, −4.8 ppm; IR 
(ATR): ߥmax = 2955 (w), 2929 (w), 2857 (w), 1665 (w), 1471 (w), 1383 (w), 1366 (w), 
1251 (m), 1205 (w), 1158 (m), 1142 (w), 1099 (m), 1084 (m), 1010 (w), 943 (m), 882 (m), 
831 (s), 771 (m), 756 (m), 669 (m) cm−1; HRMS (EI): calc. for C17H36O2Si2 [M]+: 328.2248, 
found: 328.2240. 
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Enone S6 To a stirred solution of enol ether S5 (400 mg, 1.22 mmol, 1.0 eq) in CH2Cl2 
(12 mL) at r.t. was added CH2NMe2+I− (338 mg, 1.82 mmol, 1.5 eq) and the resulting reaction 
mixture was stirred at r.t. for 12 h. The reaction was quenched by addition of aq. HCl solution 
(0.5 M, 8 mL), followed by addition of sat. aq. Na2CO3 solution (160 mL) until pH 12. The 
layers were separated and the aqueous layer was extracted with EtOAc (3 × 20 mL) and the 
combined organic layers were dried over Na2SO4. After filtration and concentration in vacuo, 
the crude amine was obtained as a colorless oil which was used in the next step without 
further purification. To a stirred solution of the crude amine in CH2Cl2 (8 mL) at r.t. was added 
mCPBA (77% pure, 547 mg, 2.44 mmol, 2.0 eq) and the resulting reaction mixture was 
stirred at r.t. for 90 min. The reaction was quenched by addition of H2O (80 mL). The layers 
were separated and the aqueous layer was extracted with CH2Cl2 (3 × 20 mL) and the 
combined organic layers were dried over Na2SO4. After filtration and concentration in vacuo, 
the crude product was purified by flash column chromatography (pentane:Et2O 50:1) on silica 
to afford enone S6 (154 mg, 547 μmol, 45%) as a colorless oil. 
 
Data for S6: Rf: 0.34 (pentane:Et2O 20:1); 1H NMR (400 MHz, C6D6): δ = 5.96 (d, J = 1.5 Hz, 
1H), 4.97 (d, J = 1.5 Hz, 1H), 3.31 (dd, J = 6.6, 3.0 Hz, 1H), 2.54 (ddd, J = 16.8, 8.5, 7.0 Hz, 
1H), 2.15 (dt, J = 16.9, 6.5 Hz, 1H), 1.64 (dddd, J = 14.0, 8.6, 6.5, 3.1 Hz, 1H), 1.54 (dq, 
J = 13.6, 6.7 Hz, 1H), 0.97 (s, 3H), 0.91 (s, 9H), 0.84 (s, 3H), −0.03 (s, 3H), −0.07 (s, 
3H) ppm; 13C NMR (100 MHz, C6D6): δ = 200.2, 154.0, 117.7, 75.4, 43.1, 36.0, 27.7, 26.7, 
26.0, 23.7, 18.3, −4.3, −4.9 ppm; IR (ATR): ߥmax = 2955 (m), 2930 (m), 2857 (m), 1698 (m), 
1614 (w), 1472 (w), 1462 (w), 1389 (w), 1361 (w), 1285 (w), 1254 (m), 1178 (w), 1158 (w), 
1084 (s), 1006 (w), 993 (w), 961 (w), 935 (m), 884 (w), 835 (s), 803 (w), 774 (s), 735 (w), 
676 (w), 606 (w), 587 (w), 568 (w), 558 (w) cm−1; HRMS (EI): calc. for C14H25O2Si [M-CH3]+: 
253.1618, found: 253.1609. 
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Spirocycle S7/S7’ To a stirred solution of enone S6 (12.2 mg, 45.4 μmol, 1.0 eq.) in CH2Cl2 
(0.8 mL) at 0 °C was added isoprene (1.0 M in CH2Cl2, 0.136 mL, 136 μmol, 3.0 eq) and 
Me2AlCl (0.2 M, 86.0 μL, 13.6 μmol, 0.3 eq) and the resulting reaction mixture was stirred for 
1.5 h. The reaction was quenched by addition of half sat. aq. Na2CO3 solution (10 mL) and 
the aqueous layer was extracted with Et2O (3 × 10 mL). The combined organic layers were 
dried over Na2SO4. After filtration and concentration in vacuo, the crude product was purified 
by flash column chromatography (hexanes:EtOAc 80:1) on silica to afford enone S7/S7’ 
(7.3 mg, 21.7 μmol, 48%) in an inseparable 1:1.2 diastereomeric mixture as a colorless oil.  
 
NMR shifts which could be clearly assigned to the major diastereomer are marked with an 
asterisk * and shifts which could be clearly assigned to the minor diastereomer are marked 
with a hash #. Due to the ratio of the two diastereomer the integrals in the 1H-NMR differ from 
the expected values. 
Data for S7/S7’: Rf: 0.34 (hexanes:EtOAc 1:19); 1H NMR (800 MHz, C6D6): δ = 5.48 (s, 
1H)#, 5.42 (s, 1H)*, 3.88 (dd, J = 11.0, 5.0 Hz, 1H)#, 3.44 (dd, J = 5.5, 3.6 Hz, 1H)*, 2.71 (td, 
J = 12.1, 6.0 Hz, 1H)*, 2.65 (dd, J = 13.3, 5.4 Hz, 1H)*, 2.52 (d, J = 15.5 Hz, 1H)#, 2.34 (d, 
J = 18.6 Hz, 1H)*, 2.26 (td, J = 13.6, 6.6 Hz, 1H)#, 2.17 (dt, J = 12.3, 5.9 Hz, 1H)*, 2.08 (ddd, 
J = 13.3, 5.1, 2.9 Hz, 1H)#, 2.02 (t, J = 14.3 Hz, 1H)#, 1.86 (d, J = 16.9 Hz, 1H)*, 1.79 – 1.71 
(m, 5H), 1.69 – 1.54 (m, 13H), 1.51 – 1.45 (m, 2H), 0.96 (s, 22H), 0.89 (s, 4H)*, 0.88 (s, 3H)#, 
0.78 (s, 3H)# , 0.66 (s, 4H)*, 0.05 (s, 3H)#, 0.02 (s, 3H)#, 0.01 (s, 4H)*, −0.04 (s, 4H)* ppm; 
13C NMR (200 MHz, C6D6): δ = 212.1*, 210.4#, 132.9*, 130.7#, 121.7#, 120.0*, 76.1*, 73.1#, 
54.7*, 54.4#, 45.5*, 44.9#, 35.0#, 33.5*, 31.8, 31.6, 28.5, 28.3, 27.8, 27.2, 27.1, 27.0, 
26.1 (2C), 23.5 (2C), 23.3, 21.9#, 19.5*, 18.3 (2C), 16.2#, −3.8#, −4.3*, −4.7#, −4.9* ppm; IR 
(ATR): ߥmax = 2954 (w), 2929 (w), 2899 (w), 2857 (w), 1709 (m), 1472 (w), 1462 (w), 
1446 (w), 1390 (w), 1366 (w), 1328 (w), 1296 (w), 1255 (m), 1230 (w), 1160 (w), 1133 (w), 
1115 (w), 1085 (m), 1056 (m), 1042 (w), 1026 (w), 1004 (w), 991 (w), 971 (w), 938 (w), 
924 (w), 907 (w), 880 (m), 834 (s), 804 (w), 773 (s), 714 (w), 669 (w), 640 (w) cm−1; HRMS 
(ESI): calc. for C20H37O2Si [M+H]+: 337.2557, found: 337.2559. 
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Enol ether 13 
 
Preparation of the Grignard reagent:  
Magnesium turnings (2.60 g, 107 mmol, 1.0 eq) and a catalytic amount of iodine were 
suspended in Et2O (75 mL). TMSCH2Cl (14.7 mL, 105 mmol, 1.0 eq) was added in small 
portions over 20 min. The resulting mixture was heated under reflux for 30 min. The obtained 
Grignard solution was titrated with iodine solution, transferred to a flame dried flask and 
stored under Argon atmosphere. 
 
1,4-Addition to enone 12: 
The Grignard-reagent (1.25 M, 20.0 mL, 25.0 mmol, 1.5 eq) was added to a stirred 
suspension of CuI (442 mg, 2.32 mmol, 0.14 eq) in THF (32 mL). The mixture was cooled to 
−30 °C and protected enone 12 (4.00 g, 16.6 mmol, 1.0 eq) in THF (15 mL) was added. The 
resulting reaction mixture was stirred for 1 h and then cooled to –60 °C. HMPA (3.18 mL, 
18.3 mmol, 1.1 eq), NEt3 (6.92 mL, 50.0 mmol, 3.0 eq) and freshly distilled TMSCl (4.28 mL, 
33.3 mmol, 2.0 eq) were added. The reaction was immediately cooled to –78 °C and stirred 
for 30 min. The reaction mixture was warmed to 0 °C over 10 min and was stirred at this 
temperature for 30 min. The reaction was quenched by addition of half-sat. aq. NaHCO3 
solution (140 mL) and the aqueous layer was extracted with Et2O (3 × 100 mL). The 
combined organic layers were washed with H2O (5 × 150 mL) and dried over Na2SO4. After 
filtration and concentration in vacuo, enol ether 13 (5.81 g, 14.5 mmol, 87%) was obtained as 
a colorless oil which was used in the next step without further purification. 
 
Data for 13: Rf: 0.53 (hexanes); 1H NMR (400 MHz, C6D6): δ = 4.89 (s, 1H), 3.59 (dd, 
J = 7.2, 4.8 Hz, 1H), 2.20 – 2.06 (m, 2H), 1.79 – 1.67 (m, 2H), 1.19 (s, 3H), 1.01 (s, 9H), 0.91 
(d, J = 14.5 Hz, 1H), 0.86 (d, J = 14.5 Hz, 1H), 0.23 (s, 9H), 0.15 (s, 9H), 0.10 (s, 3H), 0.07 
(s, 3H) ppm; 13C NMR (100 MHz, C6D6): δ = 148.2, 113.8, 76.3, 40.0, 31.4, 28.3, 27.8, 26.2, 
25.9, 18.4, 1.2, 0.6, −3.8, −4.5 ppm; IR (ATR): ߥmax = 2954 (w), 2857 (w), 1664 (w), 1375 (w), 
1250 (m), 1201 (w), 1175 (w), 1102 (m), 1005 (w), 946 (w), 893 (m), 834 (s), 772 (m), 
687 (w) cm−1; HRMS (ESI): calc. for C20H45O2Si3 [M+H]+: 401.2722, found: 401.2727. 
 
 
246  Supporting information for Chapter 2.2.2 
 
 
Enone 14 A solution of enol ether 13 (6.60 g, 16.5 mmol, 1.0 eq) in CH2Cl2 (110 mL) was 
added to a stirred suspension of CH2NMe2+Cl− (3.08 g, 32.9 mmol, 2.0 eq) and Li2CO3 
(1.34 g, 18.1 mmol, 1.1 eq) in MeCN (110 mL) at 0 °C and the resulting reaction mixture was 
stirred at r.t. for 6 h. The reaction was quenched by addition of H2O (350 mL). The layers 
were separated and the aqueous layer was extracted with EtOAc (6 × 150 mL) and the 
combined organic layers were dried over Na2SO4. After filtration and concentration in vacuo, 
the crude amine was obtained as a colorless oil which was used in the next step without 
further purification. To a stirred solution of the crude amine in CH2Cl2 (220 mL) at −78 °C was 
added freshly purified mCPBA165 (4.26 g, 24.7 mmol, 1.5 eq) dissolved in CH2Cl2 (110 mL) 
and the resulting reaction mixture was stirred for 1.5 h. The reaction was quenched by 
addition of ice-cold sat. aq. NaHCO3 solution (containing 1% Na2S2O3, 300 mL). The layers 
were separated and the aqueous layer was extracted with CH2Cl2 (3 × 250 mL) and the 
combined organic layers were dried over Na2SO4. After filtration and concentration in vacuo, 
the crude product was purified by flash column chromatography (pentane:Et2O 20:1) on silica 
to afford enone 14 (4.53 g, 13.3 mmol, 81%) as a white solid. The compound was stored in 
benzene matrix at −20 °C. Evaporation from benzene afforded crystals suitable for single 
crystal X-ray diffraction analysis. 
 
Data for 14: Rf: 0.43 (hexanes:EtOAc 9:1); 1H NMR (400 MHz, C6D6): δ = 5.86 (s, 1H), 4.90 
(s, 1H), 3.46 (s, 1H), 2.66 (ddd, J = 16.4, 12.7, 7.5 Hz, 1H), 2.31 (ddd, J = 16.4, 5.8, 1.7 Hz, 
1H), 1.92 (dddd, J = 14.7, 12.8, 5.8, 2.1 Hz, 1H), 1.57 – 1.46 (m, 1H), 1.12 (s, 3H), 0.91 (s, 
9H), 0.60 (d, J = 14.8 Hz, 1H), 0.50 (d, J = 14.8 Hz, 1H), 0.02 (s, 3H), 0.01 (s, 9H), −0.03 (s, 
3H) ppm; 13C NMR (100 MHz, C6D6): δ = 201.5, 154.8, 116.9, 76.3, 46.3, 35.4, 29.6, 27.2, 
26.0, 24.2, 18.4, 1.0, −4.3, −4.8 ppm; IR (ATR): ߥmax = 2954 (w), 2894 (w), 2858 (w), 
1698 (m), 1612 (w), 1472 (w), 1411 (w), 1362 (w), 1286 (w), 1250 (m), 1190 (w), 1083 (m), 
1046 (w), 993 (w), 966 (w), 937 (w), 863 (w), 835 (s), 774 (m), 738 (w), 687 (w) cm−1; 
melting point: 45.0 – 46.0 °C; HRMS (ESI): calc. for C18H40NO2Si2 [M+NH4]+: 358.2592, 
found: 358.2598. 
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Spirocycle 15 To a solution of enone 14 (1.00 g, 
2.94 mmol, 1.0 eq) in pentane (14 mL) in a high 
pressure Teflon vial (left picture) was added isoprene 
(1.76 mL, 17.6 mmol, 6.0 eq) and anhydrous ZnBr2 
(132 mg, 587 μmol, 0.2 eq) and the resulting reaction 
mixture was placed in a Hofer high pressure apparatus 
(right picture) at 6 kbar for 24 h. The reaction was 
quenched by addition of sat. aq. NaHCO3 solution 
(120 mL) and H2O (60 mL). The layers were separated and the aqueous layer was extracted 
with CH2Cl2 (3 × 50 mL) and the combined organic layers were dried over Na2SO4. After 
filtration and concentration in vacuo, the crude product was purified by flash column 
chromatography (pentane:CH2Cl2 5:11:1) on silica to afford spirocycle 15 (897 mg, 
2.19 mmol, 74%) as a white solid. 
 
Data for 14: Rf: 0.38 (hexanes:EtOAc 19:1); 1H NMR (400 MHz, C6D6): δ = 5.48 – 5.40 (m, 
1H), 3.80 (dd, J = 6.9, 3.8 Hz, 1H), 2.92 (d, J = 17.4 Hz, 1H), 2.61 (dt, J = 13.0, 8.1 Hz, 1H), 
2.32 – 2.11 (m, 3H), 2.02 (dd, J = 13.8, 4.8 Hz, 1H), 1.90 – 1.73 (m, 2H), 1.69 – 1.59 (m, 4H), 
1.46 (td, J = 12.2, 6.2 Hz, 1H), 0.98 (s, 9H), 0.96 (s, 3H), 0.86 (d, J = 15.2 Hz, 1H), 0.77 (d, 
J = 15.2 Hz, 1H), 0.08 (s, 3H), 0.04 (s, 9H), 0.02 (s, 3H) ppm; 13C NMR (100 MHz, C6D6): δ = 
212.2, 133.1, 120.2, 75.9, 55.8, 49.8, 34.1, 31.9, 30.5, 28.4, 26.1, 25.8, 25.7, 23.5, 18.5, 
18.3, 1.5, −4.2, −4.4 ppm; IR (ATR): ߥmax = 2952 (w), 2929 (w), 2896 (w), 2857 (w), 
1706 (m), 1471 (w), 1463 (w), 1445 (w), 1432 (w), 1377 (w), 1304 (w), 1249 (m), 1204 (w), 
1193 (w), 1147 (w), 1085 (m), 1066 (m), 1023 (w), 944 (m), 959 (w), 937 (w), 914 (w), 
880 (m), 857 (m), 832 (s), 804 (m), 772 (s), 685 (m), 666 (m), 629 (w), 611 (w), 589 (w), 
557 (w) cm−1; melting point: 95.0 – 97.0 °C; HRMS (ESI): calc. for C23H44O2Si2 [M+H]+: 
409.2953, found: 409.2958. 
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Spirocycle 16 To a stirred solution of cyclohexene 15 (36.5 mg, 89.3 μmol, 1.0 eq) in DMSO 
(1 mL) was added H2O (54 μL) and KOtBu (10.0 mg, 89.3 μmol, 1.0 eq) and the resulting 
reaction mixture was heated to 90 °C for 30 min. The reaction was quenched by addition of 
sat. aq. NH4Cl solution (15 mL). The layers were separated and the aqueous layer was 
extracted with EtOAc (4 × 10 mL) and the combined organic layers were dried over Na2SO4. 
After filtration and concentration in vacuo, the crude product was purified by flash column 
chromatography (hexanes:EtOAc 2:1) on silica to afford spirocycle 16 (9.2 mg, 41.4 mmol, 
46%) as a white solid. Crystallization from hexanes/CH2Cl2 afforded crystals suitable for 
single crystal X-ray diffraction analysis. 
 
Data for 16: Rf: 0.34 (hexanes:EtOAc 1:1); 1H NMR (800 MHz, CD2Cl2): δ = 5.34 (dd, 
J = 4.5, 1.7 Hz, 1H), 4.18 (dd, J = 11.4, 3.5 Hz, 1H), 2.76 (td, J = 13.9, 6.7 Hz, 1H), 2.26 – 
2.21 (m, 1H), 2.18 – 2.12 (m, 2H), 2.08 (dddd, J = 13.0, 7.0, 4.9, 2.4 Hz, 1H), 1.88 – 1.82 (m, 
2H), 1.75 – 1.67 (m, 2H), 1.60 – 1.56 (m, 4H), 1.50 (s, 1H), 1.03 (s, 3H), 0.69 (s, 3H) ppm; 
13C NMR (200 MHz, CD2Cl2): δ = 213.0, 131.8, 121.1, 72.2, 54.8, 44.5, 35.7, 31.5, 27.8, 
27.5, 26.9, 23.4, 21.3, 15.7 ppm; IR (ATR): ߥmax = 3448 (br w), 2965 (m), 1702 (s), 1451 (w), 
1432 (m), 1367 (w), 1328 (w), 1288 (w), 1225 (w), 1150 (w), 1106 (w), 1065 (m), 1040 (m), 
1019 (m), 966 (m), 826 (w), 801 (w), 761 (w), 726 (w) cm−1; melting point: 95.8 – 98.6 °C; 
HRMS (EI): calc. for C14H20O [M-H2O]+: 204.1509, found: 204.1508. 
 
 
 
Alkene 17 To a stirred suspension of Nysted reagent (20% in THF, 46.8 mL, 21.1 mmol, 
10.8 eq) was added TiCl4 (1.0 M in toluene, 19.6 mL, 19.6 mmol, 10.0 eq) at 0 °C followed by 
ketone 15 (800 mg, 1.96 mmol, 1.0 eq) in THF (20 mL) and the resulting reaction mixture 
was stirred at 50 °C for 18 h. The reaction was quenched by addition of sat. aq. NH4Cl 
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solution (200 mL),  brine (150 mL) and aq. HCl solution (1.0 M, 100 mL). The layers were 
separated and the aqueous layer was extracted with pentane/Et2O (1:1, 3 × 150 mL) and 
Et2O (100 mL) and the combined organic layers were washed with brine (150 mL) and dried 
over Na2SO4. After filtration and concentration in vacuo, the crude product was purified by 
flash column chromatography (pentane) on silica to afford enone 17 (540 mg, 1.33 mmol, 
68%) as a white solid.  
 
Data for 17: Rf: 0.88 (hexanes); 1H NMR (400 MHz, C6D6): δ = 5.34 (s, 1H), 4.98 (s, 1H), 
4.74 (s, 1H), 3.75 (dd, J = 11.1, 4.8 Hz, 1H), 2.28 – 1.98 (m, 4H), 1.77 – 1.49 (m, 9H), 1.22 
(d, J = 15.3 Hz, 1H), 1.02 (s, 9H), 1.01 (s, 3H), 0.76 (d, J = 15.3 Hz, 1H), 0.20 (s, 9H), 0.13 
(s, 3H), 0.10 (s, 3H) ppm; 13C NMR (100 MHz, C6D6): δ = 148.0, 133.0, 120.3, 111.9, 76.9, 
47.7, 46.5, 33.2, 31.4, 30.3, 28.0, 26.3, 26.2, 25.0, 23.7, 18.5, 15.9, 1.9, −3.8, −4.0 ppm; IR 
(ATR): ߥmax = 2954 (m), 2932 (m), 2896 (m), 2871 (w), 2857 (m), 1632 (w), 1462 (w), 1446 
(w), 1408 (w), 1379 (w), 1364 (w), 1249 (m), 1234 (w), 1151 (w), 1093 (m), 1084 (m), 1064 
(s), 988 (w), 956 (w), 894 (s), 835 (s), 802 (m), 773 (s), 692 (w), 680 (w), 668 (w) cm−1; 
melting point: 83.0 – 84.0 °C; HRMS (EI): calc. for C24H46OSi2 [M]+: .406.3082, found: 
406.3073. 
 
 
 
 
One step protocol for 17 A solution of exocyclic alkene 14 (227 mg, 666 μmol, 1.0 eq) in 
CH2Cl2 (2.0 mL) was cooled to –78 °C. Isoprene (265 µL, 2.64 mmol, 4.0 eq) and BCl3 (1.0 M 
in heptane, 865 µL, 865 µmol, 1.3 eq) were added and the reaction was stirred for 1 h. To a 
separate flask charged with a suspension of Nysted reagent (20% in THF, 13.5 mL, 6.09 
mmol, 9.1 eq) was added TiCl4 (1 M in CH2Cl2, 5.54 ml, 5.54 mmol, 8.3 eq) at 0 °C turning 
the suspension brown. As soon as the addition of TiCl4 was complete, the reaction was 
heated to 60 °C. When the Diels–Alder reaction was deemed complete by TLC the yellow 
solution was cannulated into the suspension of Nysted reagent and allowed to react 
overnight. After completion, it was cooled to 0 °C, quenched with methanol. The solution was 
filtered through a pad of silica (EtOAc). The crude organic solution was concentrated and 
diluted with methanol. This methanol layer was extracted with hexanes and dried over 
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Na2SO4. After filtration and concentration in vacuo, the crude product was purified by flash 
chromatography (pentane) on silica to afford alkene 17 (115 mg, 283 μmol, 42% yield) as a 
white solid.  
 
 
 
Alcohol X To a stirred solution of silane X (530 mg, 1.30 mmol, 1.0 eq) in DMSO/benzene 
(20 mL, 3:2) was added H2O (23.5 μL, 1.30 mmol, 1.0 eq) and KOtBu (168 mg, 1.50 mmol, 
1.15 eq) at r.t. and the resulting reaction mixture was stirred at 90 °C for 17 h. The reaction 
was quenched by addition of sat. aq. NH4Cl solution (30 mL). The layers were separated and 
the aqueous layer was extracted with EtOAc (3 × 40 mL) and the combined organic layers 
were washed with brine (2 × 40 mL) and dried over Na2SO4. After filtration and concentration 
in vacuo, the crude product was purified by flash column chromatography (hexanes:EtOAc 
9:1) on silica to afford alcohol X (285 mg, 1.29 mmol, 99%) as a white solid.  
 
Data for X: Rf: 0.23 (hexanes:EtOAc 9:1); 1H NMR (400 MHz, C6D6): δ = 5.31 (s, 1H), 4.93 
(t, J = 1.8 Hz, 1H), 4.69 (s, 1H), 3.50 (dt, J = 11.6, 4.9 Hz, 1H), 2.08 (dddd, J = 15.1, 7.3, 3.7, 
1.7 Hz, 2H), 2.00 – 1.87 (m, 2H), 1.66 – 1.49 (m, 7H), 1.43 – 1.30 (m, 2H), 0.94 (s, 3H), 0.79 
(s, 3H), 0.68 (d, J = 5.1 Hz, 1H) ppm; 13C NMR (100 MHz, C6D6): δ = 147.5, 132.6, 120.5, 
111.9, 73.0, 45.6, 42.2, 32.7, 30.5, 29.6, 27.9, 26.0, 23.6, 20.6, 15.3 ppm; IR (ATR): ߥmax = 
3376 (br w), 2934 (m), 2905 (m), 2830 (w), 1638 (w), 1472 (w), 1449 (m), 1428 (m), 
1386 (m), 1364 (m), 1258 (w), 1226 (w), 1160 (w), 1079 (m), 1066 (m), 1040 (s), 1023 (s), 
983 (s), 957 (m), 890 (s), 822 (w), 802 (m), 762 (w), 694 (m), 666 (w) cm−1; melting point: 
69.0 – 71.0 °C; HRMS (EI): calc. for C15H24O1 [M]+: 220.1822, found: 220.1826. 
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Imidazole 19 To a stirred solution of alcohol 18 (287 mg, 1.30 mmol, 1.0 eq) in THF (15 mL) 
was added TCDI (1.16 g, 6.52 mmol, 5.0 eq) and DMAP (478 mg, 3.91 mmol, 3.0 eq) at r.t. 
and the resulting reaction mixture was stirred at 60 °C for 16 h. After concentration in vacuo, 
the crude product was purified by flash column chromatography (hexanes:EtOAc 10:1) on 
silica to afford imidazole 19 (396 mg, 1.20 mmol, 92%) as a colorless oil. 
 
Data for 19: Rf: 0.33 (hexanes:EtOAc 4:1); 1H NMR (400 MHz, C6D6): δ = 8.37 (s, 1H), 7.43 
(s, 1H), 6.96 (s, 1H), 5.80 (dd, J = 12.1, 4.7 Hz, 1H), 5.24 (s, 1H), 4.87 (t, J = 1.6 Hz, 1H), 
4.66 (s, 1H), 2.05 (td, J = 14.0, 13.5, 4.4 Hz, 1H), 1.97 – 1.75 (m, 4H), 1.65 – 1.50 (m, 6H), 
1.40 – 1.25 (m, 2H), 0.72 (s, 3H), 0.70 (s, 3H) ppm; 13C NMR (100 MHz, C6D6): δ = 184.4, 
145.7, 136.7, 132.9, 131.6, 119.8, 118.2, 113.1, 87.1, 46.1, 41.8, 29.6, 29.09, 27.7, 27.4, 
26.1, 23.5, 20.2, 17.6 ppm; IR (ATR): ߥmax = 2965 (w), 2940 (w), 2907 (w), 2877 (w), 
2830 (w), 1640 (w), 1530 (w), 1471 (w), 1458 (m), 1382 (s), 1336 (s), 1280 (s), 1280 (s), 
1228 (s), 1195 (m), 1092 (m), 1046 (w), 992 (m), 970 (s), 933 (m), 895 (s), 822 (m), 803 (w), 
779 (w), 735 (m), 655 (w) cm−1; HRMS (EI): calc. for C19H26N2OS [M]+: 330.1760, found: 
330.1768. 
 
 
 
10-Bromo-β-chamigrene (9) To a solution of 19 (253 mg, 766 μmol, 1.0 eq) and α-
bromoacid 21 (661 mg, 3.80 mmol, 5.0 eq) at 60 °C in benzene (24 mL, degassed by 
sparging with N2 for 15 min) was added hyponitrite 20 (566 mg, 3.04 mmol, 4.0 eq) in 
benzene (24 mL, degassed by sparging with N2 for 15 min) over 2 h by syringe pump 
followed by stirring for an additional 30 min. After concentration in vacuo, the crude product 
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was purified by flash chromatography (pentane:Et2O 1:04:1) to afford the desired product 9 
(120 mg, 424 μmol, 56%) as colorless oil in a 93:7 diastereomeric mixture. This compound 
was found to be volatile over prolonged periods under high vacuum. 
 
Data for 10-bromo-β-chamigrene (9): Rf: 0.46 (pentane); IR (ATR): ߥmax = 2933 (s), 
2854 (s), 1638 (m), 1453 (s), 1389 (m), 1369 (m), 1341 (w), 1314 (w), 1288 (w), 1253 (w), 
1221 (w), 1157 (m), 1121 (w), 1064 (m), 1020 (w), 981 (w), 943 (w), 894 (s), 870 (s), 820 (w), 
802 (w), 778 (w), 724 (w), 677 (w) cm−1;HRMS (EI): calc. for C15H23Br79 [M]+: 282.0978, 
found: 282.0987. 
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NMR-data:94c 
 
No. 
1H NMR Isolation  
300 MHz, CDCl3 
[ppm] 
1H NMR Synthetic 
600 MHz, CDCl3 
[ppm] 
13C NMR  
Isolation  
75 MHz, CDCl3 
[ppm] 
13C NMR 
Synthetic 
150 MHz, CDCl3 
[ppm] 
1 2.04 (br d, J = 15.3 Hz, 1H) 2.23 (br d, J = 15.3 Hz, 1H) 
2.10 – 2.00 (m, 1H) 
2.28 – 2.19 (m, 1H) 30.3 30.3 
2 5.28 (br s, 1H) 5.27 (s, 1H) 119.7 119.7 
3   132.7 132.7 
4 1.62 (m, 1H) 1.76 (m, 1H) 
1.68 – 1.58 (m, 1H) 
1.78 – 1.73 (m, 1H) 27.5 27.5 
5 1.58 (m, 1H) 1.88 (dm, J = 10.8 Hz, 1H) 
1.68 – 1.58 (m, 1H) 
1.90 – 1.85 (m, 1H) 25.6 25.6 
6   47.0 47.0 
7   145.6 145.6 
8 
2.14 (ddd, J = 13.8, 4.8, 
2.2 Hz, 1H) 
2.37 (ddd, J = 13.8, 13.8, 
5.2 Hz, 1H) 
2.14 (ddd, J = 13.7, 4.9, 
2.3 Hz, 1H) 
2.36 (tdt, J = 13.9, 4.9, 
1.4 Hz, 1H) 
33.9 33.0 
9 
2.06 (dddd, J = 13.8, 12.8, 
12.7, 4.8 Hz, 1H) 
2.23 (dddd, J = 12.8, 5.2, 
4.4, 2.2 Hz, 1H) 
2.10 – 2.00 (m, 1H) 
 
2.28 – 2.19 (m, 1H) 
35.7 35.7 
10 4.65 (dd, J = 12.7, 4.4 Hz, 1H) 
4.65 (dd, J = 12.9, 4.5 Hz, 
1H) 66.1 66.1 
11   42.7 42.7 
12 0.94 (s, 3H) 0.94 (s, 3H) 17.5 17.5 
13 1.10 (s, 3H) 1.10 (s, 3H) 23.9 23.8 
14 4.61 (br s, 1H) 4.93 (t, J = 1.8 Hz, 1H) 
4.61 (s, 1H) 
4.93 (t, J = 1.7 Hz, 1H) 112.6 112.6 
15 1.54 (br s, 3H) 1.57 (s, 3H) 23.1 23.1 
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3,4-Dihydroxy-10-bromo-β-chamigrene (25) To a solution of spirocycle 9 (33.0 mg, 
117 μmol, 1.0 eq) in THF/Water (5:1, 8.3 mL) was added NMO (20.0 mg, 176 μmol, 1.5 eq) 
and OsO4 (2.5% in tBuOH, 58.0 µl, 5.85 μmol, 0.05 eq) at 0 °C. The reaction was allowed to 
stir for 2 h followed by dilution with H2O/sat. aq. Na2S2O4 (1:1). The layers were separated 
and the aqueous layer was extracted with EtOAc and the combined organic layers were 
washed with brine and dried over Na2SO4. After filtration and concentration in vacuo, the 
crude product was purified by flash column chromatography (pentane:EtOAc 7:3) on silica to 
afford 25 (36.0 mg, 113 μmol, 97%) as a white solid. 
 
Data for 25: Rf: 0.19 (pentane:EtOAc 7:3); 1H NMR (800 MHz, CDCl3): δ = 5.13 (s, 1H), 4.85 
(s, 1H), 4.58 (dd, J = 12.9, 4.7 Hz, 1H), 3.74 (dd, J = 11.3, 5.1 Hz, 1H), 2.35 – 2.29 (m, 1H), 
2.26 (dtd, J = 14.1, 5.0, 2.1 Hz, 1H), 2.10 (ddd, J = 13.3, 5.4, 1.9 Hz, 1H), 2.04 (qd, J = 12.9, 
5.4 Hz, 1H), 1.95 – 1.88 (m, 2H), 1.76 – 1.70 (m, 1H), 1.70 – 1.65 (m, 1H), 1.57 (dt, J = 14.2, 
3.4 Hz, 1H), 1.21 (s, 3H), 1.21 – 1.17 (m, 1H), 1.16 (s, 3H), 0.97 (s, 3H) ppm; 13C NMR 
(200 MHz, CDCl3): δ = 147.0, 113.7, 71.8, 70.6, 65.0, 49.8, 43.8, 36.1, 33.8, 33.4, 33.3, 27.3, 
23.7, 22.7, 17.5 ppm; IR (ATR): ߥmax = 3380 (s), 2972 (s), 1638 (w), 1452 (m), 1393 (m), 
1373 (m), 1264 (w), 1198 (w), 1139 (w), 1055 (s), 1031 (m), 967 (w), 902 (s), 872 (w), 
778 (w), 737 (w), 670 (w) cm−1; melting point: 145.6 – 149.5 °C; HRMS (ESI): calc. for 
C17H28Br79O4 [M+AcO]– : 375.1171, found: 375.1179. 
This diastereomer corresponds to a naturally occurring chamigrane96c initially reported by 
Stonik and coworkers but does not match the reported spectrum. This discrepancy was also 
noted by Snyder and coworkers in their recent report.166  
 
 
 
3-Hydroxy-10-bromo-β-chamigren-4-one (S8) To a solution of diol 25 (24.0 mg, 75.6 μmol, 
1.0 eq) in EtOAc (2.8 mL) was added IBX (55.0 mg, 196 μmol, 2.6 eq). The reaction was 
Supporting information for Chapter 2.2.2  255 
 
vigorously stirred at 50 °C for 24 h. The reaction was filtered over a pad of celite (EtOAc). 
After concentration in vacuo, the crude product was purified by flash column chromatography 
(pentane/EtOAc 9:1) on silica to afford ketone S8 (19.0 mg, 60.3 μmol, 80%) as a white solid. 
 
Data for S8: Rf: 0.29 (pentane:EtOAc 9:1); 1H NMR (800 MHz, CDCl3): δ = 5.00 (s, 1H), 
4.71 (s, 1H), 4.61 (dd, J = 12.9, 4.4 Hz, 1H), 2.94 (d, J = 14.8 Hz, 1H), 2.56 (dd, J = 14.8, 
3.2 Hz, 1H), 2.31 – 2.19 (m, 3H), 2.16 – 2.11 (m, 1H), 2.06 (qd, J = 12.6, 4.9 Hz, 1H), 1.87 
(dq, J = 13.6, 3.4 Hz, 1H), 1.83 (dt, J = 14.4, 3.3 Hz, 1H), 1.64 (s, 1H), 1.48 (td, J = 14.1, 
3.2 Hz, 1H), 1.25 (s, 3H), 1.22 (s, 3H), 0.96 (s, 3H) ppm; 13C NMR (200 MHz, CDCl3): 
δ = 210.7, 147.4, 114.9, 73.4, 63.9, 52.3, 43.2, 42.8, 35.3, 34.4, 33.7, 24.1, 24.0, 22.9, 
17.6 ppm; IR (ATR): ߥmax = 3421 (b), 2975 (m), 2940 (s), 1712 (w), 1638 (m), 1452 (m), 
1392 (m), 1374 (m),1295 (w), 1202 (w), 1153 (w), 1091 (m), 1038 (w), 933 (w), 966 (w), 
908 (m), 871 (m), 780 (w) cm-1; melting point: 139.5 °C; HRMS (ESI) calc. for C17H26Br79O4  
[M+AcO]–: 373.1020, found: 373.1022. 
 
 
Dactylone (2) To a solution of S8 (15.0 mg, 47.6 μmol, 1.0 eq) in pyridine (750 µl) was 
added thionylchloride (23.2 µl, 319 μmol, 6.7 eq) dropwise at r.t. After 5 min, the reaction was 
quenched by addition of H2O. The layers were separated and the aqueous layer was 
extracted with Et2O and the combined organic layers were washed with aq. 10% HCl 
solution, sat. aq. NaHCO3 solution and brine and was dried over Na2SO4. After filtration and 
concentration in vacuo, the crude product was purified by flash column chromatography 
(pentane:EtOAc 19:1) on silica to afford dactylone (2, 11.5 mg, 38.7 μmol, 81%) as a white 
solid. Isomerically pure dactylone (2) could be obtained by further purification by reverse-
phase semipreparative HPLC (30% MeCN + 0.1% formic acid/70% H2O + 0.1% formic acid) 
on a Microsorb 60 C18 column.  
 
Data for dactylone (2): Rf: 0.65 (pentane:Et2O 9:1); IR (ATR): ߥmax = 2975 (m), 2947 (m), 
2922 (m), 2359 (w), 2332 (w), 1670 (s), 1450 (m), 1431 (m), 1390 (m), 1371 (m), 1297 (w), 
1260 (w), 1196 (m), 1159 (w), 1113 (m), 904 (m), 872 (m), 782 (m), 716 (w) cm−1; HRMS (EI) 
calc. for C15H21Br79O [M]+: 296.0776 , found: 296.0781. 
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UV-Vis Spectrum (c = 0.05 mM in CH2Cl2) 
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NMR-data:167 
 
No. 
1H NMR Isolation  
300 MHz, CDCl3 
[ppm] 
1H NMR Synthetic 
400 MHz, CDCl3 
[ppm] 
13C NMR  
Isolation  
75 MHz, CDCl3 
[ppm] 
13C NMR 
Synthetic 
100 MHz, CDCl3 
[ppm] 
1 2.65 (m, 2H) 2.68 – 2.61 (m, 2H) 33.7 33.6 
2 6.50 (m, 1H) 6.50 (td, J = 4.5, 1.4 Hz, 1H) 140.7 141.3 
3   135.5 135.4 
4   198.8 199.5 
5 2.74 (br d, J = 16.5 Hz, 1H) 2.57 (d, J = 16.5 Hz, 1H) 
2.75 (d, J = 16.4 Hz, 1H) 
2.56 (d, J = 16.4 Hz, 1H) 44.2 44.1 
6   51.4 51.2 
7   146.1 146.0 
8 2.37 (m, 1H) 2.17 (m, 1H) 
2.41 – 2.31 (m, 1H) 
2.20 – 2.11 (m, 1H) 30.0 29.7 
9 2.26 (m, 1H) 2.11 (m, 1H) 
2.29 – 2.21 (m, 1H) 
2.11 – 2.02 (m 1H) 35.5 35.3 
10 4.52 (dd, J = 12.5, 4.5 Hz, 1H) 
4.53 (dd, J = 12.5, 4.5 Hz, 
1H) 63.0 63.1 
11   43.2 43.1 
12 1.73 (d, J = 1.8 Hz, 3H) 1.73 (s, 3H) 15.3 15.3 
13 0.99 (s, 3H) 0.99 (s, 3H) 25.1 25.0 
14 4.98 (br d, J = 1.5 Hz, 1H) 4.61 (s, 1H) 
4.97 (s, 1H) 
4.60 (s, 1H) 114.0 114.2 
15 1.19 (s, 3H) 1.19 (s, 3H) 17.7 17.5 
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Aplydactone (1) A solution of 2 (11.0 mg, 37.0 μmol, 1.0 eq) in benzene (11 mL) was 
degassed (N2 sparging, 15 min) and sealed in a screw capped tube. This was irradiated 
using a Rayonet lamp (350 nm, 250 W) for 24 h. After concentration in vacuo, the crude 
product was purified by flash column chromatography (pentane:CH2Cl2 1:1) on silica to afford 
aplydactone (1, 10.5 mg, 35.3 μmol, 95% yield) as a white solid.  
Solar irradiation of dactylone (2): Dactylone (2) (1.0 mg, 3.36 μmol, 1.0 eq) was dissolved 
in CDCl3 (0.5 mL) in a NMR tube. This was irradiated in an Erlenmeyer flask filled with water 
under Munich sunlight for 6 days on top of the LMU Chemistry Building (Munich summer 
time). The NMR spectrum reveals complete consumption of the starting material during this 
time period.  
 
Data for aplydactone (1): Rf: 0.64 (pentane:CH2Cl2 1:1); IR (ATR): ߥmax = 3423 (w), 
2925 (s), 2888 (m), 1733 (m), 1717 (s), 1683 (m), 1669 (m), 1653 (m), 1457 (m), 1446 (m), 
1260 (w), 1093 (w), 1025 (w), 803 (w); HRMS (EI) calc. for C15H21Br79O [M]+: 296.0770 , 
found: 296.0787.  
 
 
Solar Irradiation of dactylone (2) 
 
  
Supporting information for Chapter 2.2.2  259 
 
NMR-data:95 
 
 
No. 
1H NMR Isolation  
300 MHz, C6D6 
[ppm] 
1H NMR Synthetic 
800 MHz, C6D6 
[ppm] 
13C NMR  
Isolation  
75 MHz, C6D6 
[ppm] 
13C NMR 
Synthetic 
200 MHz, C6D6 
[ppm] 
1   40.2 40.2 
2 1.29 (d, J = 11.0 Hz, 1H) 1.81 (d, J = 11.0 Hz, 1H) 
1.29 (d, J = 10.6 Hz, 1H) 
1.80 (d, J = 10.9 Hz, 1H) 40.6 40.6 
3   48.9 48.9 
4   210.4 210.5 
5 
2.12 (d, J = 16.5 Hz, 1H) 
2.51 (dd, J = 16.5, 2.7 Hz, 
1H) 
2.13 (d, J = 16.4 Hz, 1H) 
2.51 (dd, J = 16.4, 2.8 Hz, 
1H) 
42.9 42.9 
6   47.1 47.1 
7   38.2 38.3 
8 3.90 (m, 1H) 3.89 (dd, J = 11.9, 3.9 Hz, 1H) 65.7 65.8 
9 1.69 (m, 2H) 1.74 – 1.63 (m, 2H) 31.0 31.0 
10 1.30 (m, 2H) 1.35 – 1.26 (m, 2H) 33.8 33.9 
11 1.58 (d, J = 5.6 Hz, 1H) 1.58 (d, J = 5.6 Hz, 1H) 45.5 45.5 
12 
1.05 (d, J = 11.3 Hz, 1H) 
1.72 (ddd, J = 11.3, 5.6, 2.7 
Hz, 1H) 
1.04 (d, J = 11.3 Hz, 1H) 
1.74 – 1.63 (m, 1H) 31.7 31.7 
13 1.09 (s, 3H) 1.10 (s, 3H) 18.6 18.7 
14 0.75 (s, 3H) 0.75 (s, 3H) 18.3 18.3 
15 0.70 (s, 3H) 0.70 (s, 3H) 22.9 22.9 
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2-Hydroxy-10-bromo-β-chamigrene (26) To a stirred solution of 9 (15.0 mg, 53.0 μmol, 
1.0 eq) in CH2Cl2 (1 mL) was added SeO2 (11.0 mg, 99.1 μmol, 1.9 eq) at r.t. The reaction 
was allowed to stir for 25 h. The reaction was filtered over a pad of celite (EtOAc). After 
concentration in vacuo, the crude product was purified by flash column chromatography 
(pentane:CH2Cl2:EtOAc 9:0.5:0.5) on silica to afford alcohol 26 (6.0 mg, 20.1 μmol, 38%) as 
a colorless oil. This compound was found to be volatile over prolonged periods under high 
vacuum.  
 
Data for 26: Rf: 0.19 (pentane:CH2Cl2:EtOAc 9:0.5:0.5); 1H NMR (800 MHz, CDCl3): 
δ = 5.43 (s, 1H), 4.93 (s, 1H), 4.64 (dd, J = 13.0, 4.5 Hz, 1H), 4.59 (s, 1H), 3.74 (s, 1H), 2.46 
(td, J = 13.9, 5.0 Hz, 1H), 2.33 – 2.24 (m, 3H), 2.22 – 2.17 (m, 1H), 2.11 – 2.03 (m, 2H), 1.71 
(s, 3H), 1.58 (m, 1H, overlap), 1.15 (s, 3H), 0.93 (s, 3H) ppm; 13C NMR (200 MHz, CDCl3): δ 
= 145.3, 134.8, 122.7, 112.6, 69.1, 65.1, 48.8, 42.8, 35.9, 35.6, 33.1, 30.5, 23.9, 18.4, 
16.9 ppm; IR (ATR): ߥmax = 3352 (s), 2973 (s), 2851 (m), 2361 (w), 2340 (w), 1708 (w), 
1679 (w), 1639 (w), 1453 (m), 1390 (m), 1369 (m), 1254 (w), 1181 (w), 1159 (w), 1042 (m), 
1023 (m), 997 (m), 896 (m), 872 (m) 779 (w); HRMS (EI) calc. for C15H21Br79O [M]+: 
298.0932, found: 298.0914. 
 
 
 
10-Epi-dactylone (3) To a solution of 22 (7.5 mg, 25.1 μmol, 1.0 eq) in CH2Cl2 (1.0 mL) was 
added MnO2 (45.0 mg, 518 μmol, 21 eq) and the resulting reaction mixture was stirred at r.t. 
overnight. The reaction was filtered over a pad of celite (EtOAc). After concentration in 
vacuo, the crude product was purified by flash column chromatography (hexanes: CH2Cl2 
2:3) on silica to afford 10-epi-dactylone (3, 5.0 mg, 16.7 mmol, 68%) as a colorless oil. 
 
Data for 10-epi-dactylone (3): Rf: 0.70 (pentanes:EtOAc  9:1); IR (ATR): ߥmax = 2925 (m), 
2872 (m), 1718 (s), 1683 (m), 1675 (w), 1456 (w), 1376 (w), 1367 (w), 1299 (w), 1279 (w), 
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1237 (w), 1188 (w), 1131 (w), 1112 (w), 984 (w), 847 (w), 779 (w) cm−1; HRMS (EI) calc. for 
C15H21Br79O [M]+: 296.0770 , found: 296.0787. 
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NMR-data:96c 
 
No. 
1H NMR Isolation  
300 MHz, CDCl3 
[ppm] 
1H NMR Synthetic 
400 MHz, CDCl3 
[ppm] 
13C NMR  
Isolation  
75 MHz, CDCl3 
[ppm] 
13C NMR 
Synthetic 
100 MHz, CDCl3 
[ppm] 
1 2.53 (dm, J = 18.9 Hz, 1H) 2.67 (dm, J = 18.9 Hz, 1H) 
2.52 (dd, J = 18.4, 5.5 Hz, 
1H) 
2.71 – 2.59 (m, 1H) 
32.6 32.5 
2 6.63 (m, 1H) 6.62 (ddd, J = 5.9, 2.5, 1.4 Hz, 1H) 142.9 143.1 
3   134.6 134.5 
4   198.2 198.4 
5 
2.81 (dd, J = 14.9, 2.3 Hz, 
1H) 
2.65 (d, J = 14.9 Hz, 1H) 
2.80 (dd, J = 14.8, 2.4 Hz, 
1H) 
2.71 – 2.59 (m, 1H) 
43.2 43.0 
6   51.8 51.7 
7   144.3 144.1 
8 2.42 (m, 1H) 2.15 (m, 1H) 
2.47 – 2.37 (m, 1H) 
2.18 – 2.10 (m, 1H) 31.7 31.6 
9 2.03 (m, 1H) 2.25 (m, 1H) 
2.09 – 1.97 (m, 1H) 
2.29 – 2.20 (m, 1H) 35.4 35.3 
10 4.48 (dd, J = 12.4, 4.5 Hz, 1H) 
4.48 (dd, J = 12.5, 4.5 Hz, 
1H) 63.6 63.7 
11   43.1 43.0 
12 1.00 (s, 3H) 0.99 (s, 3H) 17.3 17.2 
13 1.20 (s, 3H) 1.19 (s, 3H) 24.8 24.8 
14 5.00 (br s, 1H) 4.54 (s, 1H) 
4.98 (s, 1H) 
4.54 (s, 1H) 114.6 114.7 
15 1.71 (dt, J = 2.6, 1.4 Hz, 3H) 
1.70 (dt, J = 2.6, 1.3 Hz, 
3H) 15.2 15.3 
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8-epi-isoaplydactone (8) A solution of 3 (3.5 mg, 11.8 μmol, 1.0 eq) in benzene (4.5 mL) 
was degassed (N2 sparging, 15 min) and sealed in a screw capped tube. This was irradiated 
using a Rayonet lamp (350 nm, 250 W) for 3 h. After concentration in vacuo, the crude 
product was purified by flash column chromatography (hexanes: CH2Cl2 2:3) to afford 8-epi-
isoaplydactone (8, 3.4 mg, 11,4 μmol, 97%) as a white solid. 
 
Data for 8-epi-isoaplydactone (8): Rf: 0.65 (pentanes:Et2O 9:1); IR (ATR): ߥmax = 2960 (s), 
2923 (s), 2850 (m), 1688 (w), 1468 (m), 1447 (m), 1411 (w), 1388 (w), 1367 (w), 1295 (w), 
1281 (w), 1259 (w), 1192 (w), 1092 (w), 1052 (w), 970 (w), 861 (w), 780 (w), 711 cm−1; 
HRMS (EI) calc. for C15H21BrO [M]+ : 296.0770 , found: 296.0778. 
NMR-data: 
 
 
1H NMR (400 MHz, CDCl3): δ = 4.33 (dd, J = 11.5, 4.9 Hz, 1H, H-8), 2.41 – 2.31 (m, 2H, H-5, 
H-11), 2.26 – 2.06 (m, 5H, H’-2, H’-5, H-9, H-12), 1.88 (d, J = 7.8 Hz, 1H, H-2), 1.66 (dt, J = 
14.4, 3.4 Hz, 1H, H-10), 1.42 – 1.34 (m, 2H, H’-10, H’-12), 1.27 (s, 3H, H-15), 1.11 (s, 3H, H-
13), 1.06 (s, 3H, H-14) ppm; 13C NMR (200 MHz, CDCl3): δ = 216.5 (C-4), 65.2 (C-3), 
63.9 (C-8), 56.1 (C-1), 51.1 (C-6), 48.1 (C-5), 42.3 (C-11), 40.2 (C-2), 39.5 (C-7), 37.7 (C-
12), 30.9 (C-9), 27.5 (C-14), 25.8 (C-10), 20.3 (C-15), 7.5 (C-13); 
 
  
264  Supporting information for Chapter 2.2.2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6.3.2 1H and 13C NMR spectra 
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400 MHz, CDCl3 
100 MHz, CDCl3 
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400 MHz, CDCl3 
100 MHz, CDCl3 
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400 MHz, C6D6 
100 MHz, C6D6 
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400 MHz, C6D6 
100 MHz, C6D6 
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1H, 800 MHz, C6D6 
1H, 800 MHz, C6D6 
range: 5.6 ppm − −0.2 ppm 
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13C, 200 MHz, C6D6 
13C, 200 MHz, C6D6 
range: 80 ppm − −10 ppm 
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OTMS
TBSO
13
CH3
TMS
400 MHz, C6D6 
100 MHz, C6D6 
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O
TBSO
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CH3
TMS
400 MHz, C6D6 
100 MHz, C6D6 
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1H, 400 MHz, C6D6 
1H, 400 MHz, C6D6 
range: 5.5 ppm − −0.1 ppm 
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13C, 100 MHz, C6D6 
13C, 100 MHz, C6D6 
range: 80 ppm − −10 ppm 
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800 MHz, CD2Cl2 
200 MHz, CD2Cl2 
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400 MHz, C6D6 
100 MHz, C6D6 
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600 MHz, CDCl3 
150 MHz, CDCl3 
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800 MHz, CDCl3 
200 MHz, CDCl3 
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800 MHz, CDCl3 
200 MHz, CDCl3 
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400 MHz, CDCl3 
100 MHz, CDCl3 
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800 MHz, C6D6 
200 MHz, C6D6 
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1H, 800 MHz, CDCl3 
13C, 200 MHz, CDCl3 
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13C, 100 MHz, CDCl3 
1H, 400 MHz, CDCl3 
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800 MHz, CDCl3 
200 MHz, CDCl3 
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COSY, CDCl3 
COSY, CDCl3 
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HSQC, CDCl3 
HSQC, CDCl3 
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HSQC, CDCl3 
HSQC, CDCl3 
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NOESY, CDCl3 
NOESY, CDCl3 
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6.3.3 X-ray crystallographic data 
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1. Enone 14 
 
Figure 6.7 ORTEP of the molecular structure of enone 14. 
CCDC 1493586 contains the supplementary crystallographic data for enone 14. These data 
can be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
        
Table 6.7 Crystallographic data for enone 14. 
net formula C18H36O2Si2 
Mr/g mol−1 340.65 
crystal size/mm 0.440 × 0.269 × 0.100 
T/K 123(2) 
radiation MoKα 
diffractometer 'Oxford XCalibur' 
crystal system triclinic 
space group 'P -1' 
a/Å 6.9583(4) 
b/Å 12.3699(9) 
c/Å 25.385(2) 
α/° 92.024(6) 
β/° 91.543(6) 
γ/° 101.580(5) 
V/Å3 2137.9(3) 
Z 4 
calc. density/g cm−3 1.058 
μ/mm−1 0.171 
absorption correction 'multi-scan' 
transmission factor range 0.89289–1.00000 
refls. measured 9874 
Rint ? 
mean σ(I)/I 0.0794 
θ range 4.118–28.327 
observed refls. 7319 
x, y (weighting scheme) 0.0709, 0.0000 
hydrogen refinement constr 
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refls in refinement 9874 
parameters 416 
restraints 0 
R(Fobs) 0.0537 
Rw(F2) 0.1297 
S 0.974 
shift/errormax 0.001 
max electron density/e
Å−3 
0.405 
min electron density/e Å−3 −0.434 
          2-component-twin, Rotation by 180° at (001), BASF 0.49 
 
2. Spirocycle 16 
 
Figure 6.8 ORTEP of the molecular structure of spirocycle 16 
CCDC 1493587 contains the supplementary crystallographic data for spirocycle 16. These 
data can be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
 
net formula C14H22O2 
Mr/g mol−1 222.31 
crystal size/mm 0.080 × 0.060 × 0.040
T/K 100(2) 
radiation MoKα 
diffractometer 'Bruker D8Venture' 
crystal system triclinic 
space group 'P -1' 
a/Å 7.5248(9) 
b/Å 13.2697(15) 
c/Å 13.7491(15) 
Table 6.8 Crystallographic data for spirocycle 16. 
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α/° 107.523(3) 
β/° 101.200(3) 
γ/° 100.468(3) 
V/Å3 1241.2(2) 
Z 4 
calc. density/g cm−3 1.190 
μ/mm−1 0.077 
absorption correction multi-scan 
transmission factor range 0.8824–0.9580 
refls. measured 10897 
Rint 0.0573 
mean σ(I)/I 0.0741 
θ range 3.069–25.40 
observed refls. 3314 
x, y (weighting scheme) 0.0369, 0.9403 
hydrogen refinement mixed 
refls in refinement 4493 
parameters 303 
restraints 0 
R(Fobs) 0.0586 
Rw(F2) 0.1387 
S 1.067 
shift/errormax 0.001 
max electron density/e Å−3 0.304 
min electron density/e Å−3 −0.212 
 Racemic. 
 C-H: constr, O-H: refall. 
 
 
 
 
NOTE: The computational calculations were performed by Dr. Patrick Kölle of the research 
group of Professor Regina de Vivie-Riedle, LMU Munich. Because these investigations were 
not part of this thesis, they are not reported herein. For further details see: B. S. Matsuura, P. 
Kölle, D. Trauner, R. de Vivie–Riedle, R. Meier, ACS Cent. Sci. 2017, 3, 39–46. 
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6.4 Supporting information for Chapter 4.2 
6.4.1 Experimental procedures 
119
(89%)
CH3COCl (1.1 eq), AlCl3 (2.2 eq), CH2Cl2,
0 °C, 1.5 h then r.t., 20 min
OMe
OMeMeO
O
OMe
OMe
O
OMeO
 
2-Acetyl-3,5-dimethoxyphenylacetic acid methyl ester (11) To a stirred solution of 
phenylacetic acid methyl ester 9 (5.50 g, 26.2 mmol, 1.0 eq) and acetyl chloride (2.06 mL, 
28.8 mmol, 1.1 eq) in CH2Cl2 (240 mL) at 0 °C was added AlCl3 (7.68 g, 57.6 mmol, 2.2 eq) 
and the resulting reaction mixture was stirred at 0 °C for 1.5 h. The reaction mixture was 
allowed to warm up to r.t. for 20 min before adding aq. 10% HCl solution (450 mL). The 
layers were separated and the aqueous layer was extracted with CH2Cl2 (3 × 150 mL). The 
combined organic layers were washed with brine (100 mL) and dried over Na2SO4. After 
filtration and concentration in vacuo, the crude product was purified by flash column 
chromatography (hexanes:EtOAc 3:1) on silica to afford methyl ester 11 (5.89 g, 23.3 mmol, 
89%) as a white solid. Compound 11 has been reported in the literature.168 
 
Data for 11: Rf: 0.32 (hexanes:EtOAc 3:1); 1H NMR (300 MHz, CDCl3): δ = 6.42 (d, 
J = 2.3 Hz, 1H), 6.36 (d, J = 2.3 Hz, 1H), 3.84 (s, 3H), 3.82 (s, 3H), 3.70 (s, 2H), 3.68 (s, 3H), 
2.51 (s, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ = 203.9, 171.9, 161.7, 159.6, 135.1, 123.9, 
108.4, 97.7, 55.8, 55.6, 52.1, 39.2, 32.4 ppm; IR (ATR): ߥmax = 2951 (m), 2921 (s), 2868 (m), 
2851 (m), 1719 (m), 1667 (m), 1594 (m), 1577 (m), 1457 (m), 1425 (m), 1415 (w), 1377 (m), 
1354 (m), 1320 (m), 1298 (w), 1276 (s), 1260 (m), 1196 (m), 1175 (m), 1162 (s), 1096 (s), 
1073 (s), 1039 (s), 1016 (s), 981 (m), 953 (m), 944 (m), 925 (w), 900 (w), 864 (w), 842 (m), 
834 (m), 799 (s), 765 (m), 715 (w), 693 (w), 674 (m) cm−1; melting point: 60.9 – 61.4 °C (lit.: 
58 – 60 °C)155; HRMS (EI): calc. for C13H16O5 [M]+: 252.0992, found: 252.0998. 
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6,8-Dihydroxy-1,3-dimethoxynaphthalene (12) To a stirred solution of ketone 11 (5.89 g, 
23.3 mmol, 1.0 eq) in DMF (350 mL) at r.t. was added NaH (60% dispersion in mineral oil, 
3.07 g, 76.9 mmol, 3.3 eq) and the resulting reaction mixture was stirred at r.t. for 3 h. The 
reaction was quenched by addition of sat. aq. NH4Cl solution (300 mL) and H2O (300 mL) 
followed by extraction with EtOAc (3 × 200 mL). The combined organic layers were washed 
with 10% aq. NaCl solution (4 × 200 mL), brine (200 mL) and dried over Na2SO4. After 
filtration and concentration in vacuo, the crude product was purified by flash column 
chromatography (hexanes:EtOAc 4:13:1) on silica to afford naphthalene 12 (4.77 g, 
21.7 mmol, 93%) as a slightly yellow solid. Compound 12 has been reported in the 
literature.169 
 
Data for 12: Rf: 0.18 (hexanes:EtOAc 3:1); 1H NMR (300 MHz, CDCl3): δ = 9.24 (s, 1H), 
6.55 (d, J = 2.4 Hz, 1H), 6.51 (d, J = 2.2 Hz, 1H), 6.37 (d, J = 2.4 Hz, 1H), 6.27 (d, 
J = 2.2  Hz, 1H), 5.60 (s, 1H), 3.97 (s, 3H), 3.84 (s, 3H) ppm; 13C NMR (75 MHz, CDCl3): 
δ = 158.5, 157.6, 156.4, 155.8, 138.7, 106.4, 101.3, 99.8, 98.6, 95.7, 56.2, 55.5 ppm; IR 
(ATR): ߥmax = 3429 (w), 3401 (w), 3246 (w), 2996 (w), 2921 (w), 2841 (w), 1636 (m), 
1609 (m), 1544 (w), 1526 (w), 1487 (m), 1452 (m), 1435 (w), 1397 (m), 1385 (s), 1307 (m), 
1274 (m), 1243 (m), 1205 (m), 1159 (s), 1148 (s), 1127 (s), 1085 (m), 1054 (m), 1043 (m), 
1007 (s), 936 (m), 857 (m), 836 (s), 806 (s), 768 (m), 751 (w), 725 (m) cm−1; melting point: 
124.1 – 125.5 °C (lit.:119 – 122 °C)155; HRMS (EI): calc. for C12H12O4 [M]+: 220.0730, found: 
220.0731.  
 
 
 
1,3-Dimethoxy-6,8-bis(tert-butyldimethylsilyloxy)naphthalene (13) To a stirred solution 
of naphthalene 12 (200 mg, 908 μmol, 1.0 eq) in CH2Cl2 (9 mL) at 0 °C was added 2,6-
lutidine (368 μL, 3.18 mmol, 3.5 eq) and TBSOTf (626 μL, 2.72 mmol, 3.0 eq) and the 
resulting reaction mixture was stirred at 0 °C for 1 h. The reaction was quenched by addition 
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of H2O (30 mL) followed by extraction with CH2Cl2 (3 × 20 mL). The combined organic layers 
were washed with brine (30 mL) and dried over Na2SO4. After filtration and concentration in 
vacuo, the crude product was purified by flash column chromatography (hexanes:EtOAc 
40:1) on silica to afford protected naphthalene 13 (403 mg, 898 μmol, 99%) as a white solid.  
 
Data for 13: Rf: 0.83 (hexanes:EtOAc 4:1); 1H NMR (600 MHz, CDCl3): δ = 6.69 (d, 
J = 2.3 Hz, 1H), 6.52 (d, J = 2.3 Hz, 1H), 6.29 − 6.28 (m, 2H), 3.86 (s, 3H), 3.84 (s, 3H), 1.04 
(s, 9H), 1.00 (s, 9H), 0.22 (s, 6H), 0.22 (s, 6H) ppm; 13C NMR (150 MHz, CDCl3): δ = 158.5, 
158.4, 154.5, 153.8, 139.1, 111.5, 109.5, 108.8, 97.8, 96.3, 55.3, 55.2, 26.1, 25.9, 18.7, 18.5, 
−4.1 (2C) ppm; IR (ATR): ߥmax = 3000 (w), 2956 (w), 2929 (w), 2897 (w), 2857 (w), 1619 (m), 
1602 (m), 1586 (m), 1504 (w), 1463 (m), 1453 (w), 1425 (w), 1380 (m), 1278 (m), 1255 (m), 
1203 (m), 1163 (s), 1157 (s), 1122 (m), 1054 (m), 1019 (m), 1005 (m), 941 (m), 874 (s), 
828 (s), 815 (s), 779 (s), 719 (m), 698 (m), 666 (m) cm−1; melting point: 57.7 – 58.3 °C; 
HRMS (ESI): calc. for C24H41O4Si2 [M+H]+: 449.2538, found: 449.2546.  
 
 
TIPSO
TIPSO
14
OH
HO
12
(99%)
TIPSOTf (4.8 eq),
2,6-lutidine (5.3 eq),
CH2Cl2, 0 °C to r.t., 13 h
OMe
OMe
OMe
OMe
 
1,3-Dimethoxy-6,8-bis(triisopropylsilyloxy)naphthalene (14) To a stirred solution of 
naphthalene 12 (4.77 g, 21.7 mmol, 1.0 eq) in CH2Cl2 (200 mL) at 0 °C was added  
2,6-lutidine (11.3 mL, 97.7 mmol, 4.5 eq) and TIPSOTf (23.3 mL, 86.8 mmol, 4.0 eq). The 
resulting reaction mixture was allowed to warm up to r.t. over 12 h followed by addition of 
2,6-lutidine (2.01 mL, 17.4 mmol, 0.8 eq) and TIPSOTf (4.67 mL, 17.4 mmol, 0.8 eq). The 
reaction was quenched after additional 45 min of stirring by addition of H2O (500 mL) 
followed by extraction with CH2Cl2 (3 × 200 mL). The combined organic layers were washed 
with brine (200 mL) and dried over Na2SO4. After filtration and concentration in vacuo, the 
crude product was purified by flash column chromatography (hexanes:Et2O 40:1) on silica to 
afford protected naphthalene 14 (11.4 g, 21.4 mmol, 99%) as a colorless oil which turned into 
a white solid in the freezer (−25 °C). 
 
Data for 14: Rf: 0.87 (hexanes:EtOAc 4:1); 1H NMR (600 MHz, CDCl3): δ = 6.70 (d, J = 
2.3 Hz, 1H), 6.50 (d, J = 2.3 Hz, 1H), 6.33 (d, J = 2.3 Hz, 1H), 6.27 (d, J = 2.3 Hz, 1H), 3.86 
(s, 3H), 3.83 (s, 3H), 1.36 – 1.24 (m, 6H), 1.13 – 1.11 (m, 36H)  ppm; 13C NMR (150 MHz, 
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CDCl3): δ = 158.8, 158.3, 154.9, 154.5, 139.1, 111.2, 108.5, 108.2, 97.7, 96.0, 55.3, 55.2, 
18.2, 18.1, 13.5, 12.9 ppm; IR (ATR): ߥmax = 2944 (m), 2892 (m), 2861 (m), 1619 (m), 
1604 (m), 1578 (m), 1506 (w), 1463 (m), 1423 (w), 1380 (s), 1348 (m), 1278 (m), 1257 (m), 
1205 (m), 1197 (m), 1185 (m), 1171 (s), 1157 (s), 1124 (m), 1056 (s), 1021 (m), 1013 (m), 
997 (m), 943 (m), 922 (w), 880 (s), 858 (s), 842 (m), 813 (m), 785 (s), 775 (m), 727 (w), 
680 (s) cm−1; melting point: 57.1 – 57.7 °C; HRMS (ESI): calc. for C30H53O4Si2 [M+H]+: 
533.3477, found: 533.3485. 
 
 
 
2-Chloro-1,3-dimethoxy-6,8-bis(tert-butyldimethylsilyloxy)naphthalene (15) To a stirred 
solution of protected naphthalene 13 (750 mg, 1.67 mmol, 1.0 eq) in n-hexane (15 mL) at 
−10 °C was added TMEDA (327 μL, 2.17 mmol, 1.3 eq) and n-BuLi (2.4 M in n-hexane, 
770 μL, 1.84 mmol, 1.1 eq). The resulting reaction mixture was stirred at −10 °C for 2.5 h 
followed by dropwise addition of C2Cl6 (514 mg, 2.17 mmol, 1.3 eq) dissolved in n-hexane 
(4 ml). The reaction was allowed to warm up to 0 °C over 45 min before quenching the 
reaction by addition of H2O (50 mL) followed by extraction with Et2O (3 × 100 mL). The 
combined organic layers were washed with brine (100 mL) and dried over Na2SO4. After 
filtration and concentration in vacuo, the crude product was purified by flash column 
chromatography (hexanes:Et2O 100:1) on silica to afford chloride 15 (697 mg, 1.44 mmol, 
86%) as a colorless oil which turned into a white solid in the freezer (−25 °C). 
 
Data for 15: Rf: 0.73 (hexanes:Et2O 8:1); 1H NMR (400 MHz, CD3CN): δ = 7.02 (s, 1H), 6.85 
(d, J = 2.3 Hz, 1H), 6.43 (d, J = 2.3 Hz, 1H), 3.92 (s, 3H), 3.77 (s, 3H), 1.01 (s, 9H), 1.00 (s, 
9H), 0.24 (s, 6H), 0.24 (s, 6H)  ppm; 13C NMR (100 MHz, CD3CN): δ = 155.4, 154.7, 154.5, 
153.4, 137.7, 115.6, 114.7, 111.2, 109.6, 103.7, 62.2, 56.8, 26.5, 26.0, 19.5, 18.9, −3.8, 
−4.1 ppm; IR (ATR): ߥmax = 2956 (m), 2930 (m), 2889 (w), 2859 (m), 1614 (s), 1596 (m), 
1571 (m), 1469 (w), 1463 (w), 1380 (s), 1339 (m), 1251 (s), 1197 (m), 1181 (m), 1164 (m), 
1101 (m), 1022 (w), 1004 (w), 947 (w), 877 (s), 836 (s), 781 (m) cm−1; melting point: 71.6 –
 72.7 °C; HRMS (ESI): calc. for C24H40ClO4Si2 [M+H]+: 483.2148, found: 483.2151. 
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2-Chloro-1,3-dimethoxy-6,8-bis(triisopropylsilyloxy)naphthalene (16) To a stirred 
solution of protected naphthalene 14 (2.50 g, 4.69 mmol, 1.0 eq) in n-hexane (50 mL) at 
−10 °C was added TMEDA (920 μL, 6.10 mmol, 1.3 eq) and n-BuLi (2.85 M in n-hexane, 
1.98 mL, 5.63 mmol, 1.2 eq). The resulting reaction mixture was stirred at −10 °C for 1 h 
45 min followed by dropwise addition of C2Cl6 (1.78 g, 7.50 mmol, 1.6 eq) dissolved in  
n-hexane (5 ml). The reaction was allowed to warm up to 0 °C over 45 min before quenching 
by addition of H2O (100 mL) followed by extraction with Et2O (3 × 100 mL). The combined 
organic layers were washed with brine (100 mL) and dried over Na2SO4. After filtration and 
concentration in vacuo, the crude product was purified by flash column chromatography on a 
Biotage Isolera One automated purification system (normal phase HP Ultra 100 g column, 
solvent A: hexanes, solvent B: 5% Et2O/hexanes, starting gradient: 7% B, end gradient: 
33% B, over 16 column volumes) to afford chloride 16 (2.29 g, 4.04 mmol, 86%) as a white 
solid. 
 
Data for 16: Rf: 0.49 (hexanes:Et2O 20:1); 1H NMR (400 MHz, C6D6): δ = 7.01 (d, J = 2.3 Hz, 
1H), 6.79 (d, J = 2.3 Hz, 1H), 6.63 (s, 1H), 3.78 (s, 3H), 3.31 (s, 3H), 1.49 – 1.28 (m, 6H), 
1.20 – 1.14 (m, 36H)  ppm; 13C NMR (100 MHz, C6D6): δ = 155.2, 154.9, 154.8, 153.9, 137.2, 
116.2, 114.6, 109.7, 108.8, 102.7, 61.6, 55.5, 18.3, 18.2, 13.9, 13.2 ppm; IR (ATR): ߥmax = 
2944 (m), 2892 (w), 2867 (m), 1612 (s), 1597 (w), 1568 (m), 1491 (w), 1463 (m), 1426 (w), 
1412 (w), 1380 (s), 1339 (s), 1271 (w), 1249 (s), 1198 (m), 1185 (m), 1166 (s), 1102 (s), 
1072 (w), 1024 (m), 1015 (m), 1002 (m), 948 (w), 920 (w), 881 (s), 862 (s), 819 (s), 786 (w), 
757 (m), 685 (s), 659 (m) cm−1; melting point: 75.1 – 75.8 °C; HRMS (ESI): calc. for 
C30H52ClO4Si2 [M+H]+: 567.3087, found: 567.3091. 
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Silylacetate S1 To a stirred solution of DIPA (2.89 mL, 20.6 mmol, 1.1 eq) in THF (40 mL) at 
–78 °C was added n-BuLi (2.4 M in n-hexane, 8.57 mL, 20.6 mmol, 1.1 eq) dropwise. The 
cooling bath was removed for 10 min followed by recooling to –78 °C. Ethyl 
trimethylsilylacetate (17, 3.42 ml, 18.7 mmol, 1.0 eq) was added dropwise over 8 min and the 
resulting reaction mixture was stirred for 1 h followed by addition of geranyl bromide (10, 
4.83 mL, 24.3 mmol, 1.3 eq) dissolved in THF (10 mL). The reaction mixture was allowed to 
warm up to –30 °C over 3 h. The reaction was quenched by addition of sat. aq. NH4Cl 
solution (25 mL) and H2O (25 mL) followed by extraction with Et2O (3 × 100 mL). The 
combined organic layers were washed with brine (80 mL) and dried over Na2SO4. After 
filtration and concentration in vacuo, the crude product was purified by flash column 
chromatography (hexanes:Et2O 80:1) on silica to afford silylacetate S1 (4.29 g, 14.5 mmol, 
78%) as a colorless oil. 
 
Data for S1: Rf: 0.51 (hexanes:EtOAc 20:1); 1H NMR (300 MHz, CDCl3): δ = 5.16 – 5.02 (m, 
2H), 4.09 (q, J = 7.2 Hz, 2H), 2.53 – 2.38 (m, 1H), 2.20 – 1.89 (m, 6H), 1.67 (s, 3H), 1.61 (s, 
3H), 1.59 (s, 3H), 1.23 (t, J = 7.5 Hz, 3H), 0.08 (s, 9H) ppm; 13C NMR (75 MHz, CDCl3): 
δ = 176.9, 136.1, 131.5, 124.5, 121.8, 59.9, 41.7, 40.2, 30.2, 26.7, 25.8, 17.8, 16.4, 14.6, 
−2.1 ppm; IR (ATR): ߥmax = 2962 (w), 2915 (w), 2856 (w), 1716 (s), 1445 (w), 1376 (w), 
1365 (w), 1329 (w), 1296 (w), 1250 (m), 1191 (m), 1139 (s), 1047 (w), 1009 (w), 984 (w), 
839 (s), 756 (w), 738 (m), 695 (m) cm−1; HRMS (ESI): calc. for C17H33O2Si [M+H]+: 297.2244, 
found: 297.2248. 
 
 
 
Ethyl ester 18 To a stirred solution of DIPA (2.07 mL, 14.7 mmol, 1.1 eq) in THF (40 mL) at 
–78 °C was added n-BuLi (2.5 M in n-hexane, 5.89 mL, 14.7 mmol, 1.1 eq) dropwise. The 
cooling bath was removed for 10 min followed by recooling to –78 °C. Silylacetate S1 (3.97 
g, 13.4 mmol, 1.0 eq) in THF (10 mL) was added dropwise over 15 min and the resulting 
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reaction mixture was stirred for 1 h followed by the addition of acetone (1.96 mL, 26.8 mmol, 
2.0 eq) dissolved in THF (2 mL). The reaction mixture was allowed to warm up to –30 °C 
over 4 h. The reaction was quenched by addition of sat. aq. NH4Cl solution (30 mL) and H2O 
(30 mL) followed by extraction with Et2O (3 × 60 mL). The combined organic layers were 
washed with brine (50 mL) and dried over Na2SO4. After filtration and concentration in vacuo, 
the crude product was purified by flash column chromatography (hexanes:Et2O 80:1) on 
silica to afford ethyl ester 18 (3.23 g, 12.2 mmol, 91%) as a colorless oil.  
 
Data for 18: Rf: 0.50 (hexanes:EtOAc 20:1); 1H NMR (300 MHz, CDCl3): δ = 5.11 – 5.00 (m, 
2H), 4.17 (q, J = 7.1 Hz, 2H), 3.00 (d, J = 7.7 Hz, 2H), 2.12 – 1.91 (m, 7H), 1.81 (s, 3H), 
1.67 (s, 3H), 1.65 (s, 3H), 1.59 (s, 3H), 1.28 (t, J = 7.1 Hz, 3H) ppm; 13C NMR (75 MHz, 
CDCl3): δ = 169.8, 141.8, 135.8, 131.5, 127.4, 124.4, 121.8, 60.1, 39.9, 29.0, 26.8, 25.8, 
23.1, 22.0, 17.8, 16.2, 14.5 ppm; IR (ATR): ߥmax = 2978 (w), 2916 (m), 2856 (w), 1711 (s), 
1633 (w), 1444 (m), 1375 (m), 1300 (m), 1278 (m), 1251 (w), 1206 (s), 1170 (s), 1066 (s), 
1024 (w), 985 (w), 949 (w), 841 (m), 778 (w), 696 (w) cm−1; HRMS (EI): calc. for C17H28O2 
[M]+: 264.2089, found: 264.2083. 
 
 
 
 
Alcohol S2 To a stirred solution of ethyl ester 18 (3.20 g, 12.1 mmol, 1.0 eq) in CH2Cl2 (80 
mL) at –78 °C was added DIBAL-H (1.0 M in CH2Cl2, 42.4 mL, 42.4 mmol, 3.5 eq) dropwise 
over 30 min. The resulting reaction mixture was stirred for 1 h followed by addition of sat. aq. 
Na+/K+-tartrate solution (450 mL) and H2O (300 mL). The mixture was stirred vigorously for 
1 h at r.t. whereupon the layers were separated and the aqueous phase was extracted with 
CH2Cl2 (3 × 300 mL). The combined organic layers were washed with brine (300 mL) and 
dried over Na2SO4. After filtration and concentration in vacuo, the crude product was purified 
by flash column chromatography (hexanes:Et2O 10:1) on silica to afford alcohol S2 (2.51 g, 
11.3 mmol, 93%) as a colorless oil. 
 
Data for S2: Rf: 0.28 (hexanes:EtOAc 10:1); 1H NMR (300 MHz, CDCl3): δ = 5.14 – 5.02 (m, 
2H), 4.11 (s, 2H), 2.87 (d, J = 7.0 Hz, 2H), 2.17 – 1.92 (m, 4H), 1.77 (s, 3H), 1.72 (s, 3H), 
1.68 (s, 6H), 1.60 (s, 3H), 1.17 (br s, 1H) ppm; 13C NMR (75 MHz, CDCl3): δ = 136.0, 131.7, 
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131.6, 130.2, 124.4, 122.9, 62.6, 39.9, 29.9, 26.8, 25.8, 20.7, 20.4, 17.8, 16.2 ppm; IR 
(ATR): ߥmax = 3316 (br m), 2966 (m), 2914 (m), 2853 (m), 2722 (w), 1659 (w), 1442 (m), 
1375 (m), 1328 (w), 1263 (w), 1236 (w), 1177 (w), 1141 (w), 1108 (w), 1076 (w), 994 (s), 
927 (w), 887 (w), 832 (m), 778 (w), 739 (w), 723 (w) cm−1; HRMS (EI): calc. for C15H26O [M]+: 
222.1978, found: 222.1985. 
 
 
 
Bromide 19 To a stirred solution of alcohol S2 (200 mg, 899 μmol, 1.0 eq) in CH2Cl2 (10 mL) 
at 0 °C was added PPh3 (259 mg, 987 μmol, 1.1 eq) and NBS (176 mg, 989 μmol, 1.1 eq). 
The resulting reaction mixture was stirred for 2 h. The reaction was quenched by addition of 
H2O (25 mL) followed by extraction with CH2Cl2 (3 × 15 mL) and combined organic layers 
were dried over Na2SO4. After filtration and concentration in vacuo crude product was 
purified by filtration over neutral Davisil® (Et2O) to afford bromide 19 (244 mg, 855 μmol, 
95%) as a slightly yellow oil. Due to its instability on silica and neutral aluminium oxide, 
bromide 19 was used without further purification. Compound 19 was synthesized 
previously.156 
 
Data for 19: Rf: 0.90 (hexanes:Et2O 10:1, slow degradation on silica plate); 1H NMR 
(300 MHz, C6D6): δ = 5.22 – 5.08 (m, 2H), 3.93 (s, 2H), 2.92 (d, J = 7.3 Hz, 2H), 2.20 – 2.00 
(m, 4H), 1.66 (s, 3H), 1.65 (s, 3H), 1.55 (s, 3H), 1.50 (s, 3H), 1.46 (s, 3H) ppm; 13C NMR 
(75 MHz, C6D6): δ = 136.5, 133.4, 131.3, 129.4, 124.8, 122.7, 40.2, 34.5, 30.0, 27.1, 25.9, 
20.8, 20.4, 17.8, 16.2 ppm; IR (ATR): ߥmax = 2967 (m), 2914 (s), 2855 (m), 2728 (w), 
1650 (w), 1597 (w), 1441 (s), 1375 (s), 1330 (w), 1272 (w), 1201 (s), 1167 (w), 1100 (m), 
1080 (w), 1044 (w), 983 (w), 951 (w), 895 (m), 829 (m), 777 (w), 743 (w), 715 (w), 665 (m) 
cm−1; HRMS (EI): calc. for C15H2479Br [M-H]+: 283.1056, found: 283.1043.  
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Naphthol 22 To a stirred solution of chloride 16 (600 mg, 1.06 mmol, 1.0 eq) and proton-
sponge® (362 mg, 1.69 mmol, 1.6 eq) in CH2Cl2 (20 mL) at −78 °C was added BBr3 (1.0 M in 
CH2Cl2, 3.71 mL, 3.71 mmol, 3.5 eq) dropwise. The resulting reaction mixture was stirred at 
−78 °C for 10 min and was then allowed to warm up from −50 °C to 0 °C over 2.5 h. After 
additional stirring for 2 h at 0 °C the reaction was diluted with CH2Cl2 (20 mL) and cannulated 
to a stirred sat. aq. NaHCO3 solution (300 mL) followed by extraction with CH2Cl2 
(4 × 100 mL). The combined organic layers were dried over Na2SO4. After filtration and 
concentration in vacuo, the crude product was evaporated from MeOH (2 × 10 mL) and 
filtered over a short plug of silica (hexanes:EtOAc 1:1). The resulting crude product was 
purified by flash column chromatography (hexanes:EtOAc 80:120:1) on silica to afford 
naphthol 22 (388 mg, 701 μmol, 66%) as a slightly rose solid. 
 
Data for 22: Rf: 0.50 (hexanes:EtOAc 9:1); 1H NMR (400 MHz, C6D6): δ = 6.99 (s, 1H), 6.86 
(d, J = 2.3 Hz, 1H), 6.72 (d, J = 2.3 Hz, 1H), 5.33 (s, 1H), 3.66 (s, 3H), 1.45 – 1.34 (m, 3H), 
1.32 – 1.20 (m, 3H), 1.19 – 1.09 (m, 36H) ppm; 13C NMR (100 MHz, C6D6): δ = 155.3, 154.2, 
153.7, 150.7, 137.5, 114.4, 114.1, 109.6, 108.3, 106.6, 61.8, 18.3, 18.2, 13.8, 13.2 ppm; IR 
(ATR): ߥmax = 3544 (br w), 2946 (s), 2897 (w), 2868 (s), 1625 (m), 1608 (m), 1568 (s), 
1493 (w), 1464 (m), 1429 (w), 1382 (s), 1343 (m), 1289 (m), 1255 (w), 1187 (m), 1154 (m), 
1118 (w), 1098 (m), 1070 (m), 1014 (m), 997 (w), 965 (w), 918 (w), 882 (m), 864 (m), 
826 (m), 787 (w), 759 (w), 688 (w) cm−1; melting point: 95.8 – 98.7 °C HRMS (ESI): calc. for 
C29H50ClO4Si2 [M+H]+: 553.2931, found: 553.2933. 
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Naphthol 23 To a stirred solution of naphthol 22 (171 mg, 309 μmol, 1.0 eq) in n-hexane 
(3.4 mL) at r.t. was added NaH (60% dispersion in mineral oil, 12.4 mg, 309 μmol, 1.0 eq). 
The resulting dark purple reaction mixture was stirred for 25 min followed by the addition of 
bromide 19 (141 mg, 494 μmol, 1.6 eq). After 15 h at r.t. the reaction was quenched by 
addition of aq. phosphate buffer (pH = 8.0, 15 ml) followed by extraction with Et2O (3 × 20 
mL) and combined organic layers were dried over Na2SO4. After filtration and concentration 
in vacuo, the crude product was purified by flash column chromatography (hexanes:EtOAc 
100:1) on deactivated silica (by NEt3 flush) to afford naphthol 23 (139 mg, 183 μmol, 59%) in 
an inseparable 4:1 isomeric mixture as a colorless oil. Compound 23 was stored at −80 °C 
under argon atmosphere. 
 
Data for 23 (major isomer): Rf: 0.50 (hexanes:EtOAc 20:1);  1H NMR (400 MHz, C6D6): δ = 
7.18 (d, J = 2.2 Hz, 1H), 6.76 (d, J = 2.2 Hz, 1H), 5.74 (s, 1H), 5.20 (t, J = 6.9 Hz, 1H), 5.12 
(t, J = 7.2 Hz, 1H), 3.99 (s, 2H), 3.73 (s, 3H), 2.73 (d, J = 6.7 Hz, 2H), 2.10 – 2.02 (m, 2H), 
2.00 – 1.93 (m, 2H), 1.91 (s, 3H), 1.77 (s, 3H), 1.67 (s, 3H), 1.56 (s, 3H), 1.47 – 1.37 (m, 3H), 
1.36 – 1.26 (m, 6H), 1.22 – 1.16 (m, 36H) ppm; 13C NMR (100 MHz, C6D6): δ = 155.2, 154.1, 
152.5, 148.7, 137.4, 134.1, 131.3, 131.0, 125.7, 125.2, 123.9, 115.1, 114.4, 114.1, 109.5, 
106.0, 61.8, 40.3, 30.1, 29.9, 27.2, 25.9, 21.1, 20.9, 18.3, 18.3, 17.8, 15.9, 13.8, 13.2 ppm; 
IR (ATR): ߥmax = 3537 (br w), 2944 (s), 2926 (s), 2867 (s), 1740 (w), 1610 (s), 1572 (s), 
1495 (w), 1462 (m), 1428 (m), 1377 (s), 1348 (s), 1285 (s), 1260 (m), 1195 (m), 1164 (s), 
1106 (m), 1072 (m), 1035 (m), 1015 (m), 997 (m), 986 (m), 930 (m), 882 (s), 850 (m), 
807 (s), 759 (s), 686 (s) cm−1; HRMS (ESI): calc. for C44H72ClO4Si2 [M-H]−: 755.4663, found: 
755.4658. 
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Benzoate 24 Lead(IV) benzoate was prepared from Pb(OAc)4 according to a literature 
known procedure.170 To a stirred solution of prenylated naphthol 23 (31.0 mg, 40.9 µmol, 
1.0 eq) in CH2Cl2/TFE (1:2, 3 mL) at −40 °C was added lead(IV) benzoate (29.8 mg, 
43.0 µmol, 1.05  eq) dissolved in CH2Cl2/TFE (1:2, 3 mL) by syringe pump over 45 min. The 
reaction was quenched by addition of sat. aq. NH4Cl solution (10 mL) followed by extraction 
with Et2O (3 × 10 mL) and combined organic layers were dried over Na2SO4. After filtration 
and concentration in vacuo, the crude product was purified by flash column chromatography 
(n-pentane:EtOAc 75:1) on silica to afford benzoate 24 (12.9 mg, 14.7 µmol, 36%) in an 
inseparable 4:1 isomeric mixture as a colorless oil. 
Data for 24 (major isomer): Rf: 0.44 (hexanes:EtOAc 10:1); 1H NMR (400 MHz, CDCl3): δ = 
8.05 (d, J = 7.1 Hz, 2H), 7.56 (t, J = 7.4 Hz, 1H), 7.43 (t, J = 7.7 Hz, 2H), 6.53 (d, J = 2.4 Hz, 
1H), 6.32 (d, J = 2.4 Hz, 1H), 5.05 (t, J = 6.9 Hz, 1H), 4.92 (t, J = 6.8 Hz, 1H), 3.92 (s, 3H), 
2.88 (d, J = 13.7 Hz, 1H), 2.78 (d, J = 13.7 Hz, 1H), 2.59 (d, J = 6.6 Hz, 2H), 2.08 – 2.00 (m, 
2H), 2.00 – 1.91 (m, 2H), 1.66 (s, 3H), 1.63 (s, 3H), 1.58 (s, 6H), 1.38 (s, 3H), 1.36 – 1.27 (m, 
3H), 1.17 – 1.09 (m, 18H), 1.04 – 0.94 (m, 3H), 0.92 – 0.84 (m, 18H) ppm; 13C NMR (100 
MHz, CDCl3): δ = 190.7, 167.3, 164.5, 158.8, 155.5, 144.5, 135.5, 133.3, 133.0, 131.5, 
130.0, 129.9, 128.4, 124.8, 124.4, 122.8, 116.3, 112.2, 112.1, 110.8, 84.8, 60.8, 44.0, 39.9, 
32.5, 26.8, 25.9, 21.2, 20.9, 18.1, 17.9, 17.7, 16.3, 13.5, 12.6 ppm; IR (ATR): ߥmax = 2943 (s), 
2925 (s), 2867 (s), 1730 (m), 1688 (m), 1598 (s), 1582 (s), 1534 (w), 1464 (m), 1447 (m), 
1437 (w), 1425 (w), 1385 (w), 1350 (s), 1305 (m), 1273 (s), 1177 (s), 1144 (w), 1089 (m), 
1067 (w), 997 (w), 973 (w), 920 (w), 812 (w), 751 (w), 687 (m) cm−1; HRMS (ESI): calc. for 
C51H78ClO6Si2 [M+H]+: 877.5020, found: 877.5018. 
 
306  Supporting information for Chapter 4.2 
 
 
Triisopropylsilyl merochlorin B (26) PhIO was prepared from PhI(OAc)2 by a literature 
known procedure.171 To a stirred suspension of PhIO (45.3 mg, 206 μmol, 1.2 eq) in CH2Cl2 
(10 mL) at room temperature was added TfOH (18.1 µL, 206 μmol, 1.2 eq). After stirring for 
15 min a clear solution formed, followed by dilution with TFE (10 mL). The resulting mixture 
was added to a cloudy solution of prenylated naphthol 23 (130 mg, 172 μmol, 1.0 eq) in 
CH2Cl2/TFE (1:9, 30 mL) at −40 °C by syringe pump over 1 h. The reaction was quenched by 
addition of sat. aq. NH4Cl solution (15 mL) and H2O (15 mL) followed by extraction with Et2O 
(3 × 20 mL) and combined organic layers were dried over Na2SO4. After filtration and 
concentration in vacuo, the crude product was purified by flash column chromatography 
(pentane:EtOAc 80:1) on silica to afford crude cyclization product 26 (41.6 mg) inseparable 
from impurities as pale yellow oil. 26 was used without further purification in the next step. 
Data for 26: Rf: 0.41 (hexanes:EtOAc 20:1); HRMS (ESI): calc. for C34H50ClO4Si [M+H]+: 
585.3161, found: 585.3158. 
 
 
 
Merochlorin B (2) To a stirred solution of ketone 26 (41.6 mg, 71.1 µmol, 1.0 eq) in THF 
(10 mL) at 0 °C was added TBAF (0.1 M in THF, 0.711 ml, 71.1 µmol, 1.0 eq) and the 
resulting reaction mixture was stirred for 10 min. The reaction was quenched by addition of 
H2O (10 mL) followed by extraction with Et2O (3 × 10 mL). The combined organic layers were 
dried over Na2SO4. After filtration and concentration in vacuo, the crude product was purified 
by flash column chromatography (pentane:Et2O 4:125:10) on silica to afford 
merochlorin B (2, 21.9 mg, 51.1 µmol, 30% over 2 steps) as pale yellow wax. 
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Data for merochlorin B (2): Rf: 0.65 (hexanes:EtOAc 3:2); IR (ATR): ߥmax = 3267 (br w), 
2974 (w), 2914 (w), 2856 (w), 1643 (m), 1598 (s), 1454 (m), 1383 (w), 1326 (s), 1279 (s), 
1238 (m), 1212 (w), 1190 (m), 1160 (m), 1140 (m), 1095 (m), 1063 (s), 1023 (m), 1004 (w), 
899 (w), 875 (w), 839 (s), 804 (m), 790 (m), 748 (w), 703 (w), 668 (w)  cm−1; HRMS (ESI): 
calc. for C25H30ClO4 [M+H]+: 429.1827, found: 429.1824. 
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NMR data:154  
 
 
 
 
 
 
 
No. 
1H NMR Isolation  
500 MHz, d6-DMSO 
[ppm] 
1H NMR Synthetic 
400 MHz, d6-DMSO 
[ppm] 
13C NMR 
Isolation 
125 MHz, d6-DMSO 
[ppm] 
13C NMR 
Synthetic 
100 MHz, d6-DMSO 
[ppm] 
1   184.2 184.1 
2   105.9 105.9 
3   163.8 163.4 
4 6.17 (d, J = 2.2 Hz, 1H) 6.18 (d, J = 2.1 Hz, 1H) 101.3 101.0 
5   163.5 163.3 
6 6.15 (d, J = 2.4 Hz, 1H) 6.16 (d, J = 2.2 Hz, 1H) 103.9 103.6 
7   147.9 147.7 
8   60.2 60.1 
9 2.99 (d, J = 8.2 Hz, 1H) 3.00 (d, J = 7.9 Hz, 1H) 52.2 52.0 
10   98.1 97.9 
11   176.1 176.0 
12   99.9 99.7 
13 2.81 (d, J = 18.0 Hz, 1H) 2.48 (d, J = 18.4 Hz, 1H) 
2.82 (d, J = 18.6 Hz, 1H) 
2.48 (d, J = 18.2 Hz, 1H)* 49.3 49.1 
14   130.7 130.6 
15 2.88 (d, J = 18.6 Hz, 1H) 2.72 (d, J = 18.0 Hz, 1H) 
2.89 (d, J = 18.6 Hz, 1H) 
2.73 (d, J = 18.6 Hz, 1H) 34.6 34.4 
16 1.77 – 1.71 (m, 2H) 1.77 – 1.71 (m, 2H) 43.3 43.2 
17 2.04 – 1.92 (m, 2H) 2.04 – 1.93 (m, 2H) 22.0 21.9 
18 5.05 (t, J = 7.5 Hz, 1H) 5.05 (t, J = 7.0 Hz, 1H) 123.4 123.3 
19   131.5 131.3 
20 1.48 (s, 3H) 1.48 (s, 3H) 17.5 17.4 
21 1.57 (s, 3H) 1.57 (s, 3H) 25.5 25.4 
22 1.48 (s, 3H) 1.48 (s, 3H) 21.4 21.3 
23   125.7 125.5 
24 1.70 (s, 3H) 1.70 (s, 3H) 21.4 21.3 
25 1.41 (s, 3H) 1.41 (s, 3H) 22.3 22.1 
5-OH - 10.55 (br s, 1H) - - 
3-OH 12.9 (br s, 1H) 12.91 (br s, 1H) - - 
* This signal partially overlaps with the d6-DMSO peak. Therefore, the chemical shift and the coupling constant were determined from the COSY and HSQC spectra.   
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Verification of the relative stereochemistry: NOESY (d6-DMSO) 
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6.4.2 1H and 13C NMR spectra 
  
Supporting information for Chapter 4.2  311 
 
 
 
 
 300 MHz; CDCl3 
75 MHz, CDCl3 
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300 MHz; CDCl3 
75 MHz, CDCl3 
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600 MHz, CDCl3 
150 MHz , CDCl3 
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600 MHz, CDCl3 
150 MHz , CDCl3 
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TBSO
TBSO
OMe
OMe
15
Cl
400 MHz, CD3CN 
100 MHz, CD3CN 
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400 MHz, C6D6 
100 MHz, C6D6 
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O
EtO SiMe3
S1
300 MHz, CDCl3 
75 MHz, CDCl3 
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300 MHz, CDCl3  
O
EtO
18
75 MHz, CDCl3 
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300 MHz, CDCl3 
75 MHz, CDCl3 
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300 MHz, C6D6 
19
Br
75 MHz, C6D6 
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TIPSO
TIPSO
22
OMe
OH
Cl
400 MHz, C6D6 
100 MHz, C6D6 
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400 MHz, C6D6 
(4:1 isomeric mixture) 
100 MHz, C6D6 
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400 MHz, CDCl3 
(4:1 isomeric mixture) 
100 MHz, CDCl3 
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1H, 400 MHz, d6-DMSO 
1H, 400 MHz, d6-DMSO 
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13C, 100 MHz, d6-DMSO 
13C, 100 MHz, d6-DMSO 
326  Supporting information for Chapter 4.2 
 
 
 
 
COSY, d6-DMSO 
COSY, d6-DMSO 
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HSQC, d6-DMSO 
HSQC, d6-DMSO 
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HMBC, d6-DMSO 
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